0001638833-19-000038.txt : 20190510 0001638833-19-000038.hdr.sgml : 20190510 20190510164647 ACCESSION NUMBER: 0001638833-19-000038 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190510 DATE AS OF CHANGE: 20190510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Surgery Partners, Inc. CENTRAL INDEX KEY: 0001638833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 473620923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37576 FILM NUMBER: 19815670 BUSINESS ADDRESS: STREET 1: 310 SEVEN SPRINGS WAY STREET 2: SUITE 500 CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 615-234-5900 MAIL ADDRESS: STREET 1: 310 SEVEN SPRINGS WAY STREET 2: SUITE 500 CITY: BRENTWOOD STATE: TN ZIP: 37027 10-Q 1 a1q1910-q.htm 10-Q Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________________
Form 10-Q
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2019
or
o    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number:  001-37576
Surgery Partners, Inc.
(Exact name of registrant as specified in its charter)
Delaware
 
47-3620923
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)

310 Seven Springs Way, Suite 500
Brentwood, Tennessee 37027
(Address of principal executive offices and zip code)
(615) 234-5900
(Registrant’s telephone number, including area code) 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  x No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 
Large accelerated filer o
 
Accelerated filer x
Non-accelerated filer o
 
Smaller reporting company o
 
 
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o  No  x
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
SGRY
The Nasdaq Global Select Market
As of May 8, 2019, there were 49,428,103 shares of the registrant’s common stock outstanding.
 



SURGERY PARTNERS, INC.
FORM 10-Q
TABLE OF CONTENTS

 
 
Page
 
 
 
 
 
 
Item 1.
 
 
 
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
 
 
 
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
 
 
Item 2.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Item 4.
 
 
 
 
 
 
Item 1.
Item 1A.
Risk Factors
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.
Defaults Upon Senior Securities
Item 4.
Mine Safety Disclosures
Item 5.
Other Information
Item 6.
Exhibits




PART I - FINANCIAL INFORMATION
Item 1.  Financial Statements
SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, dollars in millions, except per share amounts)

 
 
March 31,
2019
 
December 31,
2018
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
142.5

 
$
184.3

Accounts receivable
 
294.9

 
307.6

Inventories
 
43.8

 
43.4

Prepaid expenses and other current assets
 
54.1

 
53.0

Total current assets
 
535.3

 
588.3

Property and equipment, net of accumulated depreciation of $59.9 and $56.1, respectively
 
400.1

 
426.3

Intangible assets, net
 
54.3

 
54.3

Goodwill
 
3,393.0

 
3,382.8

Investments in and advances to affiliates
 
78.5

 
78.5

Long-term deferred tax assets
 
100.9

 
109.2

Other long-term assets
 
318.8

 
36.9

Total assets
 
$
4,880.9

 
$
4,676.3

 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable
 
$
69.7

 
$
83.3

Accrued payroll and benefits
 
41.0

 
55.2

Other current liabilities
 
191.8

 
155.2

Current maturities of long-term debt
 
57.1

 
55.6

Total current liabilities
 
359.6

 
349.3

Long-term debt, less current maturities
 
2,384.6

 
2,270.9

Other long-term liabilities
 
370.0

 
271.3

 
 
 
 
 
Non-controlling interests—redeemable
 
314.6

 
326.6

Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $367.8 and $359.3, respectively
 
367.8

 
359.3

 
 
 
 
 
Stockholders' equity:
 
 
 
 
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none
 

 

Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 49,385,974 and 48,869,204, respectively
 
0.5

 
0.5

Additional paid-in capital
 
673.9

 
673.5

Accumulated other comprehensive loss
 
(33.9
)
 
(22.4
)
Retained deficit
 
(249.1
)
 
(247.0
)
Total Surgery Partners, Inc. stockholders' equity
 
391.4

 
404.6

Non-controlling interests—non-redeemable
 
692.9

 
694.3

Total stockholders' equity
 
1,084.3

 
1,098.9

Total liabilities and stockholders' equity
 
$
4,880.9

 
$
4,676.3


See notes to unaudited condensed consolidated financial statements.


1


SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, dollars in millions, except per share amounts, shares in thousands)

 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Revenues
 
$
416.8

 
$
411.3

Operating expenses:
 
 
 
 
Salaries and benefits
 
129.2

 
129.7

Supplies
 
115.0

 
114.4

Professional and medical fees
 
35.1

 
35.7

Lease expense
 
20.6

 
21.4

Other operating expenses
 
26.2

 
26.1

Cost of revenues
 
326.1

 
327.3

General and administrative expenses
 
21.7

 
24.2

Depreciation and amortization
 
18.8

 
15.7

Income from equity investments
 
(2.0
)
 
(1.9
)
Loss on disposals and deconsolidations, net
 
0.6

 

Transaction and integration costs
 
2.0

 
5.0

Other income
 

 
(0.2
)
Total operating expenses
 
367.2

 
370.1

Operating income
 
49.6

 
41.2

Tax receivable agreement expense
 
(2.4
)
 

Interest expense, net
 
(42.0
)
 
(34.3
)
Income before income taxes
 
5.2

 
6.9

Income tax expense
 
1.7

 
1.8

Net income
 
3.5

 
5.1

Less: Net income attributable to non-controlling interests
 
(23.6
)
 
(22.6
)
Net loss attributable to Surgery Partners, Inc.
 
(20.1
)
 
(17.5
)
Less: Amounts attributable to participating securities
 
(8.5
)
 
(7.8
)
Net loss attributable to common stockholders
 
$
(28.6
)
 
$
(25.3
)
 
 
 
 
 
Net loss per share attributable to common stockholders
 
 
 


Basic
 
$
(0.60
)
 
$
(0.53
)
Diluted (1)
 
$
(0.60
)
 
$
(0.53
)
Weighted average common shares outstanding
 
 
 
 
Basic
 
48,047

 
48,007

Diluted (1)
 
48,047

 
48,007

(1) The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.

See notes to unaudited condensed consolidated financial statements.



2


SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited, dollars in millions)

 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Net income
 
$
3.5

 
$
5.1

Other comprehensive income, net of tax:
 
 
 
 
Derivative activity
 
(11.5
)
 

Comprehensive (loss) income
 
$
(8.0
)
 
$
5.1

Less: Comprehensive income attributable to non-controlling interests
 
(23.6
)
 
(22.6
)
Comprehensive loss attributable to Surgery Partners, Inc.
 
$
(31.6
)
 
$
(17.5
)
See notes to unaudited condensed consolidated financial statements.



3


SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited, dollars in millions, shares in thousands)

 
 
 
 
 
 
 
Accumulated Other Comprehensive Loss
 
 
 
 
 
 
 
Common Stock
 
Additional
Paid-in Capital
 
 
Retained Deficit
 
Non-Controlling Interests—
Non-Redeemable
 
Total
 
Shares
 
Amount
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2017
48,687

 
$
0.5

 
$
695.5

 
$

 
$
(41.3
)
 
$
681.9

 
$
1,336.6

Net (loss) income

 

 

 

 
(17.5
)
 
15.9

 
(1.6
)
Equity-based compensation

 

 
2.0

 

 

 

 
2.0

Preferred dividends

 

 
(7.8
)
 

 

 

 
(7.8
)
Issuance of restricted and unrestricted shares
440

 

 

 

 

 

 

Cancellation of restricted shares
(72
)
 

 
(0.7
)
 

 

 

 
(0.7
)
Repurchase of shares
(157
)
 

 
(2.0
)
 

 

 

 
(2.0
)
Acquisition and disposal of shares of non-controlling interests, net (1)

 

 
2.0

 

 

 
(1.2
)
 
0.8

Distributions to non-controlling interests—non-redeemable holders

 

 

 

 

 
(22.5
)
 
(22.5
)
Balance at March 31, 2018
48,898

 
$
0.5

 
$
689.0

 
$

 
$
(58.8
)
 
$
674.1

 
$
1,304.8

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2018
48,869

 
$
0.5

 
$
673.5

 
$
(22.4
)
 
$
(247.0
)
 
$
694.3

 
$
1,098.9

Net (loss) income

 

 

 

 
(20.1
)
 
16.0

 
(4.1
)
Equity-based compensation

 

 
1.9

 

 

 

 
1.9

Preferred dividends

 

 
(8.5
)
 

 

 

 
(8.5
)
Other comprehensive loss

 

 

 
(11.5
)
 

 

 
(11.5
)
Issuance of restricted and unrestricted shares
593

 

 

 

 

 

 

Cancellation of restricted shares
(76
)
 

 
(1.0
)
 

 

 

 
(1.0
)
Net effect of adoption of new accounting standard (see Note 1)

 

 

 

 
18.0

 

 
18.0

Acquisition and disposal of shares of non-controlling interests, net (1)

 

 
8.0

 

 

 
6.1

 
14.1

Distributions to non-controlling interests—non-redeemable holders

 

 

 

 

 
(23.5
)
 
(23.5
)
Balance at March 31, 2019
49,386

 
$
0.5

 
$
673.9

 
$
(33.9
)
 
$
(249.1
)
 
$
692.9

 
$
1,084.3

(1) 
Includes post acquisition date adjustments.

See notes to unaudited condensed consolidated financial statements.



4


SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, dollars in millions)

 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Cash flows from operating activities:
 
 
 
 
Net income
 
$
3.5

 
$
5.1

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
Depreciation and amortization
 
18.8

 
15.7

Non-cash interest income, net
 
(0.3
)
 
(0.1
)
Non-cash lease expense
 
10.1

 

Equity-based compensation
 
1.9

 
2.0

Loss on disposals and deconsolidations, net
 
0.6

 

Deferred income taxes
 
1.3

 
1.4

Income from equity investments, net of distributions received
 
0.2

 
0.3

Changes in operating assets and liabilities, net of acquisitions and divestitures:
 
 
 
 
Accounts receivable
 
13.4

 
14.1

Other operating assets and liabilities
 
(29.0
)
 
(8.5
)
Net cash provided by operating activities
 
20.5

 
30.0

 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
Purchases of property and equipment
 
(11.8
)
 
(10.0
)
Payments for acquisitions, net of cash acquired
 
(7.6
)
 
(25.6
)
Proceeds from disposals of facilities and other assets
 
1.2

 

Other investing activities
 
(0.2
)
 
(0.8
)
Net cash used in investing activities
 
(18.4
)
 
(36.4
)
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
Principal payments on long-term debt
 
(12.9
)
 
(16.3
)
Borrowings of long-term debt
 
2.4

 
0.4

Payments of preferred dividends
 

 
(3.9
)
Distributions to non-controlling interest holders
 
(33.8
)
 
(30.9
)
Receipts (payments) related to ownership transactions with non-controlling interest holders
 
1.5

 
(0.8
)
Repurchase of shares
 

 
(2.0
)
Other financing activities
 
(1.1
)
 
(2.2
)
Net cash used in financing activities
 
(43.9
)
 
(55.7
)
Net decrease in cash, cash equivalents and restricted cash
 
(41.8
)
 
(62.1
)
Cash, cash equivalents and restricted cash at beginning of period
 
184.6

 
175.2

Cash, cash equivalents and restricted cash at end of period
 
$
142.8

 
$
113.1

See notes to unaudited condensed consolidated financial statements.


5

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


1. Organization and Summary of Accounting Policies
Organization
Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."
As of March 31, 2019, the Company owned or operated a portfolio of 123 surgical facilities, comprised of 108 ASCs and 15 surgical hospitals in 31 states. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in 84 of the surgical facilities and consolidated 106 of these facilities for financial reporting purposes.
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Boards ("FASB") Accounting Standards Codification 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of both March 31, 2019 and December 31, 2018, the consolidated VIEs include four surgical facilities, three anesthesia practices and four physician practices.
The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of March 31, 2019 and December 31, 2018, were $11.0 million and $11.2 million, respectively, and the total liabilities of the consolidated VIEs were $3.4 million and $3.6 million, respectively.
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.


6

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

A summary of the carrying amounts and fair values of the Company's long-term debt follows (in millions):
 
 
Carrying Amount
 
Fair Value
 
 
March 31,
2019
 
December 31,
2018
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
 
 
 
 
Term Loan
 
$
1,444.4

 
$
1,447.9

 
$
1,417.3

 
$
1,382.8

Senior Unsecured Notes due 2021
 
$
406.1

 
$
406.7

 
$
411.2

 
$
407.2

Senior Unsecured Notes due 2025
 
$
370.0

 
$
370.0

 
$
333.0

 
$
320.5

The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations approximate their fair values under Level 3 calculations.
In 2018, the Company entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activity"). The fair value of these derivative instruments was $33.9 million and $22.4 million at March 31, 2019 and December 31, 2018, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation. As of March 31, 2019 and December 31, 2018, the fair value of both the assets and liabilities in the SERP were $1.3 million and $1.4 million, respectively, and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.
Revenues
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
A summary of revenues by service type as a percentage of total revenues follows:
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Patient service revenues:
 
 
 
 
   Surgical facilities revenues
 
93.8
%
 
93.5
%
   Ancillary services revenues
 
4.7
%
 
4.9
%
 
 
98.5
%
 
98.4
%
Other service revenues:
 
 
 
 
   Optical services revenues
 
0.3
%
 
0.7
%
   Other revenues
 
1.2
%
 
0.9
%
 
 
1.5
%
 
1.6
%
Total revenues
 
100.0
%
 
100.0
%
Patient service revenues. This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.


7

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Other service revenues. Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
215.3

 
52.4
%
 
$
216.5

 
53.5
%
Government
 
164.9

 
40.2
%
 
156.9

 
38.8
%
Self-pay
 
10.8

 
2.6
%
 
12.8

 
3.1
%
Other (1)
 
19.8

 
4.8
%
 
18.5

 
4.6
%
Total patient service revenues
 
410.8

 
100.0
%
 
404.7

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
1.1

 
 
 
2.9

 
 
Other revenues
 
4.9

 
 
 
3.7

 
 
Total revenues
 
$
416.8

 
 
 
$
411.3

 
 
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Cash, Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.
Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both March 31, 2019 and December 31, 2018. These restricted investments represents restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities’ cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.
Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government


8

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of March 31, 2019 and December 31, 2018, the Company had a net third-party Medicaid settlements liability of $7.6 million and $4.8 million, respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient’s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were $10.6 million and $8.5 million at March 31, 2019 and December 31, 2018, respectively.
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the three months ended March 31, 2019 is included in Note 2. "Acquisitions."
A summary of activity related to goodwill for the three months ended March 31, 2019 is as follows (in millions):
Balance at December 31, 2018
 
$
3,382.8

Acquisitions, including post acquisition adjustments
 
10.2

Divestitures and deconsolidations
 

Balance at March 31, 2019
 
$
3,393.0

Derivative Instruments and Hedging Activities
In accordance with Accounting Standards Codification 815, Derivatives and Hedging, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interestsredeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.


9

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

A summary of activity related to the non-controlling interests—redeemable is as follows (in millions):
Balance at December 31, 2018
 
$
326.6

Net income attributable to non-controlling interests—redeemable
 
7.6

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
(9.3
)
Distributions to non-controlling interest—redeemable holders
 
(10.3
)
Balance at March 31, 2019
 
$
314.6

(1)
Includes post acquisition date adjustments.
Income Taxes
The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in healthcare regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.
The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company’s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.
The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was $18.0 million reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.
The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company’s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.


10

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

2. Acquisitions
During the three months ended March 31, 2019, the Company paid cash consideration of $7.6 million for acquisitions, which primarily consisted of a physician practice. The acquisition was funded through cash from operations. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):
Cash consideration
 
$
7.6

Fair value of non-controlling interests
 
3.7

Aggregate acquisition date fair value
 
$
11.3

Net assets acquired:
 
 
Current Assets
 
$
0.6

Property and equipment
 
0.2

Goodwill
 
10.6

Current liabilities
 
(0.1
)
Aggregate acquisition date fair value
 
$
11.3

The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the three months ended March 31, 2019, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2018. The goodwill acquired was primarily allocated to the Company's ancillary services reportable segment. The results of operations of the acquisitions are included in the Company’s results of operations beginning on the dates of acquisition, and were not considered significant for the three months ended March 31, 2019.
3. Long-Term Debt
A summary of long-term debt is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Revolver
 
$

 
$

Term Loan (1)
 
1,444.4

 
1,447.9

Senior Unsecured Notes due 2021 (2)

406.1

 
406.7

Senior Unsecured Notes due 2025
 
370.0

 
370.0

Notes payable and secured loans
 
79.3

 
79.4

Finance lease obligations (3)
 
144.6

 
25.4

Less: unamortized debt issuance costs and original issue discount
 
(2.7
)
 
(2.9
)
Total debt
 
2,441.7

 
2,326.5

Less: Current maturities
 
57.1

 
55.6

Total long-term debt
 
$
2,384.6

 
$
2,270.9

(1)
Includes unamortized fair value discount of $5.4 million and $5.5 million as of March 31, 2019 and December 31, 2018, respectively.
(2)
Includes unamortized fair value premium of $6.1 million and $6.7 million as of March 31, 2019 and December 31, 2018, respectively.
(3)
In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."
4. Leases
On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted.


11

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities.
The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years, and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at March 31, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Balance Sheets
 
March 31, 2019
Assets:
 
 
 
 
Operating lease assets
 
Other long-term assets
 
$
288.3

Finance lease assets
 
Property and equipment, net of accumulated depreciation
 
144.0

Total leased assets
 
 
 
$
432.3

 
 
 
 
 
Liabilities:
 
 
 
 
Operating lease liabilities:
 
 
 
 
Current
 
Other current liabilities
 
$
36.6

Long-term
 
Other long-term liabilities
 
255.7

Total operating lease liabilities
 
 
 
292.3

Finance lease liabilities:
 
 
 
 
Current
 
Current maturities of long-term debt
 
10.2

Long-term
 
Long-term debt, less current maturities
 
134.4

Total finance lease liabilities
 
 
 
144.6

Total lease liabilities
 

 
$
436.9



12

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the three months ended March 31, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Statement of Operations
 
March 31, 2019
 
 
 
 
 
Operating lease costs
 
Lease expense and general and administrative expenses
 
$
17.5

Finance lease costs
 
 
 
 
Amortization of leased assets
 
Depreciation and amortization
 
4.5

Interest on lease liabilities
 
Interest expense, net
 
3.8

Total finance lease costs
 
 
 
8.3

Variable and short term lease costs
 
Lease expense and general and administrative expenses
 
2.4

Total lease costs
 
 
 
$
28.2

During the three months ended March 31, 2019, the Company incurred lease expense of $5.2 million under operating lease agreements with physician investors who are related parties. During the three months ended March 31, 2019, the Company paid rent of $1.6 million under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.
The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):
 
 
March 31, 2019
Weighted-average remaining lease term (years)
 
 
Operating leases
 
8.4

Finance leases
 
13.4

Weighted-average discount rate
 
 
Operating leases
 
10.2
%
Finance leases
 
10.8
%
 
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Operating cash outflows from operating leases
 
$
16.8

Operating cash outflows from finance leases
 
$
3.8

Financing cash outflows from finance leases
 
$
2.3

 
 
 
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases
 
$
1.2

Finance leases
 
$
2.3

Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
51.2

 
$
20.4

2020
 
60.6

 
24.8

2021
 
52.9

 
22.9

2022
 
48.5

 
20.3

2023
 
45.1

 
18.4

Thereafter
 
187.5

 
187.4

Total lease payments
 
445.8

 
294.2

Less: imputed interest
 
(153.5
)
 
(149.6
)
Total lease obligations
 
$
292.3

 
$
144.6



13

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portions of the finance obligations were $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
5. Redeemable Preferred Stock
On August 31, 2017, the Company issued 310,000 shares of Series A Preferred Stock to Bain at a purchase price of $1,000 per share for an aggregate purchase price of $310.0 million (the "Preferred Private Placement").
A summary of activity related to the redeemable preferred stock follows (in millions):
Balance at December 31, 2018
 
$
359.3

Dividends accrued
 
8.5

Cash dividends declared
 

Balance at March 31, 2019
 
$
367.8

There were no unpaid cash dividends declared at both March 31, 2019 and December 31, 2018. The aggregate and per share amounts of unpaid cumulative preferred dividends as of March 31, 2019 was $42.3 million and $136.31, respectively.
6. Derivatives and Hedging Activities
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During the first quarter of 2019, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company’s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. Over the next 12 months, the Company estimates that an additional $6.6 million will be reclassified as a reduction to interest expense.
As of both March 31, 2019 and December 31, 2018, the Company had three interest rate swaps with a current notional amount of $900.0 million and a termination date of November 30, 2023. The Company classifies its derivative financial instruments as a long-term liability included in other long-term liabilities in the condensed consolidated balance sheets.
For the three months ended March 31, 2019, the Company incurred losses related to the effective portion of derivatives, which were recognized in accumulated other comprehensive income, gross of tax effect, of $12.8 million. For the three months ended March 31, 2019, the Company reclassified $1.3 million of losses from accumulated other comprehensive income to interest expense, gross of tax effect. The Company held no derivative financial instruments during the three months ended March 31, 2018.


14

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

7. Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with ASC 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.
A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Numerator:
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
 
$
(20.1
)
 
$
(17.5
)
Less: amounts allocated to participating securities (1)
 
(8.5
)
 
(7.8
)
Net loss attributable to common stockholders
 
$
(28.6
)
 
$
(25.3
)
 
 
 
 
 
Denominator:
 
 
 
 
Weighted average shares outstanding- basic
 
48,047

 
48,007

Effect of dilutive securities (2)
 

 

Weighted average shares outstanding- diluted
 
48,047

 
48,007

 
 
 
 
 
Loss per share:
 
 
 
 
Basic
 
$
(0.60
)
 
$
(0.53
)
Diluted (2)
 
$
(0.60
)
 
$
(0.53
)
 
 
 
 
 
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
 
 
 
 
Stock options
 

 
123

Restricted shares
 
18

 
58

Convertible preferred stock
 
N/A

 
N/A

(1)
Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.
(2)
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
Share Repurchase Transactions
On December 15, 2017, the Company's Board of Directors authorized a share repurchase program of up to $50.0 million of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
There were no share repurchases under the share repurchase program during the three months ended March 31, 2019. During the three months ended March 31, 2018, the Company repurchased 156,818 shares of its common stock stock at an average price of $12.64 per share through market purchases. At March 31, 2019, the Company had $46.0 million of repurchase authorization available under the December 2017 authorization.


15

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

8. Other Assets and Liabilities
Other Long-Term Assets
A summary of other long-term assets is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease assets
 
$
288.3

 
$

Other
 
30.5

 
36.9

Total
 
$
318.8

 
$
36.9

Other Current Liabilities
A summary of other current liabilities is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Accrued legal settlement
 
$
42.2

 
$
42.3

Right-of-use operating lease liabilities
 
36.6

 

Interest payable
 
23.1

 
20.8

Amounts due to patients and payors
 
19.4

 
20.0

Accrued expenses and other
 
70.5

 
72.1

Total
 
$
191.8

 
$
155.2

Other Long-Term Liabilities
A summary of other long-term liabilities is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease liabilities
 
$
255.7

 
$

Facility lease obligations
 

 
149.8

Other
 
114.3

 
121.5

Total
 
$
370.0

 
$
271.3

At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.
9. Commitments and Contingencies
Professional, General and Workers' Compensation Liability Risks
The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains


16

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.
Insurance Reserves
The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i) claims made during the policy period, which are offset by insurance recoveries and (ii) an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of March 31, 2019 and December 31, 2018 were $18.5 million and $18.2 million, respectively. The balances include expected insurance recoveries of $12.0 million at each of March 31, 2019 and December 31, 2018.
Laws and Regulations
Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.
On October 23, 2017, the Company received several civil investigative demands (“CIDs”) from the federal government under the False Claims Act (“FCA”) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company’s physicians and submitted to laboratories owned and operated by the Company. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS. The Company has been providing information to the government in response to the CIDs and currently has a non-binding agreement in principle with the DOJ on the financial terms of a settlement with the goal of resolving these matters. Based on those discussions, which are still ongoing, the Company recorded a litigation-related charge of $46.0 million relating to these matters on the consolidated statements of operations for the year ended December 31, 2018. The Company believes that this reserve is sufficient to cover a potential resolution with the government relating to these matters, including legal expenses relating to the settlement that have not previously been recorded in operating expenses. The ultimate timing, amount and/or final terms of any such resolution may differ materially from those anticipated or the Company may not be able to reach a resolution at all. It is reasonably possible that the Company will incur additional losses above the amount reserved, but the Company is not able to estimate such amounts at this time. See Item 1A “Risk Factors” in the Company's Annual Report on Form 10-K for the period ended December 31, 2018 under the heading “Risk Factors - Risks Related to Government Regulation - Companies within the healthcare industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims.” 
Acquired Facilities
The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.
The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.


17

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Potential Physician Investor Liability
A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.
Tax Receivable Agreement
On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the “TRA”), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company’s projected realized tax savings over the next six years and are not dependent on the Company’s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 500 basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.
Assuming the Company’s effective tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately $68.2 million and $64.6 million as of March 31, 2019 and December 31, 2018, respectively. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company’s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $52.6 million and $48.5 million as of March 31, 2019 and December 31, 2018, respectively. The current portion of the liability was $8.1 million and $7.6 million as of March 31, 2019 and December 31, 2018, respectively, and was included as a component of other current liabilities in the condensed consolidated balance sheet. The long-term portion was included as a component of other long-term liabilities in the condensed consolidated balance sheets.


18

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

10. Segment Reporting
The Company operates in three major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. The surgical facility services segment consists of the operation of ASCs and surgical hospitals, and includes anesthesia services. The ancillary services segment consists of a diagnostic laboratory and multi-specialty physician practices. The optical services segment consists of an optical products group purchasing organization. "All other" primarily consists of the Company's corporate general and administrative functions.
The following tables present financial information for each reportable segment (in millions):

 
Three Months Ended March 31,

 
2019
 
2018
Revenues:
 
 
 
 
Surgical facility services
 
$
395.8

 
$
388.2

Ancillary services
 
19.9

 
20.1

Optical services
 
1.1

 
3.0

Total
 
$
416.8

 
$
411.3

 
 
 
 
 
Adjusted EBITDA:
 
 
 
 
Surgical facility services
 
$
68.4

 
$
66.5

Ancillary services
 
1.2

 
1.1

Optical services
 
0.5

 
0.8

All other
 
(19.4
)
 
(21.3
)
Total
 
$
50.7

 
$
47.1

 
 
 
 
 
Cash purchases of property and equipment, net:
 
 
 
 
Surgical facility services
 
$
10.9

 
$
7.9

Ancillary services
 
0.1

 
0.2

Optical services
 

 

All other
 
0.8

 
1.9

Total
 
$
11.8

 
$
10.0

A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows (in millions):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Adjusted EBITDA
 
$
50.7

 
$
47.1

Net income attributable to non-controlling interests
 
23.6

 
22.6

Depreciation and amortization
 
(18.8
)
 
(15.7
)
Interest expense, net
 
(42.0
)
 
(34.3
)
Equity-based compensation
 
(1.9
)
 
(2.0
)
Contingent acquisition compensation expense
 

 
(0.5
)
Transaction, integration and acquisition costs (1)
 
(3.4
)
 
(5.5
)
Reserve adjustments (2)
 

 
(4.8
)
Loss on disposals and deconsolidations, net
 
(0.6
)
 

Tax receivable agreement expense
 
(2.4
)
 

Income before income taxes
 
$
5.2

 
$
6.9

(1)
This amount includes transaction and integration costs of $2.0 million and $5.0 million for three months ended March 31, 2019 and 2018, respectively. This amount includes acquisition costs of $0.2 million and $0.5 million for three months ended March 31, 2019 and 2018, respectively. This amount includes start-up costs related to a de novo surgical hospital of $1.2 million for the three months ended March 31, 2019. There were no comparable costs in the 2018 period.


19

SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.
 
 
March 31,
2019
 
December 31,
2018
Assets:
 
 
 
 
Surgical facility services
 
$
4,417.8

 
$
4,204.3

Ancillary services
 
82.3

 
52.7

Optical services
 
22.3

 
20.1

All other
 
358.5

 
399.2

Total assets
 
$
4,880.9

 
$
4,676.3

11. Subsequent Events
As previously disclosed in a Current Report on Form 8-K filed on April 12, 2019, on April 11, 2019, the Company completed the issuance and sale of $430.0 million in gross proceeds of senior unsecured notes due 2027 (the "2027 Unsecured Notes"). The 2027 Unsecured Notes bear interest at the rate of 10.000% per year, payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2019. The 2027 Unsecured Notes are senior unsecured obligations of Surgery Center Holdings, Inc. and are guaranteed on a senior unsecured basis by each of Surgery Center Holdings, Inc.'s existing and future domestic wholly-owned restricted subsidiaries that guarantees the existing 2017 Senior Secured Credit Facilities (subject to certain exceptions). In connection with issuance of the 2027 Unsecured Notes, the Company redeemed in whole the existing 2021 Unsecured Notes. The redemption price was equal to 104.438% of the outstanding principal amount plus accrued and unpaid interest. Additionally, as previously announced, on March 25, 2019, the Company entered into an amendment to the credit agreement governing its revolving credit facility. On April 11, 2019, in connection with the completion of the issuance of the 2027 Unsecured Notes, the outstanding commitments under the Company's revolving credit facility were increased by $45.0 million.


20


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report and included in our Annual Report on Form 10-K for the year ended December 31, 2018. Unless the context otherwise indicates, the terms "Surgery Partners," "we," "us," "our" or the "Company," as used herein, refer to Surgery Partners, Inc. and its subsidiaries. Unless the context implies otherwise, the term “affiliates” means direct and indirect subsidiaries of Surgery Partners, Inc., and partnerships and joint ventures in which such subsidiaries are partners. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of Surgery Partners, Inc. and the term “employees” refers to employees of affiliates of Surgery Partners, Inc.
Cautionary Note Regarding Forward-Looking Statements
This report contains forward-looking statements, which are based on our current expectations, estimates and assumptions about future events. All statements other than statements of current or historical fact contained in this report are forward-looking statements. These statements include, but are not limited to, statements regarding our future financial position, business strategy, budgets, effective tax rate, projected costs and plans and objectives of management for future operations. The words "projections," "believe," "continue," "drive," "estimate," "expect," "intend," "may," "plan," "will," "could," "would" and similar expressions are generally intended to identify forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results to differ from the expectations expressed in the statements. Many of these factors are beyond our ability to control or predict. These factors include, without limitation, our ability to execute on our operational and strategic initiatives, the timing and impact of our portfolio optimization efforts, our ability to continue to improve same-facility volume and revenue growth on the timeline anticipated, if at all, our ability to successfully integrate acquisitions, the anticipated impact and timing of our ongoing efficiency efforts, including insurance consolidations and completed headcount actions, as well as our ongoing procurement and revenue cycle efforts, the impact of adverse weather conditions and other events outside of our control, whether or not a settlement is reached with the  government relating to the previously disclosed investigation, the terms of any such settlement and the ongoing cost of complying with the terms of any such settlement, and the risks and uncertainties set forth under the heading "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 15, 2019 and discussed from time to time in our reports filed with the SEC.
In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. When you consider these forward-looking statements, you should keep in mind these risk factors and other cautionary statements in this report.
These forward-looking statements speak only as of the date made. Other than as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Executive Overview
We continue to focus on improving our same-facility performance, selectively acquiring established facilities and developing new facilities. During the three months ended March 31, 2019, we completed the acquisition of a physician practice and other assets for an investment of $7.6 million.
Revenues
Our revenues consist of patient service revenues and other service revenues. Patient service revenues consist of revenue from our surgical facility services and ancillary services segments. Specifically, patient service revenues include fees for surgical or diagnostic procedures performed at surgical facilities that we consolidate for financial reporting purposes, as well as for patient visits to our physician practices, anesthesia services, pharmacy services and diagnostic screens ordered by our physicians. Other service revenues consist of discounts and handling charges billed to the members of our optical products purchasing organization. Other service revenues also include management and administrative service fees derived from our non-consolidated facilities that we account for under the equity method, management of surgical facilities and physician practices in which we do not own an interest and management services we provide to physician practices for which we are not required to provide capital or additional assets.


21


The following table summarizes our revenues by service type as a percentage of total revenues for the periods indicated:
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Patient service revenues:
 
 
 
 
Surgical facilities revenues
 
93.8
%
 
93.5
%
Ancillary services revenues
 
4.7
%
 
4.9
%
 
 
98.5
%
 
98.4
%
Other service revenues:
 
 
 
 
Optical services revenues
 
0.3
%
 
0.7
%
Other
 
1.2
%
 
0.9
%
 
 
1.5
%
 
1.6
%
Total revenues
 
100.0
%
 
100.0
%
Payor Mix
The following table sets forth by type of payor the percentage of our patient service revenues generated at the surgical facilities which we consolidate for financial reporting purposes in the periods indicated:
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Private insurance payors
 
52.4
%
 
53.5
%
Government payors
 
40.2
%
 
38.8
%
Self-pay payors
 
2.6
%
 
3.1
%
Other payors (1)
 
4.8
%
 
4.6
%
Total
 
100.0
%
 
100.0
%
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Surgical Case Mix
We primarily operate multi-specialty surgical facilities where physicians perform a variety of procedures in various specialties. We believe this diversification helps to protect us from adverse pricing and utilization trends in any individual procedure type and results in greater consistency in our case volume.
The following table sets forth the percentage of cases in each specialty performed at the surgical facilities which we consolidate for financial reporting purposes for the periods indicated:
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Gastrointestinal
 
21.1
%
 
21.1
%
General surgery
 
3.1
%
 
3.1
%
Ophthalmology
 
23.7
%
 
25.8
%
Orthopedic and pain management
 
37.4
%
 
37.6
%
Other
 
14.7
%
 
12.4
%
Total
 
100.0
%
 
100.0
%


22


Case Growth
Same-facility Information
Same-facility information includes cases and revenues from our consolidated and non-consolidated surgical facilities (excluding facilities acquired in new markets or divested during the current and prior period).

 
Three Months Ended March 31,

 
2019
 
2018

 
 
 
 
Cases
 
131,794

 
130,962

Case growth
 
0.6
%
 
N/A

Revenue per case
 
$
3,239

 
$
3,104

Revenue per case growth
 
4.3
%
 
N/A

Number of work days in the period
 
63

 
64

Case growth (days adjusted)
 
2.2
%
 
N/A

Revenue growth (days adjusted)
 
6.7
%
 
N/A

Number of facilities
 
110

 
N/A

Accounts Receivable
Our patient service revenues and other receivables from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of our surgical facilities’ cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, we expect that any such changes would be minimal and, therefore, would not have a material effect on our financial condition or results of operations.
Our collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage our patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. We analyze accounts receivable at each of our surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required. Our days sales outstanding were 63 days for both the three months ended March 31, 2019 and the year ended December 31, 2018.
Critical Accounting Policies
A summary of significant accounting policies is disclosed in our 2018 Annual Report on Form 10-K under the caption “Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. There have been no material changes in the nature of our critical accounting policies or the application of those policies since December 31, 2018.


23


Results of Operations
Three Months Ended March 31, 2019 Compared to Three Months Ended March 31, 2018
The following table summarizes certain results from the statements of operations for the three months ended March 31, 2019 and 2018. The table also shows the percentage relationship to revenues for the periods indicated (dollars in millions):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Revenues
 
$
416.8

 
$
411.3

Operating expenses:
 
 
 
 
Cost of revenues
 
326.1

 
327.3

General and administrative expenses
 
21.7

 
24.2

Depreciation and amortization
 
18.8

 
15.7

Income from equity investments
 
(2.0
)
 
(1.9
)
Loss on disposals and deconsolidations, net
 
0.6

 

Transaction and integration costs
 
2.0

 
5.0

Other income
 

 
(0.2
)
Total operating expenses
 
367.2

 
370.1

Operating income
 
49.6

 
41.2

Tax receivable agreement expense
 
(2.4
)
 

Interest expense, net
 
(42.0
)
 
(34.3
)
Income before income taxes
 
5.2

 
6.9

Income tax expense
 
1.7

 
1.8

Net income
 
3.5

 
5.1

Less: Net income attributable to non-controlling interests
 
(23.6
)
 
(22.6
)
Net loss attributable to Surgery Partners, Inc.
 
$
(20.1
)
 
$
(17.5
)
Overview. During the three months ended March 31, 2019, our revenues increased 1.3% to $416.8 million compared to $411.3 million for the three months ended March 31, 2018. We incurred a net loss attributable to Surgery Partners, Inc. of $20.1 million for the 2019 period, compared to $17.5 million for the 2018 period.
Revenues. Revenues for the three months ended March 31, 2019 compared to the three months ended March 31, 2018 were as follows (dollars in millions):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Patient service revenues
 
$
410.8

 
$
404.7

Optical service revenues
 
1.1

 
2.9

Other service revenues
 
4.9

 
3.7

Total revenues
 
$
416.8

 
$
411.3

Patient service revenues increased 1.5% to $410.8 million for the three months ended March 31, 2019 compared to $404.7 million for the three months ended March 31, 2018.
Cost of Revenues. Cost of revenues were $326.1 million for the three months ended March 31, 2019 compared to $327.3 million for the three months ended March 31, 2018. As a percentage of revenues, cost of revenues were 78.2% for the 2019 period and 79.6% for the 2018 period.
General and Administrative Expenses. General and administrative expenses were $21.7 million for the three months ended March 31, 2019 compared to $24.2 million for the three months ended March 31, 2018. The decrease is primarily due to a decrease in contingent acquisition compensation expense. As a percentage of revenues, general and administrative expenses decreased to 5.2% for the 2019 period compared to 5.9% for the 2018 period.


24


Depreciation and Amortization. Depreciation and amortization was $18.8 million and $15.7 million for the three months ended March 31, 2019 and 2018, respectively. As a percentage of revenues, depreciation and amortization expenses increased to 4.5% for the 2019 period compared to 3.8% for the 2018 period.
Income from Equity Investments. Income from equity investments was $2.0 million and $1.9 million for the three months ended March 31, 2019 and 2018, respectively.
Transaction and Integration Costs. We incurred $2.0 million of transaction and integration costs for the three months ended March 31, 2019 compared to $5.0 million for the three months ended March 31, 2018. The decrease is primarily relates to reduced reorganization costs as we complete our planned investment in our infrastructure and the integration of acquisitions Surgery Partners completed in 2017.
Interest Expense, Net. Interest expense, net, increased 22.4%, to $42.0 million for the three months ended March 31, 2019 compared to $34.3 million for the three months ended March 31, 2018. The increase primarily relates to the $180.0 million senior secured incremental term loan, which was fully funded on October 23, 2018. As a percentage of revenues, interest expense, net increased to 10.1% for the 2019 period compared to 8.3% for the 2018 period.
Income Tax Expense.  The income tax expense was $1.7 million and $1.8 million for the three months ended March 31, 2019 and 2018, respectively. The effective tax rate was 32.7% for the three months ended March 31, 2019 compared to 26.1% for the three months ended March 31, 2018. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.
Net Income Attributable to Non-Controlling Interests. Net income attributable to non-controlling interests was $23.6 million for the three months ended March 31, 2019 compared to $22.6 million for the three months ended March 31, 2018. As a percentage of revenues, net income attributable to non-controlling interests was 5.7% in the 2019 period and 5.5% for the 2018 period.
Liquidity and Capital Resources
Operating Activities
The primary source of our operating cash flow is the collection of accounts receivable from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and individuals. During the three months ended March 31, 2019, our cash flow provided by operating activities was $20.5 million compared to $30.0 million in the three months ended March 31, 2018 primarily due to the timing of certain payroll and trade payable payments.
Investing Activities
Net cash used in investing activities during the three months ended March 31, 2019 was $18.4 million, which included $11.8 million related to purchases of property and equipment. We additionally paid $7.6 million in cash for acquisitions, which primarily included a physician practice.
Net cash used in investing activities during the three months ended March 31, 2018 was $36.4 million, which included $10.0 million related to purchases of property and equipment. Additionally, we purchased two surgical facilities and a physician practice for an aggregate purchase price of approximately $25.6 million (net of cash acquired).
Financing Activities
Net cash used in financing activities during the three months ended March 31, 2019 was $43.9 million. During this period, we made distributions to non-controlling interest holders of $33.8 million and received cash related to ownership transactions with consolidated affiliates of $1.5 million. Further, we made repayments on our long-term debt of $12.9 million, which was offset by borrowings of $2.4 million.
Net cash used in financing activities during the three months ended March 31, 2018 was $55.7 million. During this period, we made distributions to non-controlling interest holders of $30.9 million and paid cash related to ownership transactions with consolidated affiliates of $0.8 million. Further, we made repayments on our long-term debt of $16.3 million offset by borrowings of $0.4 million. In addition, we made preferred dividend payments of $3.9 million and repurchased $2.0 million of our common stock pursuant to our $50 million repurchase program announced on December 15, 2017.
Debt
As of March 31, 2019, the carrying value of our total indebtedness, was $2.442 billion, which includes net unamortized fair value premium of $0.7 million and unamortized deferred financing costs of $2.7 million.
2017 Senior Secured Credit Facilities
We have term loan borrowings with a carrying value of $1.444 billion, consisting of outstanding aggregate principal of $1.450 billion and unamortized fair value discount of $5.4 million (the "Term Loan"). The Term Loan matures on August 31, 2024. The Term Loan amortizes in equal quarterly installments of 0.25% of the aggregate original principal amount of the Term Loan.
We have a revolving credit facility providing for revolving borrowings of up to $75.0 million (the "Revolver" and, together with the Term Loan, the "2017 Senior Secured Credit Facilities"). The Revolver will mature on August 31, 2022. As of March 31, 2019, our availability on


25


the Revolver was $70.9 million (including outstanding letters of credit of $4.1 million). As disclosed in Note 11. "Subsequent Events" included in the Notes to the Condensed Consolidated Financial Statements elsewhere in this report, on April 11, 2019, in connection with the completion of the issuance of the 2027 Unsecured Notes (defined below), the outstanding commitments under the Company's revolving credit facility were increased by $45.0 million.
The Revolver may be utilized for working capital, capital expenditures and general corporate purposes. Subject to certain conditions and requirements set forth in the credit agreement, we may request one or more additional incremental term loan facilities or one or more increases in the commitments under the Revolver.
The 2017 Senior Secured Credit Facilities bear interest at a rate per annum equal to (x) LIBOR plus a margin ranging from 3.00% to 3.25% per annum, depending on our first lien net leverage ratio or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) 0.5% per annum above the federal funds effective rate and (iii) one-month LIBOR plus 1.00% per annum (solely with respect to the Term Loan, the alternate base rate shall not be less than 2.00% per annum)) plus a margin ranging from 2.00% to 2.25% per annum. In addition, we are required to pay a commitment fee of 0.50% per annum in respect of unused commitments under the Revolver.
Senior Unsecured Notes
We have senior unsecured notes due April 15, 2021 with a carrying value of $406.1 million, consisting of outstanding aggregate principal of $400.0 million and unamortized fair value premium of $6.1 million (the "2021 Unsecured Notes"). The 2021 Unsecured Notes bear interest at the rate of 8.875% per year, payable semi-annually on April 15 and October 15 of each year.
As disclosed in Note 11. "Subsequent Events" to the Condensed Consolidated Financial Statements elsewhere in this report, on April 11, 2019, the Company completed the issuance and sale of $430.0 million in gross proceeds of senior unsecured notes due 2027 (the "2027 Unsecured Notes"). In connection with issuance of the 2027 Unsecured Notes, the Company redeemed in whole the existing 2021 Unsecured Notes. The redemption price was equal to 104.438% of the outstanding principal amount plus accrued and unpaid interest.
We have $370.0 million aggregate principal amount of senior unsecured notes due July 1, 2025 outstanding (the "2025 Unsecured Notes"). The 2025 Unsecured Notes bear interest at the rate of 6.750% per year, payable semi-annually on January 1 and July 1 of each year.
Other Debt
We and certain of our subsidiaries have other debt consisting of outstanding bank indebtedness of $79.3 million, which is collateralized by the real estate and equipment owned by the surgical facilities to which the loans were made, and right-of-use finance lease obligations of $144.6 million for which we are liable to various vendors for several property and equipment leases classified as finance leases.
Summary
Based on our current level of operations, we believe cash flow from operations and available cash, together with available borrowings under the Revolver, will be adequate to meet our short-term (12 months or less) liquidity needs.
Certain Non-GAAP Metrics
Adjusted EBITDA is not a measurement of financial performance under GAAP, and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with GAAP. The items excluded from this non-GAAP metric are significant components in understanding and evaluating our financial performance. We believe such adjustments are appropriate, as the magnitude and frequency of such items can vary significantly and are not related to the assessment of normal operating performance. Our calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.
When we use the term "Adjusted EBITDA," we are referring to income before income taxes, adjusted for net income attributable to non-controlling interests, depreciation and amortization, interest expense, net, equity-based compensation expense, contingent acquisition compensation expense, transaction, integration and acquisition costs, reserve adjustments, net loss on disposals and deconsolidations and tax receivable agreement expense. We use Adjusted EBITDA as a measure of financial performance. Adjusted EBITDA is a key measure used by our management to assess operating performance, make business decisions and allocate resources.


26


The following table reconciles EBITDA and Adjusted EBITDA to income before income taxes, the most directly comparable GAAP financial measure (in millions and unaudited):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Condensed Consolidated Statements of Operations Data:
 
 
 
 
Income before income taxes
 
$
5.2

 
$
6.9

Plus (minus):
 
 
 
 
Net income attributable to non-controlling interests
 
(23.6
)
 
(22.6
)
Depreciation and amortization
 
18.8

 
15.7

Interest expense, net
 
42.0

 
34.3

Equity-based compensation
 
1.9

 
2.0

Contingent acquisition compensation expense
 

 
0.5

Transaction, integration and acquisition costs (1)
 
3.4

 
5.5

Reserve adjustments (2)
 

 
4.8

Loss on disposals and deconsolidations, net
 
0.6

 

Tax receivable agreement expense
 
2.4

 

Adjusted EBITDA
 
$
50.7

 
$
47.1

(1)
This amount includes transaction and integration costs of $2.0 million and $5.0 million for three months ended March 31, 2019 and 2018, respectively. This amount includes acquisition costs of $0.2 million and $0.5 million for three months ended March 31, 2019 and 2018, respectively. This amount includes start-up costs related to a de novo surgical hospital of $1.2 million for the three months ended March 31, 2019. There were no comparable costs in the 2018 period.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies to businesses acquired by Surgery Partners in prior periods.
We use Credit Agreement EBITDA as a measure of liquidity and to determine our compliance under certain covenants pursuant to our credit facilities. Credit Agreement EBITDA is determined on a trailing twelve-month basis. We have included it because we believe that it provides investors with additional information about our ability to incur and service debt and make capital expenditures. Credit Agreement EBITDA is not a measurement of liquidity under GAAP, and should not be considered in isolation or as a substitute for any other measure calculated in accordance with GAAP. The items excluded from Credit Agreement EBITDA are significant components in understanding and evaluating our liquidity. Our calculation of Credit Agreement EBITDA may not be comparable to similarly titled measures reported by other companies.
When we use the term “Credit Agreement EBITDA,” we are referring to Adjusted EBITDA, as defined above, further adjusted for other items related to our historical financial performance during the trailing twelve month period, including loss on litigation settlement. Also included are adjustments for acquisitions and non-cash expenses. These adjustments do not relate to our historical financial performance and instead relate to estimates compiled by our management and calculated in conformance with the definition of “Consolidated EBITDA” used in the credit agreements governing our credit facilities.


27


The following table reconciles Credit Agreement EBITDA to cash flows from operating activities, the most directly comparable GAAP financial measure (in millions and unaudited):
 
 
Twelve Months Ended March 31, 2019
 
 
 
Cash flows from operating activities
 
$
135.1

Plus (minus):
 
 
Non-cash interest income, net
 
1.6

Non-cash lease expense
 
(10.1
)
Deferred income taxes
 
(25.2
)
Income from equity investments, net of distributions received
 
(0.1
)
Changes in operating assets and liabilities, net of acquisitions and divestitures
 
(12.0
)
Income tax expense
 
26.4

Net income attributable to non-controlling interests
 
(111.1
)
Interest expense, net
 
154.7

Transaction, integration and acquisition costs
 
31.8

Loss on litigation settlements
 
46.0

Reserve adjustments
 
(2.1
)
Contingent acquisition compensation expense
 
1.0

Tax receivable agreement expense
 
2.4

Acquisitions (1)
 
38.0

Credit Agreement EBITDA
 
$
276.4

(1)
Represents impact of acquired anesthesia entities, physician practices and surgical facilities as if each acquisition had occurred on April 1, 2018 including cost savings from reductions in corporate overhead, supply chain rationalization, enhanced physician engagement, improved payor contracting and revenue synergies associated with the NSH Holdco, Inc. acquisition. Further, this includes revenue synergies from other business initiatives and an adjustment for the effects of adopting the new lease accounting standard, as defined in the Credit Agreement.
Recent Accounting Pronouncements
Please refer to Note 1 to our condensed consolidated financial statements included elsewhere in this report for a discussion of the impact of the adoption of recently issued accounting standards.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are subject to market risk primarily from exposure to changes in interest rates based on our financing, investing and cash management activities. We utilize a balanced mix of maturities along with both fixed rate and variable rate debt to manage our exposures to changes in interest rates. Additionally, we periodically enter into interest rate swap agreements to manage our exposure to interest rate fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income.
Our variable rate debt instruments are primarily indexed to the prime rate or LIBOR. Interest rate changes would result in gains or losses in the market value of our fixed rate debt portfolio due to differences in market interest rates and the rates at the inception of the debt agreements. At March 31, 2019, we had outstanding principal amount of debt of $1.454 billion in variable rate instruments. Assuming a hypothetical 100 basis points increase in LIBOR on our debt as of March 31, 2019, our quarterly interest expense would increase by approximately $3.6 million. Although there can be no assurances that interest rates will not change significantly, we do not expect changes in interest rates to have a material effect on our net earnings or cash flows in 2019 based on our indebtedness at March 31, 2019.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
An evaluation was performed under the supervision and with the participation of our management, including the chief executive officer and the chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)


28


under the Securities and Exchange Act of 1934, as amended) as of March 31, 2019. Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended March 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


29


PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Stockholder Litigation. On December 4, 2017, a purported Company stockholder filed an action in the Delaware Court of Chancery (the “Delaware Action”). That action is captioned Klein v. H.I.G. Capital, L.L.C., et al., C.A. No. 2017-0862. The plaintiff in the Delaware Action asserted claims against (i) certain current and former members of the Company’s Board of Directors (together, the “Directors”); (ii) H.I.G. Capital, LLC and certain of its affiliates (collectively, “H.I.G.”); and (iii) Bain Capital Private Equity, L.P. and certain of its affiliates (collectively, “Bain Capital” and, together with the Directors and H.I.G., the “Defendants”). The plaintiff asserted derivative claims on behalf of the Company, which is a nominal defendant in the Delaware Action, as well as putatively direct claims on behalf of a purported class of Company stockholders. The plaintiff in the Delaware Action asserted that the Defendants breached their fiduciary duties in connection with the the transactions in which (i) the Company acquired National Surgical Healthcare; (ii) Bain Capital acquired preferred equity in the Company; and (iii) Bain Capital acquired H.I.G.’s equity stake in the Company (collectively, the “Transactions”), and that, in the alternative, Bain Capital aided and abetted those purported breaches. The plaintiff also asserted an unjust enrichment claim against Bain Capital.
On January 2, 2018, the Defendants moved to dismiss the plaintiff’s complaint. On December 19, 2018, the Court of Chancery issued a decision on that motion. Following that decision, all of the Directors have been dismissed from the Delaware Action. The Court did not dismiss the plaintiff’s breach of fiduciary duty claim against H.I.G. or the aiding and abetting claim asserted against Bain Capital. However, the Court dismissed the plaintiff’s breach of fiduciary duty and unjust enrichment claims against Bain Capital. In addition, the Court dismissed all of the plaintiff’s claims that were asserted on behalf of a putative class of Company stockholders. Accordingly, all of the plaintiff’s remaining claims in the Delaware Action are asserted derivatively on the Company’s behalf.
Government Investigation. On October 23, 2017, the Company received several civil investigative demands (“CIDs”) from the federal government under the False Claims Act (“FCA”) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company’s physicians and submitted to laboratories owned and operated by the Company. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS.
The Company has been providing information to the government in response to the CIDs and currently has a non-binding agreement in principle with the DOJ on the financial terms of a settlement with the goal of resolving these matters. Based on those discussions, which are still ongoing, we recorded a litigation-related charge of $46.0 million relating to these matters on the consolidated statements of operations for the year ended December 31, 2018. We believe that this reserve is sufficient to cover a potential resolution of the investigation relating to these matters, including legal expenses relating to the settlement that have not previously been recorded in our operating expenses. The ultimate timing, amount and/or final terms of any such resolution may differ materially from those anticipated or we may not be able to reach a resolution at all. It is reasonably possible that we will incur additional losses above the amount reserved, but we are not able to estimate such amounts at this time. See Item 1A “Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2018 under the heading “Risk Factors - Risks Related to Government Regulation - Companies within the healthcare industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims.” 
Other Litigation. In addition, we are, from time to time, subject to claims and suits, or threats of claims or suits, relating to our business, including claims for damages for personal injuries, breach of management contracts and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages, which may not be covered by insurance or may otherwise have a material adverse effect on our business or results of operations.
See Note 9. "Commitments and Contingencies" for additional information regarding pending legal proceedings, which information is incorporated herein by reference.
Item 1A. Risk Factors
There have been no material changes with respect to the risk factors discussed in the Annual Report on Form 10-K for the period ended December 31, 2018.


30


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information related to our repurchases of common stock for the periods indicated:
 
 
Total Number of Shares Purchased (1)
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Programs (2)
 
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
(dollars in millions, except per share amounts)
 
 
 
 
 
 
 
 
January 1, 2019 to January 31, 2019
 
27,775

 
$
12.09

 

 
$
46.0

February 1, 2019 to February 28, 2019
 
32,184

 
$
13.47

 

 
$
46.0

March 1, 2019 to March 31, 2019
 
39,641

 
$
12.66

 

 
$
46.0

Total
 
99,600

 
$
12.76

 

 
$
46.0

(1) 
Includes shares delivered to or withheld by us in connection with employee payroll tax withholding upon exercise or vesting of stock awards.
(2) 
Made pursuant to the $50 million share repurchase program authorized by our Board of Directors on December 15, 2017. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.




31


Item 6. Exhibits
No.
 
Description
 
 
 
4.1
 
10.1
 
10.2
 
10.3
 
10.4
 
31.1
 
31.2
 
32.1
 
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema Document
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document


32


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SURGERY PARTNERS, INC.
 
 
By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: May 10, 2019


33
EX-10.3 2 a2019q1exhibit103ajemploym.htm EXHIBIT 10.3 Exhibit



Exhibit 10.3

EMPLOYMENT AGREEMENT
THIS EMPLOYMENT AGREEMENT (this "Agreement") is hereby entered into effective as of February 22. 2018 (the "Effective Date"), between Surgery Partners, Inc. (the "Company") and Angela Justice ("Executive'').

1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set forth in this Agreement for the period beginning on March 12, 2018 (the "Commencement Date'') and ending on the Termination Date, as provided for in Section 4 (the "Employment Period'').

2.Position and Duties.
(a)During the Employment Period, Executive shall serve as the Chief Human Resources Officer. Executive shall have such responsibilities, duties and authorities, and will render such services for the Company and its Subsidiaries or Affiliates as the Board of Directors of the Company (the "Board'') may from time to time reasonably direct consistent with Executive's role. At all times Executive will report directly to the CEO. Executive will devote her best efforts, energies and abilities and substantially all her business time, skill and attention to the business and affairs of the Company and its Subsidiaries, and shall perform her duties and responsibilities to the best of her ability, in a diligent, trustworthy, businesslike and efficient manner for the purpose of advancing the businesses of Company and its Subsidiaries. Executive acknowledges that her duties and responsibilities will require substantially all her business time and agrees that during the Employment Period she will not engage in any other business activity or have any business pursuits that interfere with Executive’s duties and responsibilities under this Agreement or are competitive with the businesses of the Company. Notwithstanding the foregoing. Executive shall be permitted to devote a reasonable amount of time and effort to (i) providing service to, or serving on governing boards of other companies and organizations that are not competitive with the Company, and/or (ii) personally investing and managing personal and family investments in real estate and in any corporation, partnership or other entity; but in each case, only to the extent that any ·of the activities described in clauses (i) or (ii), individually or as a whole, do not interfere with the execution of Executive's duties hereunder, or (B) otherwise violate any provision of this Agreement.

(b)For purposes of this Agreement, (i) "Subsidiaries" means any corporation or other entity (A) of which the securities or other ownership interests having the voting power to elect a majority of the board of directors or other governing body are, at the time of determination, owned by the Company, directly or through one or more subsidiaries or (B) to which the Company or any of its Affiliates provide management services, and (ii) "Affiliate" of an entity means any other person or entity, directly or indirectly controlling, controlled by or under common control with an entity.

3.Compensation and Benefits.
(a)During the Employment Period, Executive's starting base salary shall be $350,000 per annum, payable by the Company in regular installments in accordance with the Company's general payroll practices, less taxes and other applicable withholdings, and subject to at least annual review and possible upward adjustment from time to time by the Board or the Compensation Committee thereof (the "Committee''), in either case, in its discretion (as modified from time to time, the "Base Salary").

(b)In addition, during the Employment Period, Executive shall be entitled to participate in all of the Company's benefit programs for which employees of the Company are generally eligible, subject to the eligibility and participation requirements thereof, including, but not limited to, the following:




(i)medical, dental, vision, life and disability insurance, as is generally provided to other employees of the Company;

(ii)rights to indemnification and defense under a separate Indemnification Agreement and

(iii)eligibility for vacation time in accordance with the policies of the Company as from time to time in effect; provided, however, that Executive shall not have less than 20 days of vacation time per calendar year.

(c)During the Employment Period, the Company shall reimburse Executive for all reasonable out-of-pocket expenses incurred by her in the course of performing her duties and responsibilities under this Agreement which are consistent with the Company's policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company's requirements with respect to reporting and documentation of such expenses. Executive's right to payment or reimbursement for business expenses hereunder will be subject to the following additional rules: (i) no reimbursement of any expense shall affect Executive's right to reimbursement of any other expense in any other taxable year; (ii) the amount of expenses eligible for payment or reimbursement during any calendar year will not affect the expenses eligible for payment or reimbursement in any other taxable year; (iii) payment or reimbursement will be made not later than December 31 of the calendar year following the calendar year in which the expense was incurred or paid, and (iv) the right to payment or reimbursement is not subject to liquidation or exchange for any other benefit.

(d)In addition to the Base Salary, Executive will be eligible to receive an annual bonus of fifty percent (50%) of the Base Salary, with the actual amount of any such bonus being determined by the Board or the Committee, in either case, in its discretion, based on the achievement of reasonable performance goals established annually by the Board or the Committee, as applicable. Any annual bonus payable under this Section 3(d) will be paid no later than March 15th following the close of the year for which the bonus is earned. For 2018, the performance goals will be established during the first month of Executive's employment.

(e)Executive shall be eligible to participate in the Surgery Partners, Inc. 201S Omnibus Incentive Plan (as amended from time to time) ("Plan'') on terms and conditions set forth therein and in the relevant award agreement unless specifically stated otherwise in this Agreement. Specifically with regard to 2018, on the date on which the Company makes its annual equity award grants for 2018, and subject to approval by the Board of Directors of the Company (or an authorized committee thereof), the Company shall grant to Executive equity in an amount representing $200,000 as follows: (i) a restricted stock award, with the number of shares subject to the award determined by dividing $100,000 by the closing price of a share of Company common stock on the date of grant and with such shares vesting in three equal annual installments following the grant date on the terms and conditions set forth in the Equity Plan and the applicable award agreement, the execution of which shall be a condition to the award, and (ii) a performance stock unit award, with the number of shares subject to the award determined by dividing $100,000 by the closing price of a share of Company comment stock on the date of grant and such units shall be earning and vest on the terms and conditions set forth in the Equity Plan and the applicable award agreement, the execution of which shall be a condition to the award. Furthermore, on or as soon as reasonably practicable following the Commencement Date, and subject to approval by the Board (or an authorized committee thereof), the Company shall grant to Executive a leveraged performance unit award, with a target number of units equal to 11,990 shares of Company common stock under the Plan,


-2-


(f)Within ten (10) days of the Effective Date. Company shall pay Executive an amount equal to $56,859, which such amount is meant to cover Executive's reasonable out-of-pocket expenses incurred in connection with her relocation to the Brentwood, Tennessee area.

(g)All amounts payable to Executive hereunder shall be subject to all required withholdings by the Company. If additional guidance is issued under, or modifications are made to, Section 409A of the Internal Revenue Code of the Internal Revenue Code and the regulations and other interpretive guidance issued thereunder (collectively, "Section 409A''), or any other law affecting payments to be made under this Agreement. Executive agrees that the Company may take such reasonable actions and adopt such reasonable amendments as the Company believes are necessary to ensure continued compliance with the Internal Revenue Code, including Section 409A. However, the Company does not hereby or otherwise represent or warrant that any payments hereunder are or will be in compliance with Section 409A, and Executive shall be responsible for obtaining her own tax advice with regard to such matters.

4.Termination.
(a)Termination by Executive or the Company. The Employment Period (i) shall terminate upon Executive's resignation with Good Reason (as defined below) or without Good Reason, death or Disability (as defined below) or (ii) may be terminated by the Company at any time for Cause (as defined below) or without Cause.

(b)"Good Reason" shall mean without the written consent of Executive:

(i)without the express written consent of Executive, a material diminution or change of her position, title. duties, responsibilities, and/or status with the Company as in effect as of the Commencement Date or a material reduction of Executive's resources as in effect on the Commencement Date;

(ii)a material reduction in Executive's Base Salary or annual bonus target percentage;

(iii)a material reduction in the level of benefits available or awarded to Executive, other than any reduction in connection with a Company-wide reduction applicable generally to similarly situated executive officers of the Company;

(iv)a relocation by the Company of Executive's primary employment location to a location which is more than 50 miles from Executive's primary employment location on the date hereof; or

(v)a material breach by the Company of the terms of this Agreement;

but only if (x) Executive notifies the Company in writing within 90 days after the initial existence or occurrence of any of these conditions which notice describes in reasonable detail the basis for Executive's belief that Good Reason exists and that Executive intends to resign for Good Reason and the Company, within 30 days after receipt of such notice, either fails to cure the condition or delivers a written notice to Executive that the Company intends not to cure such condition and (y) Executive actually resigns prior to 1S business days after the earlier to occur of either the end of such 30-day cure period or delivery of such written notice by the Company.

(c)"Disability" as used herein shall mean that Executive is unable to perform, with or without reasonable accommodation, by reason of physical or mental incapacity, the essential duties, responsibilities

-3-


and functions of her position for a period of 180 consecutive days. A medical examination by a physician selected by the Executive or her duly appointed guardian, if any, and to whom the Company has no reasonable objection, shall determine, according to the facts then available, whether and when a Disability has occurred. Such determination shall not be arbitrary or unreasonable, and shall be final and binding on the parties hereto.

(d)
"Cause" as used herein means the occurrence of any of the following events:

(i)a material breach by Executive of any of the terms and conditions (other than paragraph 2(a)) of this Agreement; provided that, if curable, Executive shall have a reasonable period of time (which in no event shall exceed 45 days) during which to cure such material breach following the date on which Executive receives the Company's written notice of such material breach;

(ii)Executive's reporting to work (A) intoxicated (other than Executive's reasonable use of alcohol in connection with business entertainment, provided, that such use of alcohol does not cause the Company or any of its Subsidiaries or Affiliates substantial public disgrace or disrepute or economic harm) or (B) under the influence of illegal drugs;

(iii)Executive's use of illegal drugs (whether or not at the workplace) or other conduct causing the Company or any of its Subsidiaries or Affiliates substantial public disgrace or disrepute or economic harm;

(iv)breach of fiduciary duty, gross negligence or willful misconduct with respect to the Company or any of its Subsidiaries or Affiliates;

(v)Executive's material failure or willful refusal to substantially perform her duties, responsibilities and functions unrelated to illness or Disability; provided that, if curable, Executive shall have a reasonable period of time (which in no event shall exceed 45 days) during which to cure such failure following the date on which Executive receives the Company's written notice of such failure;

(vi)Executive's material failure to comply with any of the Company's or any of its Subsidiaries' written guidelines or procedures promulgated by the Company or any such Subsidiary and furnished to Executive; provided that, if curable, Executive shall have a reasonable period of time (which in no event shall exceed 45 days) during which to cure such failure following the date on which Executive receives the Company's written notice of such material failure; or

(vii)Executive has committed an act or acts constituting a felony or any other act or omission involving theft, or fraud against the Company or any of its Subsidiaries or any of their respective customers or suppliers or other business relationships.

(e)A "Change in Control" shall be deemed to have occurred upon any of the following events, provided that, to the extent required by Section 409A, such events would also qualify as a "change in control event" under Treas. Reg. §1.409A-3(i)(5):

(i)Upon the closing of a reorganization, merger, share exchange or consolidation, other than a reorganization, merger, share exchange or consolidation with respect to which those persons who were the beneficial owners, immediately prior to such reorganization, merger, share exchange or consolidation, of outstanding securities of the Company ordinarily having the right to vote in the election of directors own, immediately after the closing of such transaction, more than

-4-


51% of the outstanding securities of the resulting corporation ordinarily having the right to vote in the election of directors; or

(ii)Upon approval by the stockholders of a complete liquidation and dissolution of the Company or the sale or other disposition of all or substantially all of the assets of the Company other than to a Subsidiary or Affiliate.
(f)Termination by Executive. Executive has the right to terminate her employment under this Agreement at any time, for any or no reason, but only after giving the Company (i) 30 days prior written notice with respect to any termination without Good Reason or (ii) the number of days prior written notice set forth in the last sentence of Section 4(b) with respect to any termination with Good Reason.
(g)Compensation after Termination.
(i)If the Employment Period is terminated pursuant to Executive's resignation without Good Reason, death or Disability, Executive shall only be entitled to receive her Base Salary through the date of termination and her earned but unpaid Bonus for the previous calendar year and shall not be entitled to any other salary, bonus, compensation or benefits from the Company or its Subsidiaries, except as may be required by applicable law.

(ii)If the Employment Period is terminated by the Company for Cause, Executive shall only be entitled to her Base Salary through the date of termination and shall not be entitled to any other salary, bonus, compensation or benefits from the Company or its Subsidiaries, except as may be required by applicable law. In addition, in such event, Executive shall automatically forfeit any rights to any unvested equity owned by Executive in the Company or any Subsidiary.

(iii)If the Employment Period is terminated by the Company without Cause or by Executive for Good Reason, then subject to the conditions described in Section 4(g)(v) below, Executive shall be entitled to receive in addition to 4(g)(i) above as severance compensation the following (collectively, "Severance Pay"): (A) an amount equal to twelve (12) months of Executive's then-current annual Base Salary, payable in regular installments beginning within 30 days following the Termination Date in accordance with the Company's general payroll practices for salaried employees; (B) continuation of the welfare benefits described in Section 3(b) for twelve (12) months to the extent permissible under the terms of the relevant benefit plans at the same cost to Executive as if Executive were an active employee of the Company or an equivalent COBRA payments if such continuation is not permissible; (C) the Bonus for the current calendar year payable to Executive within 2 and 1/2 months after the end of the applicable year(to the extent not previously paid), paid in a lump sum at the time that bonuses are regularly paid to employees; (D) with respect to the portion of each restricted stock award held by Executive as of date on which the Employment Period is terminated that is subject to time-based vesting (the "Time-Based RSA''), accelerated vesting of the Time-Based RSA to the vesting event next following the date on which the Employment Period is terminated; and (E) with respect to the portion of each performance stock unit award held by the Executive as of the date on which the Employment Period is terminated that has been converted into "earned shares" (the "Earned PSUs"), accelerated vesting of the Earned PSUs to the vesting event next following the date on which the Employment Period is terminated. For purposes of this Section 4(giii), "Bonus" shall mean an amount equal to Executive's then­ current annual Base Salary, multiplied by the percentage contained in Section 3(d) hereof. For the avoidance of doubt, the unvested portion of any restricted stock awards and performance share unit awards held by Executive as of the date on which the Employment Period ends (after giving effect to the acceleration provisions set forth in subsections (D) and (E) herein and the terms and conditions of the applicable award agreements and the Surgery Partners, Inc. 2015 Omnibus

-5-


Incentive Plan (as amended from time to time) shall be forfeited and of no further force and effect. Further, for purposes of clarity, the acceleration of vesting stated in subsections (D) and (E) control despite any language to the contrary in the Plan and applicable award agreements.

(iv)If, within 90 days before or within 12 months following a Change in Control, either (A) the Company terminates the employment of Executive hereunder without Cause under Section 4(a) above, or (B) Executive terminates her employment for Good Reason under Section 4(b) above, then, in lieu of any other compensation that may be specified in this Agreement, the Company will pay Executive (A) an amount equal to twelve (12) months of Executive's then­ current annual Base Salary, payable in a lump sum no later than 60-days after the Termination Date; (B) continuation of the welfare benefits described in Section 3(b) for twelve (12) months to the extent permissible under the terms of the relevant benefit plans at the same cost to Executive as if Executive were an active employee of the Company or an equivalent COBRA payments if such continuation is not permissible; (C) the Bonus for the current calendar year payable to Executive within 2 and 1/2 months after the end of the applicable year(to the extent not previously paid), paid in a lump sum at the time that bonuses are regularly paid to employees ("Change in Control Severance Pay") as well as comply with the obligations set out in the Plan and applicable award agreements If any payment obligation under this Section 4(g) arises, no compensation received from other employment (or otherwise) will reduce the Company's obligation to make the payment(s) described in this Section 4 (g).

(v)Notwithstanding Sections 4(g)(iii) or (iv), Executive's right to receive Severance Pay or Change in Control Severance Pay hereunder is conditioned upon: (A) Executive executing, and not revoking, a written and mutually acceptable separation agreement and general release of all claims against the Company, its Subsidiaries and Affiliates and their respective managers, directors, officers, shareholders, members, representatives, agents, attorneys, predecessors, successors and assigns (other than a claim for the severance payments described in Section 4(g)(iii) or (iv) and Executive's rights to future distributions and payments related to the continued ownership of any equity securities in the Company that Executive will continue to own after such termination), in form and substance acceptable to the Company, which shall among other things, contain a general release by Executive of all claims, but not Executive's rights to vested benefits and equity, rights to indemnification and defense, arising out of her employment and termination of employment by the Company (a "Release Agreement'') within 30 days of Executive's Termination Date; and (B) Executive's material compliance with all of her obligations which survive termination of this Agreement. However, under no circumstances will Executive be required to be bound to additional restrictive covenant obligations. The Severance Pay is intended to be in lieu of all other payments to which Executive might otherwise be entitled by the Company in respect of her termination without Cause or resignation with Good Reason. If the Executive executes the Release Agreement stated herein, the Company and its Subsidiaries and Affiliates shall have no further obligations hereunder or otherwise with respect to Executive's employment from and after the date of termination of employment with the Company (the "Termination Date"), and the Company and its Subsidiaries and Affiliates shall continue to have all other rights available hereunder (including without limitation, all rights hereunder at law or in equity). The Release Agreement will be provided to Executive no later than her Termination Date,

(vi)Except as otherwise expressly provided herein, all of Executive's rights to salary, bonuses, benefits and other compensation hereunder which might otherwise accrue or become payable after the termination of the Employment Period shall cease upon such termination, other than those expressly required under applicable law (such as COBRA). All amounts payable to Executive as severance hereunder shall be subject to all required withholdings by the Company.


-6-


(h)The Company may offset any amount Executive owes the Company or its Subsidiaries or Affiliates against any amount they or their Subsidiaries or Affiliates owe Executive hereunder.

5.Confidential Information. Other than in the performance of her duties hereunder, during the Restrictive Period (as defined below) and thereafter, Executive shall keep secret and retain in strictest confidence, and shall not, without the prior written consent of the Company, furnish, make available or disclose to any third party or use for the benefit of herself or any third party, any Confidential Information. As used in this Agreement, "Confidential Information" shall mean any information relating to the business or affairs of the Company or any of its Subsidiaries or Affiliates or the Business, including but not limited to any technical or non-technical data, formulae, compilations, programs, devices, methods, techniques, designs, processes, procedures, improvements, models, manuals, financial data, acquisition strategies and information, information relating to operating procedures and marketing strategies, and any other proprietary information used by the Company or any of its Subsidiaries or Affiliates in connection with the Business, irrespective of its form; provided, however, that Confidential Information shall not include any information which is in the public domain or becomes known in the industry, in each case through no wrongful act on the part of Executive. Executive acknowledges that the Confidential Information is vital, sensitive, confidential and proprietary to the Company and its Subsidiaries and Affiliates. Executive will immediately notify the Company of any unauthorized possession, use, disclosure, copying, removal or destruction, or attempt thereof, of any Confidential Information by anyone of which Executive becomes aware and of all details thereof. Executive shall take all reasonably appropriate steps to safeguard Confidential Information and to protect it against disclosure, misuse, espionage, loss and theft. Executive shall deliver to the Company at the termination or expiration of the Employment Period, or at any other time the Company may request, all memoranda, notes, plans, records, reports, computer tapes, computers, printouts and software and other documents and data (and copies thereof) embodying or relating to the Confidential Information, Inventions and Discoveries (as defined below) or the business of the Company or any of its Subsidiaries or Affiliates which Executive may then possess or have under her control. Nothing in this Agreement limits, restricts or in any other way affects Executive's communicating with any governmental agency or entity, or communicating with any official or staff person of a governmental agency or entity, concerning matters relevant to the governmental agency or entity, or requires Executive to provide notice to the Company of the same. Executive cannot be held criminally or civilly liable under any federal or state trade secret law for disclosing a trade secret (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspended violation of law, or (2) in a compliant or other document filed under seal in a lawsuit or other proceeding. Notwithstanding this immunity from liability, Executive may be held liable if Executive unlawfully accesses trade secrets by unauthorized means.

"Business" as used herein means the business of owning, operating, developing and/or managing, or providing management or administrative services to, (a) ambulatory surgery centers anywhere in the United States or (b) physician-owned surgical hospitals within a 50 mile radius of any hospital that is owned, operated, developed or managed by the Company or any Affiliate.
6.
Inventions and Discoveries.
(a)Executive understands and agrees that all inventions, discoveries, ideas, improvements, whether patentable, copyrightable or not, pertaining to the Business or relating to Company's or any of its Subsidiaries' or Affiliates' actual or demonstrably anticipated research, development or inventions (collectively, "Inventions and Discoveries'') that result from any work performed by Executive solely or jointly with others for the Company or any of its Subsidiaries or Affiliates which Executive, solely or jointly with others, conceives, develops, or reduces to practice during the course of Executive's employment with

-7-


the Company or any of its Subsidiaries, are the sole and exclusive property of the Company. Executive will promptly disclose all such matters to the Company and will assist the Company in obtaining legal


-8-


protection for Inventions and Discoveries. Executive hereby agrees on behalf of herself, her executors, legal representatives and assignees that she will assign, transfer and convey to the Company, its successors and assigns the Inventions and Discoveries.

(b)THE COMPANY AND EXECUTIVE ACKNOWLEDGE AND AGREE THAT SECTION 6(a) SHALL NOT APPLY TO AN INVENTION OF EXECUTIVE FOR WHICH NO EQUIPMENT, SUPPLIES, FACILITY OR TRADE SECRET INFORMATION OF THE COMPANY OR ANY OF ITS SUBSIDIARIES WAS USED AND WHICH WAS DEVELOPED ENTIRELY ON EXECUTIVE'S OWN TIME, UNLESS (A) THE INVENTION RELATED (I) TO THE BUSINESS OF THE COMPANY OR ANY OF ITS SUBSIDIARIES OR AFFILIATES OR (II) TOTHE COMPANY'S OR ANY OF ITS SUBSIDIARIES' OR AFFILIATES' ACTUAL OR DEMONSTRABLY ANTICIPATED RESEARCH OR DEVELOPMENT, OR (B) THE INVENTION RESULTS FROM ANY WORK PERFORMED BY EXECUTIVE FOR THE COMPANY OR ANY OF ITS SUBSIDIARIES OR AFFILIATES.

(c)EXECUTIVE ACKNOWLEDGES THAT SHE HAS READ THIS SECTION 6 AND FULLY UNDERSTANDS THE LIMITATIONS WHICH IT IMPOSES UPON HER AND HAS RECEIVED A DUPLICATE COPY OF THIS AGREEMENT FOR HER RECORDS.

7.Restrictive Covenants. Executive acknowledges that in the course of her employment with the Company or any of its Subsidiaries or Affiliates, or their predecessors or successors, she has been and will be given access to and has and will become familiar with their trade secrets and with other Confidential Information and that her services have been and shall be of special, unique and extraordinary value to the Company and its Subsidiaries or Affiliates. Therefore, and in further consideration of the compensation to be paid to Executive hereunder and in connection with her employment, and to protect the Company's and its Subsidiaries' and Affiliates' Confidential Information, business interests and goodwill:

(a)Non-compete. Executive hereby agrees that for a period commencing on the date hereof and ending on the Termination Date, and thereafter, through the period ending twelve (12) months after the Termination Date (collectively, the "Restrictive Period"), she shall not, directly or indirectly, as employee, agent, consultant, stockholder, director, co-partner or in any other individual or representative capacity, own, operate, manage, control, engage in, invest in or participate in any manner in, act as a consultant or advisor to, render services for (alone or in association with any person, firm, corporation or entity), or otherwise assist any person or entity (other than the Company and its Subsidiaries) that engages in or owns, invests in, operates, manages or controls any venture or enterprise that directly or indirectly engages or is actively developing or attempting to develop in any element of the Business anywhere within a 50-mile radius of the Nashville, Tennessee metropolitan area or within a SO-mile radius of any area (or in the event such area is a major city, the metropolitan area relating to such city) in which the Company or any of its Subsidiaries on the Termination Date actively engages or is actively developing or attempting to develop in any element of the Business (the "Territory''); provided, however, that nothing contained herein shall be construed to prevent Executive from investing in the stock of any competing corporation listed on a national securities exchange or traded in the over-the-counter market, but only if Executive is not involved in the business of said corporation and if Executive and her associates (as such term is defined in Regulation 14(A) promulgated under the Securities Exchange Act of 1934, as in effect on the date hereof), collectively, do not own more than an aggregate of 3% of the stock of such corporation. With respect to the Territory, Executive specifically acknowledges that the Company and its Subsidiaries intend to expand the Business into and throughout the United States.

(b)Interference with Relationships. Without limiting the generality of the provisions of Section 7(a) hereof, Executive hereby agrees that, for a period commencing on the Commencement Date and ending on the Termination Date, and thereafter, through the period ending twelve (12) months after the

-9-


Termination Date (the "Non-Solicit Restrictive Period"), she will not, directly or indirectly, as employee, agent, consultant, stockholder, director, partner or in any other individual or representative capacity, (i) solicit or encourage, or participate in any business which solicits or encourages (A) any person, firm, corporation or other entity which has executed, or proposes to execute, a management services agreement or other services agreement with the Company or any of its Subsidiaries at any time during the term of this Agreement, or any successor in interest to any such person, firm, corporation or other entity, for the purpose of securing business or contracts related to any element of the Business, or (B) any present customer or patient of the Company or any of its Subsidiaries or any of their Affiliated Practices to terminate or otherwise alter his, her or its relationship with the Company or any of its Subsidiaries or such Affiliated Practice; provided, however, that nothing contained herein shall be construed to prohibit or restrict Executive from soliciting business from any such parties on behalf of the Company or any of its Subsidiaries in performance of her duties as an employee of the Company required under and as specifically contemplated by Section 2 above or (ii) divert, entice away, solicit or encourage, or attempt to divert, entice away, solicit or encourage, any physician who utilizes or has invested in an Affiliated Practice to become an owner, investor or user of another practice or facility that is not an Affiliated Practice or approach any such physician for any of the foregoing purposes or authorize or assist in the taking of any such action by any third party. In addition, at all times from and after the Termination Date, Executive shall not contact or communicate in any manner with any of Company's, or any of its Subsidiaries' or Affiliates' suppliers or vendors, or any other third party providing services to the Company or any of its Subsidiaries, regarding the Company or any of its Subsidiaries or any Company- or any such Subsidiary-related matter (which suppliers, vendors or third party service providers will include, without limitation, any third party with whom the Company or any of its Subsidiaries was, during the term of Executive's employment with the Company or any of its Subsidiaries, contemplating engaging, or negotiating with, for the future provision of products or services).

(c)Non-solicitation. Other than in the performance of her duties hereunder, during the Non- Solicit Restrictive Period, Executive shall not, directly or indirectly, as employee, agent, consultant, stockholder, director, co partner or in any other individual or representative capacity, employ, recruit or solicit for employment or engagement, any person who is employed or engaged by the Company or any of its Subsidiaries or any of its Affiliated Practices during the Non- Solicit Restrictive Period, or otherwise seek to influence or alter any such person's relationship with any of the Affiliated Practices, the Company or any of its Subsidiaries; provided, however that responses to a general solicitation (such as an internet or newspaper solicitation) that are not targeted towards any particular person shall not be deemed to be a violation of the restrictions set forth in this Section 7(c).

(d)Affiliated Practice. For purposes of this Agreement, an "Affiliated Practice" shall include any practice or facility (i) in which the Company or any of its Subsidiaries has an ownership interest or (ii) that is managed by or receives other services from the Company or any of its Subsidiaries in connection with any element of the Business.

(e)Blue Pencil. If any court of competent jurisdiction shall at any time deem the term of this Agreement or any particular Restrictive Covenant (as defined below) too lengthy or the Territory too extensive, the other provisions of this Section 7 shall nevertheless stand, the Restrictive Period herein shall be deemed to be the longest period permissible by law under the circumstances and the Territory herein shall be deemed to comprise the largest territory permissible by law under the circumstances. The court in each case shall reduce the time period and/or Territory to permissible duration or size.

(f)Covenant Not to Disparage. During the Restrictive Period and thereafter, Executive shall not disparage, denigrate or derogate in any way, directly or indirectly, the Company, any of its Subsidiaries or Affiliates, or any of its or their respective agents, officers, directors, employees, parent, subsidiaries, affiliates, Affiliated Practices, affiliated doctors (including any physicians who utilize or have invested in


-10-



any Affiliated Practice), representatives, attorneys, executors, administrators, successors and assigns (collectively, the "Protected Parties''), nor shall Executive disparage, denigrate or derogate in any way, directly or indirectly, her experience with any Protected Party, or any actions or decisions made by any Protected Party.

(g)Remedies. Executive acknowledges and agrees that the covenants set forth in this Section 7 and the preceding Sections 5 and 6 (collectively, the "Restrictive Covenants'') are reasonable and necessary for the protection of the business interests of the Company and its Subsidiaries and Affiliates, that irreparable injury may result to the Company and its Subsidiaries and Affiliates if Executive breaches any of the terms of said Restrictive Covenants, and that in the event of Executive's actual or threatened breach of any such Restrictive Covenants, the Company and its Subsidiaries and Affiliates will have no adequate remedy at law. Executive accordingly agrees that in the event of any actual or threatened breach by her of any of the Restrictive Covenants, the Company and its Subsidiaries and Affiliates shall be entitled to immediate temporary injunctive and other equitable relief subject to hearing as soon thereafter as possible. Nothing contained herein shall be construed as prohibiting the Company or any of its Subsidiaries or Affiliates from pursuing any other remedies available to it for such breach or threatened breach, including the recovery of any damages which it is able to prove. In addition and supplementary to other rights and remedies existing in its (or their) favor, in the event of the material breach by Executive of any of the provisions of this Section 7, the Company (and/or its Subsidiaries or Affiliates) shall be entitled to require Executive to account for and pay over to the Company (and/or its Subsidiaries or Affiliates) all compensation, profits, moneys, accruals, increments or other benefits actually derived from or received as a result of any transactions constituting a breach of the covenants contained in this Agreement which may require Executive to repay any severance. In addition, in the event of an alleged breach or violation by Executive of this Section 7, the restricted periods set forth in this Section 7 shall be tolled until such breach or violation has been duly cured.

(h)Executive understands that the foregoing restrictions may limit her ability to earn a livelihood in a business similar to the business of the Company and its Subsidiaries or Affiliates, but she nevertheless believes that she has received and will receive sufficient consideration and other benefits as an executive of the Company and as otherwise provided hereunder to clearly justify such restrictions which, in any event (given her education, skills and ability), Executive does not believe would prevent her from otherwise earning a living. Executive acknowledges that the Restrictive Covenants are reasonable and that she has reviewed the provisions of this Agreement with her legal counsel. Executive shall inform any prospective or future employer of any and all restrictions contained in this Agreement and provide such employer with a copy of such restrictions, prior to the commencement of that employment.
8.Executive's Representations and Covenants.
(a)Executive hereby represents and warrants to the Company that (i) the execution, delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which she is bound, (ii) Executive is not a party to or bound by any employment agreement, non­ compete agreement or confidentiality agreement with any other person or entity and (iii) upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms. Executive hereby acknowledges and represents that she has consulted with independent legal counsel regarding her rights and obligations under this Agreement and that she fully understands the terms and conditions contained herein.

(b)During the Employment Period and thereafter, Executive shall cooperate with the Company and its Subsidiaries and Affiliates in any internal investigation or administrative, regulatory or judicial proceeding as reasonably requested by the Company (including, without limitation. Executive

-11-


being available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company's request to give testimony without requiring service of a subpoena or other legal process, volunteering to the Company all pertinent information and turning over to the Company all relevant documents which are in or may come into Executive's possession, all at times and on schedules that are reasonably consistent with Executive's other permitted activities and commitments). In the event the Company requires Executive's cooperation in accordance with this Section 8(b), the Company shall reimburse Executive for reasonable travel expenses (including, without limitation, travel expenses, lodging and meals, and reasonable attorneys' fees upon submission of receipts).

9.Survival. Sections 4 through 22 shall survive and continue in full force in accordance with their terms notwithstanding the expiration or termination of the Employment Period.

10.Notices. Any notices provided for in this Agreement shall be in writing and shall be effective when delivered in person or deposited in the United States mail, postage prepaid, and addressed to Executive at her last known address on the books of the Company or, in the case of the Company, to it at its principal place of business, attention of the Chief Executive Officer, or to such other address as either party may specify by notice to the other actually received.

11.Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.

12.Complete Agreement. This Agreement, those documents expressly referred to herein and other documents of even date herewith, embody the complete agreement and understanding among Executive and the Company and its Subsidiaries and, as of the Effective Date, shall supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may have related to the subject matter hereof in any way, including, for the avoidance of doubt, the Former Employment Agreement.

13.No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction will be applied against any party hereto.

14.Counterparts. This Agreement may be executed in separate counterparts (including by facsimile or PDF signature pages), each of which is deemed to be an original and all of which taken together constitute one and the same agreement.
15.Successors and Assigns. This Agreement is intended to bind and does bind and inure to the benefit of and be enforceable by Executive and the Company and its successors and permitted assigns. Executive may not assign any of her rights or obligations hereunder without the prior written consent of the Company. The Company may (a) assign any or all of its respective rights and interests hereunder to one or more Subsidiaries or Affiliates of the Company, (b) designate one or more Subsidiaries or Affiliates of the Company to perform its obligations hereunder (in any or all of which cases the Company nonetheless shall remain responsible for the performance of all of its obligations hereunder), (c) assign its rights hereunder in connection with the sale of all or a substantial part of the business or assets of the Company or one of its Subsidiaries (whether by merger, sale of stock or assets, recapitalization or otherwise) and (d) merge any of the Subsidiaries or Affiliates with or into the Company (or vice versa). The rights of the Company


-11-


hereunder are enforceable by the Company or its Subsidiaries or Affiliates, which are the intended third party beneficiaries hereof and no other third party beneficiary is so otherwise intended.

16.Delivery by Facsimile or PDF. This Agreement and any amendments hereto, to the extent signed and delivered by means of a facsimile machine or PDF, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any party hereto, each other party hereto shall re-execute original forms thereof and deliver them to the other party. No party hereto shall raise the use of a facsimile machine or PDF to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine or PDF as a defense to the formation or enforceability of a contract and each such party forever waives any such defense.

17.Income Tax Treatment. Executive and the Company acknowledge that it is the intention of the Company to deduct all cash amounts paid under this Agreement as ordinary and necessary business expenses for income tax purposes. Executive agrees and represents that she will treat all such non­ reimbursable amounts as ordinary income for income tax purposes, and should she report such amounts as other than ordinary income for income tax purposes, she will indemnify and hold the Company harmless from and against any and all taxes, penalties, interest, costs and expenses, including reasonable attorneys' and accounting fees and costs, which are incurred by Company directly or indirectly as a result thereof.

18.Governing Law. This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Agreement shall be governed by, the laws of the state in which Executive resides, without giving effect to provisions thereof regarding conflict of laws.

19.Consent to Jurisdiction.

(a)THE COMPANY AND EXECUTIVE HEREBY CONSENT TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED WITHIN THE STATE IN WHICH EXECUTIVE RESIDES AND IRREVOCABLY AGREE THAT SUBJECT TO THE COMPANY'S ELECTION, ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT SHALL BE LITIGATED IN SUCH COURTS. EXECUTIVE ACCEPTS FOR HERSELF AND IN CONNECTION WITH her PROPERTIES, GENERALLY AND UNCONDITIONALLY, THE NONEXCLUSIVE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS, AND IRREVOCABLY AGREES TO BE BOUND BY ANY JUDGMENT RENDERED THEREBY IN CONNECTION WITH THIS AGREEMENT.

(b)Notwithstanding Section 20(a), the parties intend to and hereby confer jurisdiction to enforce the covenants contained in Sections 5 through 7 upon the courts of any jurisdiction within the geographical scope of such covenants. If the courts of any one or more of such jurisdictions hold such covenants wholly or partially invalid or unenforceable by reason of the breadth of such scope or otherwise, it is the intention of the parties that such determination not bar or in any way affect the Company's right to the relief provided above in the courts of any other jurisdiction within the geographical scope of such covenants, as to breaches of such covenants in such other respective jurisdictions, such covenants as they relate to each jurisdiction being, for this purpose, severable into diverse and independent covenants.

20.Amendment and Waiver. Any provision of this Agreement may be amended or waived only with the prior written consent of the Company and Executive, and no course of conduct or course of dealing or failure or delay by any party hereto in enforcing or exercising any of the provisions of this


-12-


Agreement shall affect the validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any provision of this Agreement.
21.Section 409A. To the maximum extent permitted by law, this Agreement sha11 be interpreted in such a manner that the payments to Executive under this Agreement are either exempt from, or comply with, Section 409A, including without limitation any such regulations or other guidance that may be issued after the date hereof. For purposes of Section 409A, each payment made under this Agreement shall be treated as a separate payment and the right to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments. Notwithstanding anything to the contrary in this Agreement, if Executive is a "specified employee" as defined below, as of Executive's termination of employment, then, to the extent any payment under this Agreement resulting from Executive's termination of employment constitutes deferred compensation (after taking into account any applicable exemptions from Section 409A) and to the extent required by Section 409A, no payments due under this Agreement as a result of Executive's termination of employment may be made until the earlier of (a) the first day following the six-month anniversary of Executive's date of termination and (b) Executive's date of death; provided, however, that any payments delayed during this six-month period shall be paid in the aggregate in a lump sum as soon as reasonably practicable following the sixth month anniversary of Executive's date of termination. For purposes of this Agreement, all references to ''termination of employment" and correlative phrases shall be construed to require a "separation from service" (as defined in Treas. Reg. §1.409A-1(h) after giving effect to the presumptions contain therein), and the term "specified employee" means an individual determined by the Company to be a specified employee under Treas. Reg. §409A-l(i). Further, notwithstanding anything to the contrary in this Agreement, if the time period provided to the Executive to review the Release Agreement allows for the Executive to choose which calendar year she will receive her payments set out in Section 4(g), all payments will be made in the later calendar year.
...    ...

-13-


IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the date first written above.


SURGERY PARTNERS, INC.

By:
/s/ Jennifer Baldock
Jennifer Baldock
Senior Vice President and General Counsel

Accepted and Agreed:

/s/ Angela Justice
Angela Justice
Date: 02/22/2017


4836-6434-1086, v. 1

EX-10.4 3 a2019q1exhibit104ggemploym.htm EXHIBIT 10.4 Exhibit



Exhibit 10.4


EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (this "Agreement") is made as of June 13, 2014, between Symbion, Inc., a Delaware corporation (the "Company"), and George M. Goodwin ("Executive").

WHEREAS, simultaneously with the execution of this Agreement, Surgery Center Holdings, LLC, a Delaware limited liability company (the "Parent"), SH Acquisition Corp. a Delaware corporation and a wholly-owned subsidiary of the Parent ("Merger Sub"), and Symbion Holdings Corporation, a Delaware corporation ("Symbion Holdings"), are entering into that certain Agreement and Plan of Merger (the "Merger Agreement") pursuant to which, among other things, Merger Sub shall merge with and into Symbion Holdings, whereupon the separate existence of the Merger Sub shall cease, and Symbion Holdings shall be the surviving corporation and shall become a wholly-owned subsidiary of Parent following such merger;

WHEREAS, the Company is wholly owned by Symbion Holdings;

WHEREAS, as a condition to the execution of the Merger Agreement, the parties hereto are entering into this Agreement pursuant to which, contingent upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), the Company will employ Executive on the terms and conditions contained in this Agreement; and

WHEREAS, the covenants and agreements contained in this Agreement are contingent upon, and subject to, the occurrence of the Closing.

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

1. Employment. The Company shall employ Executive, and Executive hereby accepts employment with the Company, upon the terms and conditions set forth in this Agreement for the period beginning on the date of the Closing (the "Commencement Date") and ending on the five (5) year anniversary of the Commencement Date; provided, however, that the term of this Agreement shall automatically be extended for one additional year on the fifth anniversary of the Commencement Date and each anniversary thereafter (the "Employment Period") unless either party gives thirty (30) days' notice of non-renewal. The parties hereto acknowledge and agree that the covenants, agreements and obligations of the parties hereto are contingent upon, and subject to, the occurrence of the Closing.

2.Position and Duties.

(a)During the Employment Period, Executive shall serve as the Group President of the Parent reporting to the CEO or COO. Executive shall have such responsibilities, duties and authorities, and will render such services for the Company and its Subsidiaries or Affiliates as the Board of Directors (the "Board") (or any designated officer of the Board or the Company or Parent), may from time to time direct. Executive will devote his best efforts, energies and abilities and his full business time, skill and attention to the business and affairs of the Company



and its Subsidiaries, and shall perform his duties and responsibilities to the best of his ability, in a diligent, trustworthy, businesslike and efficient manner for the purpose of advancing the businesses of Company and its Subsidiaries. Executive acknowledges that his duties and responsibilities will require his full time business efforts and agrees that during the Employment Period he will not engage in any other business activity or have any business pursuits that interferes with Executive's duties and responsibilities under this Agreement or are competitive with the businesses of the Company. Notwithstanding the foregoing, Executive shall be permitted to devote a reasonable amount of time and effort to (i) providing service to, or serving on governing boards of, civic and charitable organizations, and (ii) personally investing and managing personal and family investments in real estate and in any corporation, partnership or other entity; but in each case, only to the extent that any of the activities described in clauses (i) or (ii), individually or as a whole, do not (A) require or involve the active participation of Executive in the management of any corporation, partnership or other entity or interfere with the execution of Executive's duties hereunder, or (B) otherwise violate any provision of this Agreement.

(b)For purposes of this Agreement, (i) "Subsidiaries" means any corporation or other entity of which either (a) the securities or other ownership interests having the voting power to elect a majority of the board of directors or other governing body are, at the time of determination, owned by the Company, Symbion Holdings or Parent, directly or through one or more subsidiaries or (b) to which the Company, Symbion Holdings or Parent, or any of their Affiliates provide management services to, and (ii) "Affiliate" of an entity means any other person or entity, directly or indirectly controlling, controlled by or under common control with an entity.

3.Compensation and Benefits.

(a)During the Employment Period, Executive's base salary shall be $275,000 per annum (which annual base salary, as modified from time to time in accordance with this Section 3, shall be referred to herein as the "Base Salary"), payable by the Company in regular installments in accordance with the Company's general payroll practices, less taxes and other applicable withholdings. The Board or any designated officer shall perform an annual review of Executive's Base Salary based on Executive's performance of his duties and the Company's other compensation policies; provided that any modification in the Base Salary shall require approval of the Board or its Compensation Committee, which may give or withhold such approval in its sole discretion.

(b)In addition, during the Employment Period, Executive shall be entitled to participate in all of the Company's benefit programs for which employees of the Company are generally eligible, subject to the eligibility and participation requirements thereof, including, but not limited to, the following:

(i)    medical, dental, vision, life and disability insurance, as is generally provided to other employees of the Company;



2


(ii)eligibility for vacation time in accordance with the policies of the Company as are in effect as of the Commencement Date; provided, however, that Executive shall not have less than 20 days of vacation time per calendar year;

(iii)participation in the management equity plan of Parent, pursuant to which Executive shall be granted 150,000 Class B Units of Parent, which Class B Units will be subject to customary vesting, buyback and other provisions and restrictions as set forth in the applicable award agreement and Parent's LLC Agreement. Copies of both the applicable award agreement and Parent's LLC Agreement have been provided to Executive prior to the date of this Agreement; and

(iv)participation in the existing Symbion, Inc. supplemental Executive Retirement Plan, or its equivalent or a successor plan, with a minimum of a two percent (2%) match for Executive.

(c)During the Employment Period, the Company shall reimburse Executive for all reasonable out-of-pocket expenses incurred by his in the course of performing his duties and responsibilities under this Agreement which are consistent with the Company's policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company's requirements with respect to reporting and documentation of such expenses.

(d)In addition to the Base Salary, Executive will be eligible to receive an annual bonus of fifty percent (50%) of the Base Salary upon the achievement of certain performance targets to be defined by the Board.

(e)All amounts payable to Executive hereunder shall be subject to all required withholdings by the Company. If additional guidance is issued under, or modifications are made to, Section 409A of the Internal Revenue Code or any other law affecting payments to be made under the Agreement, the Executive agrees that the Company may take such reasonable actions and adopt such reasonable amendments as the Company believes are necessary to ensure continued compliance with the Internal Revenue Code, including Section 409A thereof. However, the Company does not hereby or otherwise represent or warrant that any payments hereunder are or will be in compliance with Section 409A, and Executive shall be responsible for obtaining his own tax advice with regard to such matters.

4.
Termination.

(a)Termination By Executive or the Company. The Employment Period (i) shall terminate upon Executive's resignation with Good Reason (as defined below) or without Good Reason, death or Incapacity (as defined below) or (ii) may be terminated by the Company at any time for Cause (as defined below) or without Cause.

(b)
"Good Reason" shall mean without the written consent of Executive:

(i)    without the express written consent of Executive, a material diminution of his position, duties, responsibilities, and status with the Company as in effect as of the


3



Commencement Date or a material reduction of Executive's resources as in effect on the Commencement Date;

(ii)a reduction in Executive's Base Salary or annual bonus percentage;

(iii)a material reduction in the level of benefits available or awarded to Executive, other than any reduction in connection with a Company-wide reduction applicable generally to similarly situated executive officers of the Company;

(iv)during the first twelve (12) months of this Agreement or within twelve (12) months of any Change in Control (as defined herein), a material increase in Executive's core functional responsibilities with a corresponding material change in Executive's core functional role without a corresponding increase in compensation, provided, however, the addition of additional facilities or territories to Executive's oversight responsibilities or other ordinary course growth of the Parent or Company shall not be a material increase in Executive's core functional responsibilities;

(v)a relocation by the Company of Executive's primary employment location to a location which is more than 50 miles from Executive's primary employment location on the date hereof; or

(vi)a material breach by the Company of the terms of this Agreement;

but only if (x) Executive notifies the Company in writing within 60 days after the initial existence or occurrence of any of these conditions which notice describes in reasonable detail the basis for Executive's belief that Good Reason exists and that the Executive intends to resign for Good Reason and the Company, within 15 days after receipt of such notice, either fails to cure the condition or delivers a written notice to Executive that the Company intends not to cure such condition and (y) Executive actually resigns prior to 15 days after the earlier to occur of either the end of such 15-day cure period or delivery of such written notice by the Company.

(c)"Incapacity" as used herein shall mean that Executive is unable to perform, with or without reasonable accommodation, by reason of physical or mental incapacity, the essential duties, responsibilities and functions of his or his position. A medical examination by a physician selected by the Company to whom the Executive or his duly appointed guardian, if any, has no reasonable objection shall determine, according to the facts then available, whether and when Incapacity has occurred. Such determination shall not be arbitrary or unreasonable, and shall be final and binding on the parties hereto.

(d)"Cause" as used herein means the occurrence of any of the following events:

(i)    a material breach by Executive of any of the terms and conditions of this Agreement; provided that, if curable, Executive shall have a reasonable period of time (which in no event shall exceed 45 days) during which to cure such material breach following the date on which Executive receives the Company's written notice of such material breach;


4


(ii)    Executive's reporting to work (A) intoxicated (other than Executive's reasonable use of alcohol in connection with business entertainment, provided, that such use of alcohol does not cause the Company, Parent or any of their Subsidiaries or Affiliates substantial public disgrace or disrepute or economic harm) or (B) under the influence of illegal drugs;

(iii)Executive's use of illegal drugs (whether or not at the workplace) or other conduct causing the Company, Parent or any of their Subsidiaries or Affiliates substantial public disgrace or disrepute or economic harm;

(iv)    breach of fiduciary duty, gross negligence or willful misconduct with respect to the Company, Parent or any of their Subsidiaries or Affiliates;

(v)    chronic absenteeism, which shall be deemed to have occurred if Executive has at least ten absences unrelated to paid time off, disability or illness in any ten week period;

(vi)    Executive's material failure or willful refusal to substantially perform his duties, responsibilities and functions; provided that, if curable, Executive shall have a reasonable period of time (which in no event shall exceed 45 days) during which to cure such failure following the date on which Executive receives the Company's written notice of such failure;

(vii)Executive's failure to comply with any of the Company's, Parent's or any of their Subsidiaries' written guidelines or procedures promulgated by the Company, Parent or any such Subsidiary and furnished to Executive, including, without limitation, any guidelines or procedures relating to marketing or community relations; provided that, if curable, Executive shall have a reasonable period of time (which in no event shall exceed 45 days) during which to cure such failure following the date on which Executive receives the Company's written notice of such failure; or

(viii)Executive has committed an act or acts constituting a felony or any other act or omission involving theft, dishonesty or fraud against the Company, Parent or any of their Subsidiaries or any of their respective customers or suppliers or other business relationships.

(e)A "Change in Control" shall be deemed to have occurred at such time as:

(i)Upon the closing of a reorganization, merger, share exchange or consolidation, other than a reorganization, merger, share exchange or consolidation with respect to which those persons who were the beneficial owners, immediately prior to such reorganization, merger, share exchange or consolidation, of outstanding securities of the Parent or the Company ordinarily having the right to vote in the election of directors own, immediately after the closing of such transaction, own more than 51% of the outstanding securities of the resulting corporation ordinarily having the right to vote in the election of directors; or

5



(ii)    Upon approval by the Parent or the Company stockholders or members of a complete liquidation and dissolution of the Parent or the Company or the sale or other disposition of all or substantially all of the assets of the Parent or the Company other than to a Subsidiary or Affiliate;

provided, however, that a sale, in a firm commitment underwritten public offering led by a nationally recognized underwriting firm pursuant to an effective registration statement under the Securities Act of 1933, as amended, or any successor federal statute, of units of the Parent (or common stock of an entity into which the units of the Parent convert) shall not be a Change in Control.

(f)Termination by Executive. Executive has the right to terminate his employment under this Agreement at any time, for any or no reason, but only after giving the Company (i) thirty (30) days prior written notice with respect to any termination without Good Reason or (ii) the number of days prior written notice set forth in the last sentence of Section 4(b) with respect to any termination with Good Reason.

(g)Compensation After Termination.

(i)    If the Employment Period has commenced and is terminated pursuant to Executive's resignation without Good Reason, death or Incapacity, Executive shall only be entitled to receive his Base Salary through the date of termination and shall not be entitled to any other salary, bonus, compensation or benefits from the Company, Parent or their Subsidiaries, except as may be required by applicable law.

(ii)    If the Employment Period has commenced and is terminated by the Company for Cause, Executive shall only be entitled to his Base Salary through the date of termination and shall not be entitled to any other salary, bonus, compensation or benefits from the Company, Parent or their Subsidiaries, except as may be required by applicable law. In addition, in such event, Executive shall automatically forfeit any rights to any unvested Units owned by Executive in Parent.

(iii)    If the Employment Period has commenced and is terminated (1) by the Company without Cause, (2) by Executive for Good Reason or (3) this Agreement is not renewed by the Company or allowed to expire by the Company, then subject to the conditions described in Section 4(g)(v) below, Executive shall be entitled to receive as severance compensation the following (collectively, "Severance Pay"): (A) an amount equal to the sum of Executive's then-current annual Base Salary, payable in regular installments beginning within 30 days following the Termination Date in accordance with the Company's general payroll practices for salaried employees; (B) continuation of the welfare benefits described in Section 3(b) for twelve (12) months (the "Severance Period") to the extent permissible under the terms of the relevant benefit plans at no cost to Executive and (C) the Bonus payable to the Executive within 2 and 1/2 months after the end of the applicable year. For purposes of this Section 4(g), "Bonus" shall mean an amount equal to the Executive's then-current annual Base Salary, multiplied by the percentage contained in Section 3(d) hereof.



6


(iv)If, within twelve (12) months following a Change in Control, either (A) the Company terminates the employment of Executive hereunder without Cause under Section 4(a) above, or (B) Executive terminates his employment for Good Reason under Section 4(e) above, then, in lieu of any other compensation that may be specified in this Agreement, the Company will pay Executive the Severance Pay. The Company will make any payment due under this clause (iv) in a single lump-sum payment not later than 30 days after termination. If any payment obligation under this Section 4(g) arises, no compensation received from other employment (or otherwise) will reduce the Company's obligation to make the payment(s) described in this paragraph.

(v)Notwithstanding Section 4(g)(iii), Executive's right to receive Severance Pay hereunder is conditioned upon: (A) Executive executing, and not revoking, a written separation agreement and general release of all claims against the Parent, Company, their Subsidiaries and Affiliates and their respective managers, directors, officers, shareholders, members, representatives, agents, attorneys, predecessors, successors and assigns (other than a claim for the severance payments described in Section 4(g)(iii) and (iv) and Executive's rights to future distributions and payments related to the continued ownership of any equity securities in Parent that Executive will continue to own after such termination), in form and substance acceptable to the Company, which shall among other things, contain a general release by Executive of all claims arising out of his employment and termination of employment by the Company (a "Release Agreement") within 30 days of Executive's Termination Date; and (B) Executive's material compliance with all of his obligations which survive termination of this Agreement. The Severance Pay is intended to be in lieu of all other payments to which Executive might otherwise be entitled in respect of his termination without Cause, resignation with Good Reason or this Agreement is not renewed or allowed to expire by the Company. The Company, Parent and their Subsidiaries and Affiliates shall have no further obligations hereunder or otherwise with respect to Executive's employment from and after the date of termination of employment with the Company (the "Termination Date"), and the Company, Parent and their Subsidiaries and Affiliates shall continue to have all other rights available hereunder (including without limitation, all rights hereunder at law or in equity).

(vi)    Except as otherwise expressly provided herein, all of Executive's rights to salary, bonuses, benefits and other compensation hereunder which might otherwise accrue or become payable after the termination of the Employment Period shall cease upon such termination, other than those expressly required under applicable law (such as COBRA). All amounts payable to Executive as severance hereunder shall be subject to all required withholdings by the Company (including, but not limited to, Section 409A of the Internal Revenue Code).

(h)The Company may offset any amount Executive owes it or Parent or their Subsidiaries or Affiliates against any amount they or their Subsidiaries or Affiliates owes Executive hereunder.

7




5.Confidential Information. Other than in the performance of his duties hereunder, during the Restrictive Period (as defined below) and thereafter, Executive shall keep secret and retain in strictest confidence, and shall not, without the prior written consent of the Company, furnish, make available or disclose to any third party or use for the benefit of herself or any third party, any Confidential Information. As used in this Agreement, "Confidential Information" shall mean any information relating to the business or affairs of the Company, Parent any of their Subsidiaries or Affiliates or the Business, including but not limited to any technical or non-technical data, formulae, compilations, programs, devices, methods, techniques, designs, processes, procedures, improvements, models, manuals, financial data, acquisition strategies and information, information relating to operating procedures and marketing strategies, and any other proprietary information used by the Company, Parent or any of their Subsidiaries or Affiliates in connection with the Business, irrespective of its form; provided, however, that Confidential Information shall not include any information which is in the public domain or becomes known in the industry, in each case through no wrongful act on the part of Executive. Executive acknowledges that the Confidential Information is vital, sensitive, confidential and proprietary to the Company, Parent and their Subsidiaries and Affiliates. Executive will immediately notify the Company of any unauthorized possession, use, disclosure, copying, removal or destruction, or attempt thereof, of any Confidential Information by anyone of which Executive becomes aware and of all details thereof. Executive shall take all reasonably appropriate steps to safeguard Confidential Information and to protect it against disclosure, misuse, espionage, loss and theft. Executive shall deliver to the Company at the termination or expiration of the Employment Period, or at any other time the Company may request, all memoranda, notes, plans, records, reports, computer tapes, computers, printouts and software and other documents and data (and copies thereof) embodying or relating to the Confidential Information, Inventions and Discoveries (as defined below) or the business of the Company, Parent or any of their Subsidiaries or Affiliates which he may then possess or have under his control.

"Business" as used herein means the business of owning, operating, developing and/or managing, or providing management or administrative services to, (a) ambulatory surgery centers anywhere in the United States or (b) physician-owned surgical hospitals within a fifty (50) mile radius of any hospital that is owned, operated, developed or managed by Parent or any Affiliate of Parent.

6.
Inventions and Discoveries.

(a)Executive understands and agrees that all inventions, discoveries, ideas, improvements, whether patentable, copyrightable or not, pertaining to the Business or relating to the Company's, Parent's or any of their Subsidiaries' or Affiliates' actual or demonstrably anticipated research, development or inventions (collectively, "Inventions and Discoveries") that result from any work performed by Executive solely or jointly with others for the Company, Parent or any of their Subsidiaries or Affiliates which Executive, solely or jointly with others, conceives, develops, or reduces to practice during the course of Executive' s employment with the Company, Parent or any of their Subsidiaries, are the sole and exclusive property of the Company. Executive will promptly disclose all such matters to the Company and will assist the Company in obtaining legal protection for Inventions and Discoveries. Executive hereby agrees on behalf of herself, his executors, legal

8



representatives and assignees that he will assign, transfer and convey to the Company, its successors and assigns the Inventions and Discoveries.

(b)THE COMPANY AND EXECUTIVE ACKNOWLEDGE AND AGREE THAT SECTION 6(a) SHALL NOT APPLY TO AN INVENTION OF EXECUTIVE FOR WHICH NO EQUIPMENT, SUPPLIES, FACILITY OR TRADE SECRET INFORMATION OF THE COMPANY, PARENT OR ANY OF THEIR SUBSIDIARIES WAS USED AND WHICH WAS DEVELOPED ENTIRELY ON EXECUTIVE'S OWN TIME, UNLESS (A) THE INVENTION RELATED (I) TO THE BUSINESS OF THE COMPANY, PARENT OR ANY OF THEIR SUBSIDIARIES OR AFFILIATES OR (II) TO THE COMPANY'S OR ANY OF ITS SUBSIDIARIES' OR AFFILIATES' ACTUAL OR DEMONSTRABLY ANTICIPATED RESEARCH OR DEVELOPMENT, OR (B) THE INVENTION RESULTS FROM ANY WORK PERFORMED BY EXECUTIVE FOR THE COMPANY, PARENT OR ANY OF THEIR SUBSIDIARIES OR AFFILIATES. EXECUTIVE AND THE COMPANY FURTHER ACKNOWLEDGE AND AGREE THAT SECTION 6(a) SHALL NOT APPLY TO ANY INVENTIONS OR WORK PRODUCT DEVELOPED OR VESTED BY EXECUTIVE PRIOR TO THE EFFECTIVE DATE, A COMPLETE AND ACCURATE LIST OF WHICH IS SET FORTH ON SCHEDULE 6(b).

(c)EXECUTIVE ACKNOWLEDGES THAT HE HAS READ THIS SECTION 6 AND FULLY UNDERSTANDS THE LIMITATIONS WHICH IT IMPOSES UPON HIS AND HAS RECEIVED A DUPLICATE COPY OF THIS AGREEMENT FOR HIS RECORDS.

7.Restrictive Covenants. Executive acknowledges that in the course of his employment with the Company, Parent or any of their Subsidiaries or Affiliates, or their predecessors or successors, he has been or will be given access to and has or will become familiar with their trade secrets and with other Confidential Information and that his services have been and shall be of special, unique and extraordinary value to the Company, Parent and their Subsidiaries or Affiliates. Therefore, and in further consideration of the compensation to be paid to Executive hereunder and in connection with his employment and the profit interests in Parent issued to Executive under that certain Executive Securities Agreement, dated as of the date hereof, and to protect the Company's and its Subsidiaries' and Affiliates' Confidential Information, business interests and goodwill:

(a)Non-compete. Executive hereby agrees that for a period commencing on the date hereof and ending on the Termination Date, and thereafter, through the period ending on the first anniversary of the Termination Date (collectively, the "Restrictive Period"), he shall not, directly or indirectly, as employee, agent, consultant, stockholder, director, co-partner or in any other individual or representative capacity, own, operate, manage, control, engage in, invest in or participate in any manner in, act as a consultant or advisor to, render services for (alone or in association with any person, firm, corporation or entity), or otherwise assist any person or entity (other than the Parent and its Subsidiaries) that engages in or owns, invests in, operates, manages or controls any venture or enterprise that directly or indirectly engages or is actively developing or attempting to develop in any element of the Business anywhere within a 50-mile radius of the Nashville metropolitan area or within a 50-mile radius of any area (or in the event such area is a major city, the metropolitan area relating to such city) in which the Parent, the Company or any of their Subsidiaries on the Termination Date actively engages or is actively

9


developing or attempting to develop in any element of the Business (the "Territory"); provided, however, that nothing contained herein shall be construed to prevent Executive from investing in the stock of any competing corporation listed on a national securities exchange or traded in the over-the-counter market, but only if Executive is not involved in the business of said corporation and if Executive and his associates (as such term is defined in Regulation 14(A) promulgated under the Securities Exchange Act of 1934, as in effect on the date hereof), collectively, do not own more than an aggregate of 3% of the stock of such corporation. With respect to the Territory, Executive specifically acknowledges that the Parent and its Subsidiaries intend to expand the Business into and throughout the United States.

(b)Interference with Relationships. Without limiting the generality of the provisions of Section 7(a) hereof, Executive hereby agrees that, for a period commencing on the date hereof and ending on the Termination Date, and thereafter, through the period ending on the second anniversary of the Termination Date (the "Non-Solicit Restrictive Period"), he will not, directly or indirectly, as employee, agent, consultant, stockholder, director, partner or in any other individual or representative capacity, (i) solicit or encourage, or participate in any business which solicits or encourages (A) any person, firm, corporation or other entity which has executed, or proposes to execute, a management services agreement or other services agreement with the Company, Parent or any of their Subsidiaries at any time during the term of this Agreement, or from any successor in interest to any such person, firm, corporation or other entity, for the purpose of securing business or contracts related to any element of the Business, or (b) any present customer or patient of the Company, Parent or any of their Subsidiaries or any of their Affiliated Practices to terminate or otherwise alter his, his or its relationship with the Company, Parent or any of their Subsidiaries or such Affiliate Practice; provided, however, that nothing contained herein shall be construed to prohibit or restrict Executive from soliciting business from any such parties on behalf of the Company, Parent or any of their Subsidiaries in performance of his duties as an employee of the Company required under and as specifically contemplated by Section 2 above or (ii) divert, entice away, solicit or encourage, or attempt to divert, entice away, solicit or encourage, any physician who utilizes or has invested in an Affiliated Practice to become an owner, investor or user of another practice or facility that is not an Affiliated Practice or approach any such physician for any of the foregoing purposes or authorize or assist in the taking of any such action by any third party. In addition, at all times from and after the Termination Date, Executive shall not contact or communicate in any manner with any of the Company's, the Parent's or any of their Subsidiaries' or Affiliates' suppliers or vendors, or any other third party providing services to the Company, Parent or any of their Subsidiaries, regarding the Parent, the Company, any of their Subsidiaries or any Company- or any such Subsidiary-related matter (which suppliers, vendors or third party service providers will include, without limitation, any third party with whom the Company, the Parent or any of their Subsidiaries was, during the term of Executive's employment with the Parent, the Company or any of their Subsidiaries, contemplating engaging, or negotiating with, for the future provision of products or services).

(c)Non-solicitation. Other than in the performance of his duties hereunder, during the Non-Solicit Restrictive Period, Executive shall not, directly or indirectly, as employee, agent, consultant, stockholder, director, co partner or in any other individual or representative capacity,

10



employ, recruit or solicit for employment or engagement, any person who is employed or engaged by the Parent, the Company or any of their Subsidiaries or any of its Affiliated Practices during the Non­ Solicit Restrictive Period, or otherwise seek to influence or alter any such person's relationship with any of the Affiliated Practices, the Parent, the Company or any of their Subsidiaries; provided, however that responses to a general solicitation (such as an internet or newspaper solicitation) that are not targeted towards any particular person shall not be deemed to be a violation of the restrictions set forth in this Section 7(c).

(d)Affiliated Practice. For purposes of this Agreement, an "Affiliated Practice" shall include any practice or facility (i) in which the Parent, Company or any of their Subsidiaries has an ownership interest or (ii) that is managed by or receives other services from the Parent, the Company or any of their Subsidiaries in connection with any element of the Business.

(e)Blue Pencil. If any court of competent jurisdiction shall at any time deem the term of this Agreement or any particular Restrictive Covenant (as defined below) too lengthy or the Territory too extensive, the other provisions of this Section 7 shall nevertheless stand, the Restrictive Period herein shall be deemed to be the longest period permissible by law under the circumstances and the Territory herein shall be deemed to comprise the largest territory permissible by law under the circumstances. The court in each case shall reduce the time period and/or Territory to permissible duration or size.

(f)Covenant Not to Disparage. During the Restrictive Period and thereafter, Executive shall not disparage, denigrate or derogate in any way, directly or indirectly, the Parent, the Company, any of their Subsidiaries or Affiliates, or any of its or their respective agents, officers, directors, employees, parent, subsidiaries, affiliates, Affiliated Practices, affiliated doctors (including any physicians who utilize or have invested in any Affiliated Practice), representatives, attorneys, executors, administrators, successors and assigns (collectively, the "Protected Parties"), nor shall Executive disparage, denigrate or derogate in any way, directly or indirectly, his experience with any Protected Party, or any actions or decisions made by any Protected Party.

(g)Remedies. Executive acknowledges and agrees that the covenants set forth in this Section 7 and the preceding Sections 5 and 6 (collectively, the "Restrictive Covenants") are reasonable and necessary for the protection of the business interests of the Company, Parent and their Subsidiaries and Affiliates, that irreparable injury may result to the Company, Parent and their Subsidiaries and Affiliates if Executive breaches any of the terms of said Restrictive Covenants, and that in the event of Executive's actual or threatened breach of any such Restrictive Covenants, the Company, Parent and their Subsidiaries and Affiliates will have no adequate remedy at law. Executive accordingly agrees that in the event of any actual or threatened breach by his of any of the Restrictive Covenants, the Company, Parent and their Subsidiaries and Affiliates shall be entitled to immediate temporary injunctive and other equitable relief subject to hearing as soon thereafter as possible. Nothing contained herein shall be construed as prohibiting the Company, Parent or any of their Subsidiaries or Affiliates from pursuing any other remedies available to it for such breach or threatened breach, including the recovery of any damages which it is able to prove. In addition and supplementary to other rights and remedies existing in its (or their) favor, in the event of the material breach by Executive of any of the provisions of this Section 7, the Company or Parent (and/or their Subsidiaries or Affiliates) shall be entitled to require the Executive to account for and pay over to the


11



Company or Parent (and/or their Subsidiaries or Affiliates) all compensation, profits, moneys, accruals, increments or other benefits actually derived from or received as a result of any transactions constituting a breach of the covenants contained in this Agreement which may require Executive to repay any severance. In addition, in the event of an alleged breach or violation by Executive of this Section 7, the restricted periods set forth in this Section 7 shall be tolled until such breach or violation has been duly cured.

(h)The Executive understands that the foregoing restrictions may limit his ability to earn a livelihood in a business similar to the business of the Company, Parent and their Subsidiaries or Affiliates, but he nevertheless believes that he has received and will receive sufficient consideration and other benefits as an executive of the Company and as otherwise provided hereunder to clearly justify such restrictions which, in any event (given his education, skills and ability), the Executive does not believe would prevent his from otherwise earning a living. Executive acknowledges that the Restrictive Covenants are reasonable and that he has reviewed the provisions of this Agreement with his legal counsel. The Executive shall inform any prospective or future employer of any and all restrictions contained in this Agreement and provide such employer with a copy of such restrictions, prior to the commencement of that employment.

8.
Executive's Representations and Covenants.

(a)Executive hereby represents and warrants to the Company that (i) the execution, delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which he is bound, (ii) Executive is not a party to or bound by any employment agreement, non-compete agreement or confidentiality agreement with any other person or entity which will survive the Closing and (iii) upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms; provided that the covenants, agreements and obligations contained herein shall be contingent upon, and subject to, the occurrence of the Closing. Executive hereby acknowledges and represents that he has consulted with independent legal counsel regarding his rights and obligations under this Agreement and that he fully understands the terms and conditions contained herein.

(b)During the Employment Period and thereafter, Executive shall cooperate with the Company, Parent and their Subsidiaries and Affiliates in any internal investigation or administrative, regulatory or judicial proceeding as reasonably requested by the Company (including, without limitation, Executive being available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company's request to give testimony without requiring service of a subpoena or other legal process, volunteering to the Company all pertinent information and turning over to the Company all relevant documents which are or may come into Executive's possession, all at times and on schedules that are reasonably consistent with Executive's other permitted activities and commitments). In the event the Company requires Executive's cooperation in accordance with this Section 8(b), the Company shall reimburse Executive for reasonable travel expenses (including, without limitation, travel expenses, lodging and meals, and reasonable attorneys' fees upon submission of receipts).


12



9.Survival. Sections 4 through 22 shall survive and continue in full force in accordance with their terms notwithstanding the expiration or termination of the Employment Period.

10.Notices. Any notice provided for in this Agreement must be in writing and must be either (i) personally delivered, (ii) mailed by registered or certified first class mail, prepaid with return receipt requested or (iii) sent by a recognized overnight courier service, to the recipient at the address below indicated:

Notices to the Executive:

1109 Radnor Glen Drive
Brentwood. TN 37027

Attn: [ George Goodwin ]
Telephone:
Facsimile: 615-478-4250
Email:    GGoodwin@symbion.com

with a copy to (which shall not constitute notice to Executive):

McKenzie Laird, PLLC
4015 Hillsboro Pike
Suite 222
Nashville, Tennessee 37215
Attn: Robert H. Laird, Jr.
Telephone: (615) 916-3223
Email: rlaird@mckenzielaird.com

Notices to the Company:

c/o H.I.G. Middle Market, LLC
1450 Brickell Avenue, 31st Floor
Miami, Florida 33131
Attn: Chris Laitala and Matt Lozow
Telephone: (305) 379-2322
Facsimile: (305) 381-4157
Email: claitala@higcapital.com and mlozow@higcapital.com

with copies to (which shall not constitute notice to the Company):

McDermott Will & Emery LLP
227 West Monroe Street
Chicago, Illinois 60606-5096
Attn:    Brooks B. Gruemmer


13


Telephone:     312-984-7594
Facsimile:     312-984-7700
Email:    bgruemmer@mwe.com

or such other address or to the attention of such other person or entity as the recipient party shall have specified by prior written notice to the sending party. Any notice under this Agreement will be deemed to have been given (a) on the date such notice is personally delivered, (b) three (3) days after the date of mailing if sent by certified or registered mail, or (c) one (1) day after the date such notice is delivered to the overnight courier service if sent by overnight courier.

11.Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.

12.Complete Agreement. This Agreement, those documents expressly referred to herein and other documents of even date herewith, embody the complete agreement and understanding among Executive and the Company and its Subsidiaries and, as of the Effective Date, shall supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may have related to the subject matter hereof in any way. Upon the Commencement Date, Executive will no longer be a participant in Symbion Inc. Executive Change in Control Severance Plan (the "Plan") and Executive hereby releases the Company and its Subsidiaries and waives any claims or rights that he may have under the Plan or any other prior or existing agreement or understanding he may have with the Parent, the Company or any of their Subsidiaries, Affiliates or predecessors, including, but not limited to, any claim for severance or other benefits. To the extent that any inconsistency exists between this Agreement and the LLC Agreement, the language of this Agreement shall supersede.

13.No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction will be applied against any party hereto.

14.Counterparts. This Agreement may be executed in separate counterparts (including by facsimile or PDF signature pages), each of which is deemed to be an original and all of which taken together constitute one and the same agreement.

15.Successors and Assigns. This Agreement is intended to bind and inure to the benefit of and be enforceable by Executive and the Company or Parent and their respective successors and permitted assigns. Executive may not assign any of his rights or obligations hereunder without the prior written consent of the Company. The Company may (a) assign any or all of its respective rights and interests hereunder to Parent or one or more Subsidiaries or Affiliates of Parent or the Company, (b) designate one or more Subsidiaries or Affiliates of Parent or Company to perform its obligations hereunder (in any or all of which cases the Company nonetheless shall remain responsible for the performance of all of its obligations

14


hereunder), (c) assign its rights hereunder in connection with the sale of all or a substantial part of the business or assets of the Company or Parent or one of their Subsidiaries (whether by merger, sale of stock or assets, recapitalization or otherwise) and (d) merge any of the Subsidiaries or Affiliates with or into the Company (or vice versa); provided, however, that the foregoing actions may provide Executive with Good Reason to terminate this Agreement. The rights of the Company hereunder are enforceable by Parent or the Company Subsidiaries or Affiliates, which are the intended third party beneficiaries hereof and no other third party beneficiary is so otherwise intended.

16.Delivery by Facsimile or PDF. This Agreement and any amendments hereto, to the extent signed and delivered by means of a facsimile machine or PDF, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any party hereto, each other party hereto shall re-execute original forms thereof and deliver them to the other party. No party hereto shall raise the use of a facsimile machine or PDF to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine or PDF as a defense to the formation or enforceability of a contract and each such party forever waives any such defense.

17.Income Tax Treatment. Executive and the Company acknowledge that it is the intention of the Company to deduct all cash amounts paid under this Agreement as ordinary and necessary business expenses for income tax purposes. Executive agrees and represents that he will treat all such non-reimbursable amounts as ordinary income for· income tax purposes, and should he report such amounts as other than ordinary income for income tax purposes, he will indemnify and hold the Company harmless from and against any and all taxes, penalties, interest, costs and expenses, including reasonable attorneys' and accounting fees and costs, which are incurred by Company directly or indirectly as a result thereof.

18.Governing Law. This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Agreement shall be governed by, the laws of the state in which Executive resides, without giving effect to provisions thereof regarding conflict of laws.

19.Waiver of Jury Trial. THE PARTIES HERETO HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT. THE PARTIES HERETO ALSO WAIVE ANY BOND OR SURETY OR SECURITY UPON SUCH BOND WHICH MIGHT, BUT FOR THIS WAIVER, BE REQUIRED OF THE OTHER PARTY. THE PARTIES HERETO ACKNOWLEDGE THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT AND THAT EACH WILL CONTINUE TO RELY ON THE WAIVER IN THEIR RELATED FUTURE DEALINGS. THE COMPANY AND EXECUTIVE FURTHER WARRANT AND REPRESENT THAT EACH HAS REVIEWED THIS WAIVER WITH THEIR RESPECTIVE LEGAL COUNSEL, AND THAT EACH KNOWINGLY AND VOLUNTARILY WAIVES THEIR RESPECTIVE JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. THIS


15



WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING, AND THE WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT OR TO ANY OTHER DOCUMENTS OR AGREEMENTS RELATING TO THE TRANSACTION CONTEMPLATED HEREBY. IN THE EVENT OF LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT.

20.
Consent to Jurisdiction.

(a)THE COMPANY AND EXECUTIVE HEREBY CONSENT TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED WITHIN THE STATE IN WHICH EXECUTIVE RESIDES AND IRREVOCABLY AGREE THAT SUBJECT TO THE COMPANY'S ELECTION, ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT SHALL BE LITIGATED IN SUCH COURTS. EXECUTIVE ACCEPTS FOR HERSELF AND IN CONNECTION WITH HIS PROPERTIES, GENERALLY AND UNCONDITIONALLY, THE NONEXCLUSIVE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS, AND IRREVOCABLY AGREES TO BE BOUND BY ANY JUDGMENT RENDERED THEREBY IN CONNECTION WITH THIS AGREEMENT.

(b)Notwithstanding Section 20(a), the parties intend to and hereby confer jurisdiction to enforce the covenants contained in Sections 5 through 7 upon the courts of any jurisdiction within the geographical scope of such covenants. If the courts of any one or more of such jurisdictions hold such covenants wholly or partially invalid or unenforceable by reason of the breadth of such scope or otherwise, it is the intention of the parties that such determination not bar or in any way affect the Company's right to the relief provided above in the courts of any other jurisdiction within the geographical scope of such covenants, as to breaches of such covenants in such other respective jurisdictions, such covenants as they relate to each jurisdiction being, for this purpose, severable into diverse and independent covenants.

21.Amendment and Waiver. Any provision of this Agreement may be amended or waived only with the prior written consent of the Company and Executive, and no course of conduct or course of dealing or failure or delay by any party hereto in enforcing or exercising any of the provisions of this Agreement shall affect the validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any provision of this Agreement.

22.Section 409A. To the maximum extent permitted by law, this Agreement shall be interpreted in such a manner that the payments to Executive under this Agreement are either exempt from, or comply with, Section 409A of the Internal Revenue Code and the regulations and other interpretive guidance issued thereunder (collectively, "Section 409A"), including without limitation any such regulations or other guidance that may be issued after the Commencement Date. For purposes of Section 409A, the right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments. Notwithstanding anything to the contrary in this Agreement, if Executive is a "specified employee" as defined in Section 409A as of Executive's termination of employment, then, to the extent any payment under this Agreement resulting from Executive's termination of employment

16



constitutes deferred compensation (after taking into account any applicable exemptions from Section 409A) and to the extent required by Section 409A, no payments due under this Agreement as a result of Executive's termination of employment may be made until the earlier of (a) the first day following the sixth month anniversary of Executive's date of termination and (b) Executive's date of death; provided, however, that any payments delayed during this six-month period shall be paid in the aggregate in a lump sum as soon as reasonably practicable following the sixth month anniversary of Executive's date of termination.

*    *    *    *    *


17




IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the date first written above.



SYMBION, INC.


By: /s/ Richard E. Francis, Jr.
Name:
Its:

        
George M. Goodwin





IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the date first written above.



SYMBION, INC.


By:                 
Name:             
Its: President


/s/ George M. Goodwin         
George M. Goodwin








Schedule 6(b) Prior Inventions

EX-31.1 4 a2019q1exhibit311.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1

CERTIFICATIONS

I, Wayne S. DeVeydt, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


By:
/s/ Wayne S. DeVeydt
Wayne S. DeVeydt
Chief Executive Officer
Date: May 10, 2019




EX-31.2 5 a2019q1exhibit312.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2

CERTIFICATIONS

I, Thomas F. Cowhey, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
Date: May 10, 2019


EX-32.1 6 a2019q1exhibit321.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Surgery Partners, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certifies, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

By:
/s/ Wayne S. DeVeydt
Wayne S. DeVeydt
Chief Executive Officer
Date: May 10, 2019

By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
Date: May 10, 2019





EX-101.INS 7 sgry-20190331.xml XBRL INSTANCE DOCUMENT 0001638833 2019-01-01 2019-03-31 0001638833 2019-05-08 0001638833 2018-12-31 0001638833 2019-03-31 0001638833 2018-01-01 2018-03-31 0001638833 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-03-31 0001638833 us-gaap:CommonStockMember 2019-03-31 0001638833 us-gaap:RetainedEarningsMember 2019-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2018-12-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001638833 2019-01-01 0001638833 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0001638833 2017-12-31 0001638833 us-gaap:RetainedEarningsMember 2018-12-31 0001638833 us-gaap:CommonStockMember 2018-12-31 0001638833 2018-03-31 0001638833 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001638833 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2019-03-31 0001638833 us-gaap:CommonStockMember 2018-03-31 0001638833 us-gaap:RetainedEarningsMember 2019-01-01 0001638833 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001638833 us-gaap:RetainedEarningsMember 2017-12-31 0001638833 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001638833 us-gaap:CommonStockMember 2017-12-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2017-12-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001638833 us-gaap:RetainedEarningsMember 2018-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2018-01-01 2018-03-31 0001638833 sgry:OtherServicesMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2018-01-01 2018-03-31 0001638833 sgry:OpticalServicesMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2019-01-01 2019-03-31 0001638833 sgry:OtherServicesMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2018-01-01 2018-03-31 0001638833 sgry:OpticalServicesMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2019-01-01 2019-03-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-03-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-03-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-03-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-03-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-03-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-03-31 0001638833 us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember 2018-12-31 0001638833 us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember 2019-03-31 0001638833 sgry:FacilitiesAmbulatorySurgeryCentersMember 2019-03-31 0001638833 sgry:FacilitiesSurgicalHospitalsMember 2019-03-31 0001638833 us-gaap:FairValueInputsLevel1Member 2019-03-31 0001638833 us-gaap:FairValueInputsLevel1Member 2018-12-31 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0001638833 sgry:PhysicianPracticeMember 2019-03-31 0001638833 sgry:PhysicianPracticeMember 2019-01-01 2019-03-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember 2018-12-31 0001638833 sgry:NotesPayableAndSecuredLoansMember 2019-03-31 0001638833 sgry:A2017TermLoanMaturing2024Member us-gaap:SecuredDebtMember 2019-03-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2019-03-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2019-03-31 0001638833 sgry:A2017TermLoanMaturing2024Member us-gaap:SecuredDebtMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2018-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember 2019-03-31 0001638833 sgry:NotesPayableAndSecuredLoansMember 2018-12-31 0001638833 us-gaap:InvestorMember 2019-01-01 2019-03-31 0001638833 us-gaap:SeriesAPreferredStockMember 2018-12-31 0001638833 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-03-31 0001638833 us-gaap:SeriesAPreferredStockMember 2019-03-31 0001638833 us-gaap:MajorityShareholderMember us-gaap:SeriesAPreferredStockMember 2017-08-31 2017-08-31 0001638833 us-gaap:MajorityShareholderMember us-gaap:SeriesAPreferredStockMember 2017-08-31 0001638833 us-gaap:InterestRateSwapMember 2019-03-31 0001638833 2017-12-15 0001638833 us-gaap:RestrictedStockMember 2018-01-01 2018-03-31 0001638833 us-gaap:RestrictedStockMember 2019-01-01 2019-03-31 0001638833 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0001638833 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0001638833 2018-01-01 2018-12-31 0001638833 sgry:MateriallyMoreRestrictiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001638833 sgry:NotMateriallyMoreRestrictiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2019-01-01 2019-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2018-01-01 2018-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2018-01-01 2018-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2018-01-01 2018-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2019-01-01 2019-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2019-01-01 2019-03-31 0001638833 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0001638833 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-03-31 0001638833 us-gaap:CorporateNonSegmentMember 2019-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2019-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2018-12-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2018-12-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2019-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2019-03-31 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2018-12-31 0001638833 us-gaap:CorporateNonSegmentMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2019-04-11 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2019-04-11 2019-04-11 sgry:Anesthesia_Practice sgry:swap sgry:surgical_facility xbrli:pure sgry:physician_practice iso4217:USD xbrli:shares xbrli:shares sgry:segment sgry:state iso4217:USD false --12-31 Q1 2019 2019-03-31 10-Q 0001638833 49428103 false Accelerated Filer Surgery Partners, Inc. false 900000000 500000 0 5500000 3400000 500000 200000 48500000 52600000 47100000 -21300000 1100000 800000 66500000 50700000 -19400000 1200000 500000 68400000 8300000 1600000 0 -600000 0 436900000 149800000 0 432300000 800000 2000000 -1200000 14100000 8000000 6100000 100000 300000 123 108 15 106 84 8500000 10600000 10300000 -9300000 0 1200000 0 2400000 4800000 7600000 7800000 8500000 3 4 4 4 4 3 83300000 69700000 307600000 294900000 56100000 59900000 -22400000 -33900000 673500000 673900000 7800000 7800000 8500000 8500000 2000000 2000000 1900000 1900000 0 10100000 123000 58000 0 18000 4676300000 399200000 52700000 20100000 4204300000 4880900000 358500000 82300000 22300000 4417800000 588300000 535300000 3700000 5000000 2000000 600000 100000 200000 11300000 11300000 28900000 8800000 1500000 2900000 4700000 6700000 4300000 3500000 25400000 184300000 142500000 175200000 113100000 184600000 142800000 -62100000 -41800000 6600000 0.01 0.01 300000000 300000000 48869204 49385974 48687000 48898000 48869204 48869000 49385974 49386000 500000 500000 -17500000 -31600000 22600000 23600000 5100000 -8000000 0.049 0.016 1 0.046 0.535 0.388 0.031 0.984 0.007 0.009 0.935 1 0.047 0.015 1 0.048 0.524 0.402 0.026 0.985 0.003 0.012 0.938 1 327300000 326100000 42300000 18000000 18000000 0.05 0.03 430000000.0 0.1 1.04438 5500000 5400000 2900000 2700000 6700000 6100000 1400000 1300000 1400000 1300000 64600000 68200000 109200000 100900000 7600000 8100000 15700000 18800000 1300000 22400000 33900000 0 0 -0.53 -0.60 -0.53 -0.60 0.24 55200000 41000000 12000000 12000000 3800000 3800000 25400000 144600000 7000000 10200000 149800000 134400000 294200000 187400000 20400000 18400000 20300000 22900000 24800000 149600000 2300000 144000000 4500000 0.108 P13Y5M -46000000 24200000 21700000 3382800000 3393000000 10600000 10200000 6900000 5200000 1900000 2000000 -300000 -200000 1800000 1700000 -14100000 -13400000 8500000 29000000 54300000 54300000 -34300000 -42000000 20800000 23100000 43400000 43800000 78500000 78500000 129700000 129200000 28200000 445800000 187500000 51200000 45100000 48500000 52900000 60600000 153500000 4676300000 4880900000 349300000 359600000 45000000 42300000 42200000 0 1382800000 1447900000 1447900000 407200000 406700000 406700000 320500000 370000000 370000000 79400000 0 1417300000 1444400000 1444400000 411200000 406100000 406100000 333000000 370000000 370000000 79300000 2270900000 2384600000 55600000 57100000 2326500000 2441700000 694300000 692900000 22500000 22500000 23500000 23500000 -55700000 -43900000 -36400000 -18400000 30000000 20500000 -17500000 -20100000 22600000 23600000 7600000 -25300000 -28600000 -1600000 15900000 -17500000 -4100000 16000000 -20100000 1000 3 3 31 370100000 367200000 41200000 49600000 17500000 5200000 292300000 0 36600000 0 255700000 16800000 0 288300000 0.102 P8Y5M 812500000 81500000 57200000 61300000 66700000 75600000 470200000 21400000 20600000 72100000 70500000 36900000 30500000 36900000 318800000 0 -11500000 -11500000 26100000 26200000 155200000 191800000 271300000 370000000 -200000 0 121500000 114300000 20000000 19400000 800000 200000 0 -1200000 2000000 0 30900000 33800000 3900000 0 7600000 25600000 7600000 7600000 10000000 1900000 200000 0 7900000 11800000 800000 100000 0 10900000 0.01 0.01 136.31 20000000 20000000 0 0 0 0 0 0 53000000 54100000 400000 2400000 -2200000 -1100000 -800000 1500000 35700000 35100000 5100000 3500000 426300000 400100000 326600000 314600000 359300000 367800000 16300000 12900000 300000 300000 -247000000 -249100000 411300000 20100000 3000000 388200000 404700000 18500000 216500000 156900000 12800000 2900000 3700000 416800000 19900000 1100000 395800000 410800000 19800000 215300000 164900000 10800000 1100000 4900000 2300000 1200000 18200000 18500000 2000000 1900000 1000 310000 72000 76000 440000 593000 310000000 700000 700000 1000000 1000000 50000000.0 46000000 157000 2000000 2000000 404600000 391400000 1336600000 0 695500000 500000 681900000 -41300000 1304800000 0 689000000 500000 674100000 -58800000 1098900000 -22400000 673500000 500000 694300000 -247000000 1084300000 -33900000 673900000 500000 692900000 -249100000 114400000 115000000 8500000 359300000 359300000 367800000 367800000 0 310000 310000 310000 310000 310000 310000 12.64 156818 0 7800000 8500000 12800000 4800000 0 11200000 11000000 3600000 3400000 2400000 0 0 48007000 48047000 48007000 48047000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at March 31, 2019 (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Balance Sheets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment, net of accumulated depreciation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total leased assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">432.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">134.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">436.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Non-Controlling Interests&#8212;Redeemable</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#8212;</font><font style="font-family:inherit;font-size:9pt;">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Redeemable Preferred Stock</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On August 31, 2017, the Company issued </font><font style="font-family:inherit;font-size:9pt;">310,000</font><font style="font-family:inherit;font-size:9pt;"> shares of Series A Preferred Stock to Bain at a purchase price of </font><font style="font-family:inherit;font-size:9pt;">$1,000</font><font style="font-family:inherit;font-size:9pt;"> per share for an aggregate purchase price of </font><font style="font-family:inherit;font-size:9pt;">$310.0 million</font><font style="font-family:inherit;font-size:9pt;"> (the "Preferred Private Placement").</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the redeemable preferred stock follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">359.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividends accrued</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash dividends declared</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">367.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There were </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> unpaid cash dividends declared at both </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">. The aggregate and per share amounts of unpaid cumulative preferred dividends as of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> was </font><font style="font-family:inherit;font-size:9pt;">$42.3 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$136.31</font><font style="font-family:inherit;font-size:9pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> Organization and Summary of Accounting Policies</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:12px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company owned or operated a portfolio of </font><font style="font-family:inherit;font-size:9pt;">123</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, comprised of </font><font style="font-family:inherit;font-size:9pt;">108</font><font style="font-family:inherit;font-size:9pt;"> ASCs and </font><font style="font-family:inherit;font-size:9pt;">15</font><font style="font-family:inherit;font-size:9pt;"> surgical hospitals in </font><font style="font-family:inherit;font-size:9pt;">31</font><font style="font-family:inherit;font-size:9pt;"> states. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves.&#160;The Company owned a majority interest in </font><font style="font-family:inherit;font-size:9pt;">84</font><font style="font-family:inherit;font-size:9pt;"> of the surgical facilities and consolidated </font><font style="font-family:inherit;font-size:9pt;">106</font><font style="font-family:inherit;font-size:9pt;"> of these facilities for financial reporting purposes.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Variable Interest Entities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Boards ("FASB") Accounting Standards Codification 810, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Consolidation</font><font style="font-family:inherit;font-size:9pt;">. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of both </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, the consolidated VIEs include </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> anesthesia practices and </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> physician practices.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, were </font><font style="font-family:inherit;font-size:9pt;">$11.0 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$11.2 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, and the total liabilities of the consolidated VIEs were </font><font style="font-family:inherit;font-size:9pt;">$3.4 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$3.6 million</font><font style="font-family:inherit;font-size:9pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level&#160;1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the carrying amounts and fair values of the Company's long-term debt follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,444.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,447.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,417.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,382.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">411.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">407.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">333.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">320.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations approximate their fair values under Level 3 calculations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In 2018, the Company entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activity"). The fair value of these derivative instruments was </font><font style="font-family:inherit;font-size:9pt;">$33.9 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$22.4 million</font><font style="font-family:inherit;font-size:9pt;"> at </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation. As of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, the fair value of both the assets and liabilities in the SERP were </font><font style="font-family:inherit;font-size:9pt;">$1.3 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$1.4 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of revenues by service type as a percentage of total revenues follows:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Surgical facilities revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Ancillary services revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues. </font><font style="font-family:inherit;font-size:9pt;">This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">215.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">216.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">164.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">156.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">410.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">404.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">416.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">411.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash, Cash Equivalents and Restricted Cash</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes </font><font style="font-family:inherit;font-size:9pt;">$0.3 million</font><font style="font-family:inherit;font-size:9pt;"> of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both March 31, 2019 and December 31, 2018. These restricted investments represents restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities&#8217; cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, the Company had a net third-party Medicaid settlements liability of </font><font style="font-family:inherit;font-size:9pt;">$7.6 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$4.8 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, included in other current liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient&#8217;s insurance prior to the patient&#8217;s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were </font><font style="font-family:inherit;font-size:9pt;">$10.6 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$8.5 million</font><font style="font-family:inherit;font-size:9pt;"> at </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> is included in Note 2. "Acquisitions."</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to goodwill for the </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,382.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisitions, including post acquisition adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Divestitures and deconsolidations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,393.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative Instruments and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with Accounting Standards Codification 815, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:9pt;">, the Company records all derivatives on the balance sheet at fair value.&#160;The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Non-Controlling Interests&#8212;Redeemable</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#8212;</font><font style="font-family:inherit;font-size:9pt;">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the non-controlling interests&#8212;redeemable is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">326.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests&#8212;redeemable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition and disposal of shares of non-controlling interests, net&#8212;redeemable </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distributions to non-controlling interest&#8212;redeemable holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">314.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes post acquisition date adjustments.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in healthcare regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company&#8217;s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was </font><font style="font-family:inherit;font-size:9pt;">$18.0 million</font><font style="font-family:inherit;font-size:9pt;"> reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company&#8217;s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Acquisitions</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company paid cash consideration of </font><font style="font-family:inherit;font-size:9pt;">$7.6 million</font><font style="font-family:inherit;font-size:9pt;"> for acquisitions, which primarily consisted of a physician practice. The acquisition was funded through cash from operations. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;">, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2018. The goodwill acquired was primarily allocated to the Company's ancillary services reportable segment. The results of operations of the acquisitions are included in the Company&#8217;s results of operations beginning on the dates of acquisition, and were not considered significant for the </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash, Cash Equivalents and Restricted Cash</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes </font><font style="font-family:inherit;font-size:9pt;">$0.3 million</font><font style="font-family:inherit;font-size:9pt;"> of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both March 31, 2019 and December 31, 2018. These restricted investments represents restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Professional, General and Workers' Compensation Liability Risks</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Insurance Reserves</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i)&#160;claims made during the policy period, which are offset by insurance recoveries and (ii)&#160;an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;"> were </font><font style="font-family:inherit;font-size:9pt;">$18.5 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$18.2 million</font><font style="font-family:inherit;font-size:9pt;">, respectively. The balances include expected insurance recoveries of </font><font style="font-family:inherit;font-size:9pt;">$12.0 million</font><font style="font-family:inherit;font-size:9pt;"> at each of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Laws and Regulations</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On October 23, 2017, the Company received several civil investigative demands (&#8220;CIDs&#8221;) from the federal government under the False Claims Act (&#8220;FCA&#8221;) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company&#8217;s physicians and submitted to laboratories owned and operated by the Company. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS. The Company has been providing information to the government in response to the CIDs and currently has a non-binding agreement in principle with the DOJ on the financial terms of a settlement with the goal of resolving these matters. Based on those discussions, which are still ongoing, the Company recorded a litigation-related charge of </font><font style="font-family:inherit;font-size:9pt;">$46.0 million</font><font style="font-family:inherit;font-size:9pt;"> relating to these matters on the consolidated statements of operations for the year ended December 31, 2018. The Company believes that this reserve is sufficient to cover a potential resolution with the government relating to these matters, including legal expenses relating to the settlement that have not previously been recorded in operating expenses. The ultimate timing, amount and/or final terms of any such resolution may differ materially from those anticipated or the Company may not be able to reach a resolution at all. It is reasonably possible that the Company will incur additional losses above the amount reserved, but the Company is not able to estimate such amounts at this time. See Item 1A &#8220;Risk Factors&#8221; in the Company's Annual Report on Form 10-K for the period ended December 31, 2018 under the heading &#8220;Risk Factors - Risks Related to Government Regulation -&#160;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Companies within the healthcare industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims</font><font style="font-family:inherit;font-size:9pt;">.&#8221;&#160;</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Acquired Facilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Potential Physician Investor Liability</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Tax Receivable Agreement</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September&#160;30, 2015 (as amended, the &#8220;TRA&#8221;), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company&#8217;s projected realized tax savings over the next six years and are not dependent on the Company&#8217;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus </font><font style="font-family:inherit;font-size:9pt;">500</font><font style="font-family:inherit;font-size:9pt;"> basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus </font><font style="font-family:inherit;font-size:9pt;">300</font><font style="font-family:inherit;font-size:9pt;"> basis points until paid.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Assuming the Company&#8217;s effective tax rate is </font><font style="font-family:inherit;font-size:9pt;">24%</font><font style="font-family:inherit;font-size:9pt;">, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately </font><font style="font-family:inherit;font-size:9pt;">$68.2 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$64.6 million</font><font style="font-family:inherit;font-size:9pt;"> as of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#8217;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was </font><font style="font-family:inherit;font-size:9pt;">$52.6 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$48.5 million</font><font style="font-family:inherit;font-size:9pt;"> as of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively. The current portion of the liability was </font><font style="font-family:inherit;font-size:9pt;">$8.1 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$7.6 million</font><font style="font-family:inherit;font-size:9pt;"> as of March 31, 2019 and December 31, 2018, respectively, and was included as a component of other current liabilities in the condensed consolidated balance sheet. The long-term portion was included as a component of other long-term liabilities in the condensed consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Variable Interest Entities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Boards ("FASB") Accounting Standards Codification 810, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Consolidation</font><font style="font-family:inherit;font-size:9pt;">. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of both </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, the consolidated VIEs include </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> anesthesia practices and </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> physician practices.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivatives and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Cash Flow Hedges of Interest Rate Risk</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During the first quarter of </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. Over the next 12 months, the Company estimates that an additional </font><font style="font-family:inherit;font-size:9pt;">$6.6 million</font><font style="font-family:inherit;font-size:9pt;"> will be reclassified as a reduction to interest expense.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As of both </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and December 31, 2018, the Company had </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> interest rate swaps with a current notional amount of </font><font style="font-family:inherit;font-size:9pt;">$900.0 million</font><font style="font-family:inherit;font-size:9pt;"> and a termination date of November&#160;30, 2023. The Company classifies its derivative financial instruments as a long-term liability included in other long-term liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For the three months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company incurred losses related to the effective portion of derivatives, which were recognized in accumulated other comprehensive income, gross of tax effect, of </font><font style="font-family:inherit;font-size:9pt;">$12.8 million</font><font style="font-family:inherit;font-size:9pt;">. For the three months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company reclassified </font><font style="font-family:inherit;font-size:9pt;">$1.3 million</font><font style="font-family:inherit;font-size:9pt;"> of losses from accumulated other comprehensive income to interest expense, gross of tax effect. The Company held no derivative financial instruments during the three months ended March 31, 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative Instruments and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with Accounting Standards Codification 815, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:9pt;">, the Company records all derivatives on the balance sheet at fair value.&#160;The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During the first quarter of </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted earnings per share are calculated in accordance with ASC 260, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:9pt;">, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted earnings per share are calculated in accordance with ASC 260, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:9pt;">, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands): </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to Surgery Partners, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(17.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: amounts allocated to participating securities </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding- basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,047</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effect of dilutive securities </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding- diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,047</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,007</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss per share:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.60</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.53</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Diluted </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.53</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted shares</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Convertible preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Share Repurchase Transactions</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On December 15, 2017, the Company's Board of Directors authorized a share repurchase program of up to </font><font style="font-family:inherit;font-size:9pt;">$50.0 million</font><font style="font-family:inherit;font-size:9pt;"> of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There were </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> share repurchases under the share repurchase program during the three months ended March 31, 2019. During the three months ended March 31, 2018, the Company repurchased </font><font style="font-family:inherit;font-size:9pt;">156,818</font><font style="font-family:inherit;font-size:9pt;"> shares of its common stock stock at an average price of </font><font style="font-family:inherit;font-size:9pt;">$12.64</font><font style="font-family:inherit;font-size:9pt;"> per share through market purchases. At March 31, 2019, the Company had </font><font style="font-family:inherit;font-size:9pt;">$46.0 million</font><font style="font-family:inherit;font-size:9pt;"> of repurchase authorization available under the December 2017 authorization.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level&#160;1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations approximate their fair values under Level 3 calculations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In 2018, the Company entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activity"). The fair value of these derivative instruments was </font><font style="font-family:inherit;font-size:9pt;">$33.9 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$22.4 million</font><font style="font-family:inherit;font-size:9pt;"> at </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">294.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(153.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(149.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average remaining lease term (years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from operating leases </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use assets obtained in exchange for lease obligations:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"></font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the three months ended March 31, 2019 (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Statement of Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of leased assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest on lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Variable and short term lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Leases</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years, and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at March 31, 2019 (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Balance Sheets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment, net of accumulated depreciation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total leased assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">432.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">134.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">436.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the three months ended March 31, 2019 (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Statement of Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of leased assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest on lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Variable and short term lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the three months ended March 31, 2019, the Company incurred lease expense of </font><font style="font-family:inherit;font-size:9pt;">$5.2 million</font><font style="font-family:inherit;font-size:9pt;"> under operating lease agreements with physician investors who are related parties. During the three months ended March 31, 2019, the Company paid rent of </font><font style="font-family:inherit;font-size:9pt;">$1.6 million</font><font style="font-family:inherit;font-size:9pt;"> under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average remaining lease term (years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from operating leases </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use assets obtained in exchange for lease obligations:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">294.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(153.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(149.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">470.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements.&#160;As of December 31, 2018, the current portion of the financing obligations was </font><font style="font-family:inherit;font-size:7pt;">$7.0 million</font><font style="font-family:inherit;font-size:7pt;"> and was included in other current liabilities in the consolidated balance sheets.&#160;The long-term portions of the finance obligations were </font><font style="font-family:inherit;font-size:7pt;">$149.8 million</font><font style="font-family:inherit;font-size:7pt;"> and was included as other long-term liabilities in the consolidated balance sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years, and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">294.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(153.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(149.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Leases</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years, and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at March 31, 2019 (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Balance Sheets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment, net of accumulated depreciation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total leased assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">432.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">134.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">436.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the three months ended March 31, 2019 (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Statement of Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of leased assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest on lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Variable and short term lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the three months ended March 31, 2019, the Company incurred lease expense of </font><font style="font-family:inherit;font-size:9pt;">$5.2 million</font><font style="font-family:inherit;font-size:9pt;"> under operating lease agreements with physician investors who are related parties. During the three months ended March 31, 2019, the Company paid rent of </font><font style="font-family:inherit;font-size:9pt;">$1.6 million</font><font style="font-family:inherit;font-size:9pt;"> under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average remaining lease term (years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from operating leases </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use assets obtained in exchange for lease obligations:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">294.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(153.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(149.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">470.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements.&#160;As of December 31, 2018, the current portion of the financing obligations was </font><font style="font-family:inherit;font-size:7pt;">$7.0 million</font><font style="font-family:inherit;font-size:7pt;"> and was included in other current liabilities in the consolidated balance sheets.&#160;The long-term portions of the finance obligations were </font><font style="font-family:inherit;font-size:7pt;">$149.8 million</font><font style="font-family:inherit;font-size:7pt;"> and was included as other long-term liabilities in the consolidated balance sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Long-Term Debt</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of long-term debt is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revolver</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,444.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,447.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes payable and secured loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease obligations </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: unamortized debt issuance costs and original issue discount</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,441.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,326.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: Current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,384.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,270.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes unamortized fair value discount of </font><font style="font-family:inherit;font-size:7pt;">$5.4 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$5.5 million</font><font style="font-family:inherit;font-size:7pt;"> as of </font><font style="font-family:inherit;font-size:7pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:7pt;"> and December 31, 2018, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes unamortized fair value premium of </font><font style="font-family:inherit;font-size:7pt;">$6.1 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$6.7 million</font><font style="font-family:inherit;font-size:7pt;"> as of </font><font style="font-family:inherit;font-size:7pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:7pt;"> and December 31, 2018, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company&#8217;s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was </font><font style="font-family:inherit;font-size:9pt;">$18.0 million</font><font style="font-family:inherit;font-size:9pt;"> reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company&#8217;s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> Other Assets and Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Assets</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term assets is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">318.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Current Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other current liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued legal settlement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts due to patients and payors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">191.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">155.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Facility lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">114.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">271.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other current liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued legal settlement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts due to patients and payors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">191.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">155.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Assets and Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Assets</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term assets is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">318.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Current Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other current liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued legal settlement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts due to patients and payors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">191.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">155.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Facility lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">114.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">271.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Facility lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">114.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">271.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities&#8217; cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, the Company had a net third-party Medicaid settlements liability of </font><font style="font-family:inherit;font-size:9pt;">$7.6 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$4.8 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, included in other current liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient&#8217;s insurance prior to the patient&#8217;s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,417.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,204.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">82.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">358.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">399.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,880.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,676.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(42.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent acquisition compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction, integration and acquisition costs </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Reserve adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on disposals and deconsolidations, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Tax receivable agreement expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount includes transaction and integration costs of </font><font style="font-family:inherit;font-size:7pt;">$2.0 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$5.0 million</font><font style="font-family:inherit;font-size:7pt;"> for </font><font style="font-family:inherit;font-size:7pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:7pt;"> </font><font style="font-family:inherit;font-size:7pt;">2019</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">2018</font><font style="font-family:inherit;font-size:7pt;">, respectively. This amount includes acquisition costs of </font><font style="font-family:inherit;font-size:7pt;">$0.2 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$0.5 million</font><font style="font-family:inherit;font-size:7pt;"> for </font><font style="font-family:inherit;font-size:7pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:7pt;"> </font><font style="font-family:inherit;font-size:7pt;">2019</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">2018</font><font style="font-family:inherit;font-size:7pt;">, respectively. This amount includes start-up costs related to a de novo surgical hospital of </font><font style="font-family:inherit;font-size:7pt;">$1.2 million</font><font style="font-family:inherit;font-size:7pt;"> for the three months ended March 31, 2019. There were </font><font style="font-family:inherit;font-size:7pt;">no</font><font style="font-family:inherit;font-size:7pt;"> comparable costs in the 2018 period.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the non-controlling interests&#8212;redeemable is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">326.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests&#8212;redeemable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition and disposal of shares of non-controlling interests, net&#8212;redeemable </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distributions to non-controlling interest&#8212;redeemable holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">314.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes post acquisition date adjustments.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues. </font><font style="font-family:inherit;font-size:9pt;">This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the carrying amounts and fair values of the Company's long-term debt follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,444.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,447.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,417.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,382.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">411.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">407.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">333.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">320.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of long-term debt is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revolver</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,444.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,447.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes payable and secured loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease obligations </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: unamortized debt issuance costs and original issue discount</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,441.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,326.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: Current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,384.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,270.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes unamortized fair value discount of </font><font style="font-family:inherit;font-size:7pt;">$5.4 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$5.5 million</font><font style="font-family:inherit;font-size:7pt;"> as of </font><font style="font-family:inherit;font-size:7pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:7pt;"> and December 31, 2018, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes unamortized fair value premium of </font><font style="font-family:inherit;font-size:7pt;">$6.1 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$6.7 million</font><font style="font-family:inherit;font-size:7pt;"> as of </font><font style="font-family:inherit;font-size:7pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:7pt;"> and December 31, 2018, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands): </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to Surgery Partners, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(17.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: amounts allocated to participating securities </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding- basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,047</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effect of dilutive securities </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding- diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,047</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,007</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss per share:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.60</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.53</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Diluted </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.53</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted shares</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Convertible preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">470.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements.&#160;As of December 31, 2018, the current portion of the financing obligations was </font><font style="font-family:inherit;font-size:7pt;">$7.0 million</font><font style="font-family:inherit;font-size:7pt;"> and was included in other current liabilities in the consolidated balance sheets.&#160;The long-term portions of the finance obligations were </font><font style="font-family:inherit;font-size:7pt;">$149.8 million</font><font style="font-family:inherit;font-size:7pt;"> and was included as other long-term liabilities in the consolidated balance sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">470.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements.&#160;As of December 31, 2018, the current portion of the financing obligations was </font><font style="font-family:inherit;font-size:7pt;">$7.0 million</font><font style="font-family:inherit;font-size:7pt;"> and was included in other current liabilities in the consolidated balance sheets.&#160;The long-term portions of the finance obligations were </font><font style="font-family:inherit;font-size:7pt;">$149.8 million</font><font style="font-family:inherit;font-size:7pt;"> and was included as other long-term liabilities in the consolidated balance sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to goodwill for the </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:9pt;"> is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,382.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisitions, including post acquisition adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Divestitures and deconsolidations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,393.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term assets is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">318.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">215.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">216.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">164.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">156.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">410.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">404.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">416.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">411.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types. </font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following tables present financial information for each reportable segment (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">395.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">388.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">416.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">411.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash purchases of property and equipment, net:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of revenues by service type as a percentage of total revenues follows:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Surgical facilities revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Ancillary services revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Segment Reporting</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company operates in&#160;</font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;">&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. The surgical facility services segment consists of the operation of ASCs and surgical hospitals, and includes anesthesia services. The ancillary services segment consists of a diagnostic laboratory and multi-specialty physician practices. The optical services segment consists of an optical products group purchasing organization. "All other" primarily consists of the Company's corporate general and administrative functions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following tables present financial information for each reportable segment (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">395.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">388.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">416.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">411.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash purchases of property and equipment, net:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(42.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent acquisition compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction, integration and acquisition costs </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Reserve adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on disposals and deconsolidations, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Tax receivable agreement expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount includes transaction and integration costs of </font><font style="font-family:inherit;font-size:7pt;">$2.0 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$5.0 million</font><font style="font-family:inherit;font-size:7pt;"> for </font><font style="font-family:inherit;font-size:7pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:7pt;"> </font><font style="font-family:inherit;font-size:7pt;">2019</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">2018</font><font style="font-family:inherit;font-size:7pt;">, respectively. This amount includes acquisition costs of </font><font style="font-family:inherit;font-size:7pt;">$0.2 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$0.5 million</font><font style="font-family:inherit;font-size:7pt;"> for </font><font style="font-family:inherit;font-size:7pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:7pt;"> </font><font style="font-family:inherit;font-size:7pt;">2019</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">2018</font><font style="font-family:inherit;font-size:7pt;">, respectively. This amount includes start-up costs related to a de novo surgical hospital of </font><font style="font-family:inherit;font-size:7pt;">$1.2 million</font><font style="font-family:inherit;font-size:7pt;"> for the three months ended March 31, 2019. There were </font><font style="font-family:inherit;font-size:7pt;">no</font><font style="font-family:inherit;font-size:7pt;"> comparable costs in the 2018 period.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,417.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,204.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">82.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">358.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">399.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,880.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,676.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Subsequent Events</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As previously disclosed in a Current Report on Form 8-K filed on April 12, 2019, on April 11, 2019, the Company completed the issuance and sale of </font><font style="font-family:inherit;font-size:9pt;">$430.0 million</font><font style="font-family:inherit;font-size:9pt;"> in gross proceeds of senior unsecured notes due 2027 (the "2027 Unsecured Notes"). The 2027 Unsecured Notes bear interest at the rate of </font><font style="font-family:inherit;font-size:9pt;">10.000%</font><font style="font-family:inherit;font-size:9pt;"> per year, payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2019. The 2027 Unsecured Notes are senior unsecured obligations of Surgery Center Holdings, Inc. and are guaranteed on a senior unsecured basis by each of Surgery Center Holdings, Inc.'s existing and future domestic wholly-owned restricted subsidiaries that guarantees the existing 2017 Senior Secured Credit Facilities (subject to certain exceptions). In connection with issuance of the 2027 Unsecured Notes, the Company redeemed in whole the existing 2021 Unsecured Notes. The redemption price was equal to </font><font style="font-family:inherit;font-size:9pt;">104.438%</font><font style="font-family:inherit;font-size:9pt;"> of the outstanding principal amount plus accrued and unpaid interest. Additionally, as previously announced, on March 25, 2019, the Company entered into an amendment to the credit agreement governing its revolving credit facility. On April 11, 2019, in connection with the completion of the issuance of the 2027 Unsecured Notes, the outstanding commitments under the Company's revolving credit facility were increased by </font><font style="font-family:inherit;font-size:9pt;">$45.0 million</font><font style="font-family:inherit;font-size:9pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the redeemable preferred stock follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">359.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividends accrued</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash dividends declared</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">367.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</font></div></div> The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods. Includes post acquisition date adjustments. EX-101.SCH 8 sgry-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Acquisitions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2409401 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1006000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Derivatives and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 2406401 - Disclosure - Derivatives and Hedging Activities (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - Leases - Maturities of Leases Prior to Adoption of 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Organization and Summary of Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401410 - Disclosure - Organization and Summary of Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2401405 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2401409 - Disclosure - Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 2401406 - Disclosure - Organization and Summary of Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Organization and Summary of Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2401413 - Disclosure - Organization and Summary of Accounting Policies - Recent Accounting Pronouncements (Details) link:presentationLink link:calculationLink link:definitionLink 2401411 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) link:presentationLink link:calculationLink link:definitionLink 2401412 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) link:presentationLink link:calculationLink link:definitionLink 2401407 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) link:presentationLink link:calculationLink link:definitionLink 2401408 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Organization and Summary of Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Other Assets and Liabilities link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Other Assets and Liabilities - Other Long-term Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Other Assets and Liabilities - Other Long-Term Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Other Assets and Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Redeemable Preferred Stock link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Redeemable Preferred Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Redeemable Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Segment Reporting - Assets by Operating Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Segment Reporting - Revenues and Purchases of Property and Equipment by Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Segment Reporting - Segment Operating Income (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2414401 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 sgry-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 sgry-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 sgry-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Secured Debt Secured Debt [Member] Senior Notes Senior Notes [Member] Notes payable and secured loans Notes Payable and Secured Loans [Member] Notes Payable and Secured Loans [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Revolver 2017 Revolver Loan, Maturing 2022 [Member] 2017 Revolver Loan, Maturing 2022 [Member] Term Loan 2017 Term Loan, Maturing 2024 [Member] 2017 Term Loan, Maturing 2024 [Member] Senior Unsecured Notes Due 2021 Senior Unsecured Notes Due 2021 [Member] Senior Unsecured Notes Due 2021 [Member] Senior Unsecured Notes Due 2025 Senior Unsecured Notes Due 2025 [Member] Senior Unsecured Notes Due 2025 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Long-term debt Long-term Debt Total lease obligations Finance Lease, Liability Less: unamortized debt issuance costs and original issue discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Total debt Long-term Debt and Capital Lease Obligations, Including Current Maturities Less: Current maturities Long-term Debt and Capital Lease Obligations, Current Total long-term debt Long-term Debt and Capital Lease Obligations Unamortized fair value discount Debt Instrument, Unamortized Discount Unamortized fair value premium Debt Instrument, Unamortized Premium Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Carrying Amounts and Fair Values of Long-Term Debt Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Schedule of Revenues by Service Type Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of Revenue Sources for Patient Service Revenues Schedule of Revenue Sources, Health Care Organization [Table Text Block] Schedule of Rollforward of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Rollforward of Noncontrolling Interest - Redeemable Redeemable Noncontrolling Interest [Table Text Block] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Interest rate swap agreement Derivative Liability, Noncurrent Assets of SERP Deferred Compensation Plan Assets Statement of Comprehensive Income [Abstract] Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other comprehensive income, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Derivative activity Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: Comprehensive income attributable to non-controlling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive loss attributable to Surgery Partners, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Segment Reporting [Abstract] Segment Reporting Segment Reporting Disclosure [Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] All Other Corporate, Non-Segment [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Surgical Facility Services Surgical Facility Services [Member] Surgical Facility Services [Member] Ancillary Services Ancillary Services [Member] Ancillary Services [Member] Optical Services Optical Services [Member] Optical Services [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Assets Assets Income Statement [Abstract] Revenues Revenue from Contract with Customer, Including Assessed Tax Operating expenses: Operating Expenses [Abstract] Salaries and benefits Labor and Related Expense Supplies Supplies Expense Professional and medical fees Professional Fees Lease expense Operating Leases, Rent Expense, Net Other operating expenses Other Cost and Expense, Operating Cost of revenues Cost of Revenue General and administrative expenses General and Administrative Expense Depreciation and amortization Depreciation, Depletion and Amortization Income from equity investments Income (Loss) from Equity Method Investments Loss on disposals and deconsolidations, net Gain (Loss) On Disposition Of Assets And Deconsolidation Gain (Loss) On Disposition of Assets And Deconsolidation Transaction and integration costs Business Combination, Integration Related Costs Other income Other Nonrecurring (Income) Expense Total operating expenses Operating Expenses Operating income Operating Income (Loss) Tax receivable agreement expense Tax Receivable Agreement Expense (Benefit) Tax Receivable Agreement Expense (Benefit) Interest expense, net Interest Income (Expense), Nonoperating, Net Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Domestic Income tax expense Income Tax Expense (Benefit) Net income Less: Net income attributable to non-controlling interests Net Income (Loss) Attributable to Noncontrolling Interest Net loss attributable to Surgery Partners, Inc. Net Income (Loss) Attributable to Parent Less: Amounts attributable to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Net loss per share attributable to common stockholders Earnings Per Share, Basic and Diluted [Abstract] Basic (in USD per share) Earnings Per Share, Basic Diluted (in USD per share) Earnings Per Share, Diluted Weighted average common shares outstanding Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Basic (shares) Weighted Average Number of Shares Outstanding, Basic Diluted (shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and Contingencies Disclosure [Abstract] Schedule of Guarantor Obligations [Table] Schedule of Guarantor Obligations [Table] Unusual Risk or Uncertainty, Nature [Axis] Unusual Risk or Uncertainty, Nature [Axis] Unusual Risk or Uncertainty, Nature [Domain] Unusual Risk or Uncertainty, Nature [Domain] Materially More Restrictive Materially More Restrictive [Member] Materially More Restrictive [Member] Not Materially More Restrictive Not Materially More Restrictive [Member] Not Materially More Restrictive [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] LIBOR London Interbank Offered Rate (LIBOR) [Member] Guarantor Obligations [Line Items] Guarantor Obligations [Line Items] Professional, general and workers' compensation insurance reserve Self Insurance Reserve Expected insurance recoveries Estimated Insurance Recoveries Litigation related charge Gain (Loss) Related to Litigation Settlement Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Federal effective tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Long-term tax receivable agreement liability Deferred Income Tax Liabilities, Net Net long-term tax receivable agreement liability Deferred Income Tax Liabilities, Net Of Discount Deferred Income Tax Liabilities, Net Of Discount Current portion of tax liability Deferred Tax Liabilities, Net, Current Leases [Abstract] Operating Leases Operating Lease Liabilities, Payments Due [Abstract] 2019 Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months 2020 Lessee, Operating Lease, Liability, Payments, Due Year Two 2021 Lessee, Operating Lease, Liability, Payments, Due Year Three 2022 Lessee, Operating Lease, Liability, Payments, Due Year Four 2023 Lessee, Operating Lease, Liability, Payments, Due Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Total lease payments Lessee, Operating Lease, Liability, Payments, Due Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Total lease obligations Operating Lease, Liability Finance Leases Finance Lease Liabilities, Payments, Due [Abstract] 2019 Finance Lease, Liability, Payments, Due Next Twelve Months 2020 Finance Lease, Liability, Payments, Due Year Two 2021 Finance Lease, Liability, Payments, Due Year Three 2022 Finance Lease, Liability, Payments, Due Year Four 2023 Finance Lease, Liability, Payments, Due Year Five Thereafter Finance Lease, Liability, Payments, Due after Year Five Total lease payments Finance Lease, Liability, Payments, Due Less: imputed interest Finance Lease, Liability, Undiscounted Excess Amount Temporary Equity Disclosure [Abstract] Redeemable Preferred Stock Redeemable Preferred Stock [Text Block] Redeemable Preferred Stock [Text Block] Non-Controlling Interests - Redeemable [Roll Forward] Redeemable Noncontrolling Interest [Roll Forward] Redeemable Noncontrolling Interest [Roll Forward] Beginning balance Redeemable Noncontrolling Interest, Equity, Carrying Amount Net income attributable to non-controlling interests—redeemable Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Acquisition and disposal of shares of non-controlling interests, net—redeemable Redeemable Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests Distributions to non-controlling interest—redeemable holders Redeemable Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Ending balance Organization and Summary of Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Adjusted EBITDA Earnings Before Interest Taxes Depreciation And Amortization Earnings Before Interest Taxes Depreciation And Amortization Net income attributable to non-controlling interests Depreciation and amortization Equity-based compensation Share-based Compensation Contingent acquisition compensation expense Business Combination, Contingent Acquisition Expense Business Combination, Contingent Acquisition Expense Transaction, integration and practice acquisition costs Business Combination, Integration Related Costs, And Merger Costs Business Combination, Integration Related Costs, And Merger Costs Reserve adjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired Loss on disposals and deconsolidations, net Practice acquisition costs Business Combination, Practice Acquisition Costs Business Combination, Practice Acquisition Costs Start-up costs related to de novo surgical hospital Start-Up Activities, Start-Up Costs Start-Up Activities, Start-Up Costs Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Senior Unsecured Notes, Due 2027 Senior Unsecured Notes, Due 2027 [Member] Senior Unsecured Notes, Due 2027 [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Face value of debt issued Debt Instrument, Face Amount Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Redemption price of debt Debt Instrument, Redemption Price, Percentage Outstanding commitments under revolving credit facility Line of Credit Facility, Fair Value of Amount Outstanding Subsequent Events Subsequent Events [Text Block] Products and Services [Table] Products and Services [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Facilities, Ambulatory Surgery Centers Facilities, Ambulatory Surgery Centers [Member] Facilities, Ambulatory Surgery Centers [Member] Facilities, Surgical Hospitals Facilities, Surgical Hospitals [Member] Facilities, Surgical Hospitals [Member] Products And Services [Line Items] Products And Services [Line Items] Products And Services [Line Items] Number of surgical facilities owned Number of Surgical Facilities Owned Number of Surgical Facilities Owned Number of states in which entity operates Number of States in which Entity Operates Number of surgical facilities owned, majority interest Number of Surgical Facilities Owned, Majority Interest Number of Surgical Facilities Owned, Majority Interest Number of surgical facilities owned, consolidated Number of Surgical Facilities Owned, Consolidated Number of Surgical Facilities Owned, Consolidated Third-Party Medicaid settlement liability Third-Party Settlements Payable, Current Third-Party Settlements Payable, Current Optical products receivable Optical Products Receivable Optical Products Receivable Business Combinations [Abstract] Acquisitions Business Combination Disclosure [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Revenues Revenue from Contract with Customer [Policy Text Block] Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts Receivables, Policy [Policy Text Block] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Derivative Instruments and Hedging Activities Derivatives, Policy [Policy Text Block] Non-Controlling Interests—Redeemable Redeemable Noncontrolling Interest [Policy Text Block] Redeemable Noncontrolling Interest [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Financial Information by Reportable Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Operating Income Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Reconciliation of Assets from Segment to Consolidated Reconciliation of Assets from Segment to Consolidated [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivatives and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Balance Sheet Related Disclosures [Abstract] Right-of-use operating lease assets Operating Lease, Right-of-Use Asset Other Other Assets, Miscellaneous, Noncurrent Total Other Assets, Noncurrent Statement of Financial Position [Abstract] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Redeemable preferred stock, shares authorized (shares) Temporary Equity, Shares Authorized Redeemable preferred stock, shares issued (shares) Temporary Equity, Shares Issued Redeemable preferred stock, shares outstanding (shares) Temporary Equity, Shares Outstanding Redeemable preferred stock, redemption value Redeemable Noncontrolling Interest, Equity, Preferred, Redemption Value Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (shares) Common Stock, Shares Authorized Common stock, shares issued (shares) Common Stock, Shares, Issued Common stock, shares outstanding (shares) Common Stock, Shares, Outstanding Schedule of Components of Right-of-use Assets and Liabilities Related to Leases Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Schedule of Lease Expense and Cash Flow Information Lease, Cost [Table Text Block] Maturity of Operating Leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Maturity of Finance Leases Finance Lease, Liability, Maturity [Table Text Block] Maturity of Leases Prior to Adoption of 842 Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Maturity of Leases Prior to Adoption of 842 Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block] Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Revenue Source Product Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Revenue Sales Revenue, Net [Member] Healthcare Organization, Patient Service Healthcare Organization, Patient Service [Member] Healthcare Organization, Patient Service [Member] Healthcare Organization, Other Service Healthcare Organization, Other Service [Member] Healthcare Organization, Other Service [Member] Optical Services Other Other Services [Member] Other Services [Member] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Service revenues as a percentage of total revenues Concentration Risk, Percentage Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Non-cash interest income, net Noncash Interest Income (Expense), Net Noncash Interest Income (Expense), Net Non-cash lease expense Amortization of Leased Asset Equity-based compensation Deferred income taxes Deferred Income Tax Expense (Benefit) Income from equity investments, net of distributions received Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Changes in operating assets and liabilities, net of acquisitions and divestitures: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Other operating assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Payments for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Proceeds from disposals of facilities and other assets Payments for (Proceeds from) Productive Assets Other investing activities Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Principal payments on long-term debt Repayments of Long-term Debt Borrowings of long-term debt Proceeds from Issuance of Long-term Debt Payments of preferred dividends Payments of Ordinary Dividends, Preferred Stock and Preference Stock Distributions to non-controlling interest holders Payments of Ordinary Dividends, Noncontrolling Interest Receipts (payments) related to ownership transactions with non-controlling interest holders Proceeds from (Payments to) Noncontrolling Interests Repurchase of shares Payments for Repurchase of Equity Other financing activities Proceeds from (Payments for) Other Financing Activities Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of period Long-Term Debt Long-term Debt [Text Block] Earnings Per Share [Abstract] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock options Employee Stock Option [Member] Restricted shares Restricted Stock [Member] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Net loss attributable to Surgery Partners, Inc. Less: amounts allocated to participating securities Undistributed Earnings (Loss) Allocated To Participating Securities, Basic, Net Of Temporary Equity Adjustments Undistributed Earnings (Loss) Allocated To Participating Securities, Basic, Net Of Temporary Equity Adjustments Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average shares outstanding- basic (shares) Effect of dilutive securities (shares) Weighted Average Number Diluted Shares Outstanding Adjustment Weighted average shares outstanding- diluted (shares) Loss per share: Antidilutive securities excluded from computation of (loss) per share (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Authorized share repurchase amount Stock Repurchase Program, Authorized Amount Stock repurchased (shares) Treasury Stock, Shares, Acquired Average repurchase cost (in USD per share) Treasury Stock Acquired, Average Cost Per Share Remaining repurchase authorization available Stock Repurchase Program, Remaining Authorized Repurchase Amount Schedule of Revenue Sources, Health Care Organization [Table] Schedule of Revenue Sources, Health Care Organization [Table] Health Care Organization, Revenue Sources [Axis] Health Care Organization, Revenue Sources [Axis] Health Care Organization, Revenue Sources [Domain] Health Care Organization, Revenue Sources [Domain] Private insurance Private Insurance [Member] Private Insurance [Member] Government Government [Member] Self-pay Self-Pay [Member] Other Other Patient Service Revenue Sources [Member] Other Patient Service Revenue Sources [Member] Customer Customer Concentration Risk [Member] Health Care Organization, Receivable and Revenue Disclosures [Line Items] Health Care Organization, Receivable and Revenue Disclosures [Line Items] Total revenues Restricted invested assets included in other long-term assets Restricted Cash and Investments, Noncurrent Schedule of Other Long-term Assets Schedule of Other Assets, Noncurrent [Table Text Block] Summary of Other Current Liabilities Other Current Liabilities [Table Text Block] Summary of Other Long-term Liabilities Other Noncurrent Liabilities [Table Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Activity Related to Redeemable Preferred Stock Temporary Equity [Table Text Block] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable Accounts Receivable, Net, Current Inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net of accumulated depreciation of $59.9 and $56.1, respectively Property, Plant and Equipment, Net, Excluding Capital Leased Assets Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Investments in and advances to affiliates Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Long-term deferred tax assets Deferred Tax Assets, Net, Noncurrent Other long-term assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued payroll and benefits Employee-related Liabilities, Current Other current liabilities Other Liabilities, Current Current maturities of long-term debt Total current liabilities Liabilities, Current Long-term debt, less current maturities Other long-term liabilities Other Liabilities, Noncurrent Non-controlling interests—redeemable Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $367.8 and $359.3, respectively Temporary Equity, Carrying Amount, Attributable to Parent Stockholders' equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none Preferred Stock, Value, Issued Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 49,385,974 and 48,869,204, respectively Common Stock, Value, Outstanding Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained deficit Retained Earnings (Accumulated Deficit) Total Surgery Partners, Inc. stockholders' equity Stockholders' Equity Attributable to Parent Non-controlling interests—non-redeemable Stockholders' Equity Attributable to Noncontrolling Interest Total stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and stockholders' equity Liabilities and Equity Cumulative effect of accounting change, adjustment to retained deficit Cumulative Effect of New Accounting Principle in Period of Adoption Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Emerging Growth Company Entity Emerging Growth Company Entity Small Business Entity Small Business Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Series A Preferred Stock Series A Preferred Stock [Member] Temporary Equity [Line Items] Temporary Equity [Line Items] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Beginning balance Dividends accrued Temporary Equity, Accretion of Dividends Cash dividends declared Temporary Equity, Dividends, Adjustment Ending balance Accrued legal settlement Estimated Litigation Liability, Current Right-of-use operating lease liabilities Operating Lease, Liability, Current Interest payable Interest Payable, Current Amounts due to patients and payors Payables to Customers Accrued expenses and other Other Accrued Liabilities, Current Total Assets: Operating lease assets Finance lease assets Finance Lease, Right-of-Use Asset Total leased assets Lease, Right-of-Use Asset Lease, Right-of-Use Asset Liabilities: Liabilities [Abstract] Operating lease liabilities: Operating Lease, Liability [Abstract] Operating Lease, Liability [Abstract] Current Long-term Operating Lease, Liability, Noncurrent Total operating lease liabilities Finance lease liabilities: Finance Lease, Liability [Abstract] Finance Lease, Liability [Abstract] Current Finance Lease, Liability, Current Long-term Finance Lease, Liability, Noncurrent Total finance lease liabilities Total lease liabilities Lease, Liability Lease, Liability Schedule of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Majority Shareholder Majority Shareholder [Member] Stock issued during period (shares) Stock Issued During Period, Shares, New Issues Purchase price per share (in USD per share) Shares Issued, Price Per Share Proceeds from issuance of preferred shares Stock Issued During Period, Value, New Issues Dividends payable Dividends Payable Cumulative preferred dividends Cumulative Dividends Preferred dividends payable (in USD per share) Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears Right-of-use operating lease liabilities Facility lease obligations Lease Obligation, Noncurrent Lease Obligation, Noncurrent Other Other Sundry Liabilities, Noncurrent Total Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Senior Unsecured Notes due 2021 Senior Unsecured Notes due 2025 Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Carrying Amount Reported Value Measurement [Member] Fair Value Estimate of Fair Value Measurement [Member] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Physician Practice Physician Practice [Member] Physician Practice [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Payments for acquisitions, net of cash acquired Number of businesses acquired Number of Businesses Acquired Earnings Per Share Earnings Per Share [Text Block] Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Variable Interest Entities [Axis] Variable Interest Entities [Axis] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure [Member] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Number of facilities included in VIE Variable Interest Entity, Number of Facilities Variable Interest Entity, Number of Facilities Total assets related to VIE Variable Interest Entity, Consolidated, Carrying Amount, Assets Total liabilities related to VIE Variable Interest Entity, Consolidated, Carrying Amount, Liabilities Summary of Long-term Debt Schedule of Debt [Table Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Goodwill, beginning of period Acquisitions, including post acquisition adjustments Goodwill, Acquired During Period Divestitures and deconsolidations Goodwill, Written Off Related To Sale Of Business Unit And Deconsolidations Goodwill, Written Off Related To Sale Of Business Unit And Deconsolidations Goodwill, end of period Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Noncontrolling Interest Noncontrolling Interest [Member] Physician Investors Investor [Member] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Operating lease costs Operating Lease, Cost Finance lease costs Finance Lease, Cost [Abstract] Amortization of leased assets Finance Lease, Right-of-Use Asset, Amortization Interest on lease liabilities Finance Lease, Interest Expense Total finance lease costs Finance Lease, Cost Finance Lease, Cost Variable and short term lease costs Variable Lease, Cost Total lease costs Lease, Cost Rent paid under finance lease agreement, allocated to principal and interest Finance Lease, Principal And Interest Payments Finance Lease, Principal And Interest Payments Weighted-average remaining lease term, operating leases Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term, finance leases Finance Lease, Weighted Average Remaining Lease Term Weighted-average discount rate, operating leases Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate, finance leases Finance Lease, Weighted Average Discount Rate, Percent Operating cash outflows from operating leases Operating Lease, Payments Operating cash outflows from finance leases Finance Lease, Interest Payment on Liability Financing cash outflows from finance leases Finance Lease, Principal Payments Right-of-use assets obtained in exchange for operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-use assets obtained in exchange for finance leases Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest Rate Swap One Interest Rate Swap [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Estimated reduction to interest expense Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Number of interest rate swaps Number of Interest Rate Derivatives Held Derivative notional amount Derivative, Notional Amount Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss) Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion Operating Leases (1) Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2019 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2020 Operating Leases, Future Minimum Payments, Due in Two Years 2021 Operating Leases, Future Minimum Payments, Due in Three Years 2022 Operating Leases, Future Minimum Payments, Due in Four Years 2023 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total lease payments Operating Leases, Future Minimum Payments Due Capital Leases Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2019 Capital Leases, Future Minimum Payments Due, Next Twelve Months 2020 Capital Leases, Future Minimum Payments Due in Two Years 2021 Capital Leases, Future Minimum Payments Due in Three Years 2022 Capital Leases, Future Minimum Payments Due in Four Years 2023 Capital Leases, Future Minimum Payments Due in Five Years Thereafter Capital Leases, Future Minimum Payments Due Thereafter Total lease payments Capital Leases, Future Minimum Payments Due Less: imputed interest Capital Leases, Future Minimum Payments, Interest Included in Payments Capital lease obligations Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments Current portion of finance lease Noncurrent portion of finance lease Leases Lessee, Finance Leases [Text Block] Leases Lessee, Operating Leases [Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Retained Deficit Retained Earnings [Member] Non-Controlling Interests— Non-Redeemable Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning Balance, stockholders' equity (shares) Beginning Balance, stockholders' equity Net (loss) income Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Equity-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Preferred dividends Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings Other comprehensive loss Issuance of restricted and unrestricted shares (shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Cancellation of restricted shares (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Cancellation of restricted shares Stock Issued During Period, Value, Restricted Stock Award, Forfeitures Repurchase of shares (shares) Stock Repurchased and Retired During Period, Shares Repurchase of shares Stock Repurchased and Retired During Period, Value Net effect of adoption of new accounting standard (see Note 1) Acquisition and disposal of shares of non-controlling interests, net (1) Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net Distributions to non-controlling interests—non-redeemable holders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Ending Balance, stockholders' equity (shares) Ending Balance, stockholders' equity Cash consideration Payments to Acquire Businesses, Gross Fair value of non-controlling interests Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Acquisition date fair value Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Net assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Aggregate acquisition date fair value Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Number of operating segments Number of Operating Segments Purchases of property and equipment, net Other Assets and Liabilities Other Assets Disclosure [Text Block] Other Assets and Liabilities Other Liabilities Disclosure [Text Block] EX-101.PRE 12 sgry-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 13 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2019
May 08, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name Surgery Partners, Inc.  
Entity Central Index Key 0001638833  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Document Type 10-Q  
Document Period End Date Mar. 31, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Entity Emerging Growth Company false  
Entity Small Business false  
Entity Common Stock, Shares Outstanding   49,428,103
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 142.5 $ 184.3
Accounts receivable 294.9 307.6
Inventories 43.8 43.4
Prepaid expenses and other current assets 54.1 53.0
Total current assets 535.3 588.3
Property and equipment, net of accumulated depreciation of $59.9 and $56.1, respectively 400.1 426.3
Intangible assets, net 54.3 54.3
Goodwill 3,393.0 3,382.8
Investments in and advances to affiliates 78.5 78.5
Long-term deferred tax assets 100.9 109.2
Other long-term assets 318.8 36.9
Total assets 4,880.9 4,676.3
Current liabilities:    
Accounts payable 69.7 83.3
Accrued payroll and benefits 41.0 55.2
Other current liabilities 191.8 155.2
Current maturities of long-term debt 57.1 55.6
Total current liabilities 359.6 349.3
Long-term debt, less current maturities 2,384.6 2,270.9
Other long-term liabilities 370.0 271.3
Non-controlling interests—redeemable 314.6 326.6
Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $367.8 and $359.3, respectively 367.8 359.3
Stockholders' equity:    
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none 0.0 0.0
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 49,385,974 and 48,869,204, respectively 0.5 0.5
Additional paid-in capital 673.9 673.5
Accumulated other comprehensive loss (33.9) (22.4)
Retained deficit (249.1) (247.0)
Total Surgery Partners, Inc. stockholders' equity 391.4 404.6
Non-controlling interests—non-redeemable 692.9 694.3
Total stockholders' equity 1,084.3 1,098.9
Total liabilities and stockholders' equity $ 4,880.9 $ 4,676.3
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Accumulated depreciation $ 59.9 $ 56.1
Redeemable preferred stock, shares authorized (shares) 310,000 310,000
Redeemable preferred stock, shares issued (shares) 310,000 310,000
Redeemable preferred stock, shares outstanding (shares) 310,000 310,000
Redeemable preferred stock, redemption value $ 367.8 $ 359.3
Preferred stock, par value (in USD per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (shares) 20,000,000 20,000,000
Preferred stock, shares issued (shares) 0 0
Preferred stock, shares outstanding (shares) 0 0
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock, shares authorized (shares) 300,000,000 300,000,000
Common stock, shares issued (shares) 49,385,974 48,869,204
Common stock, shares outstanding (shares) 49,385,974 48,869,204
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Revenues $ 416.8 $ 411.3
Operating expenses:    
Salaries and benefits 129.2 129.7
Supplies 115.0 114.4
Professional and medical fees 35.1 35.7
Lease expense 20.6 21.4
Other operating expenses 26.2 26.1
Cost of revenues 326.1 327.3
General and administrative expenses 21.7 24.2
Depreciation and amortization 18.8 15.7
Income from equity investments (2.0) (1.9)
Loss on disposals and deconsolidations, net 0.6 0.0
Transaction and integration costs 2.0 5.0
Other income 0.0 (0.2)
Total operating expenses 367.2 370.1
Operating income 49.6 41.2
Tax receivable agreement expense (2.4) 0.0
Interest expense, net (42.0) (34.3)
Income before income taxes 5.2 6.9
Income tax expense 1.7 1.8
Net income 3.5 5.1
Less: Net income attributable to non-controlling interests (23.6) (22.6)
Net loss attributable to Surgery Partners, Inc. (20.1) (17.5)
Less: Amounts attributable to participating securities (8.5) (7.8)
Net loss attributable to common stockholders $ (28.6) $ (25.3)
Net loss per share attributable to common stockholders    
Basic (in USD per share) $ (0.60) $ (0.53)
Diluted (in USD per share) [1] $ (0.60) $ (0.53)
Weighted average common shares outstanding    
Basic (shares) 48,047 48,007
Diluted (shares) [1] 48,047 48,007
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Statement of Comprehensive Income [Abstract]    
Net income $ 3.5 $ 5.1
Other comprehensive income, net of tax:    
Derivative activity (11.5) 0.0
Comprehensive (loss) income (8.0) 5.1
Less: Comprehensive income attributable to non-controlling interests (23.6) (22.6)
Comprehensive loss attributable to Surgery Partners, Inc. $ (31.6) $ (17.5)
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Deficit
Non-Controlling Interests— Non-Redeemable
Beginning Balance, stockholders' equity (shares) at Dec. 31, 2017   48,687,000        
Beginning Balance, stockholders' equity at Dec. 31, 2017 $ 1,336.6 $ 0.5 $ 695.5 $ 0.0 $ (41.3) $ 681.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (1.6)       (17.5) 15.9
Equity-based compensation 2.0   2.0      
Preferred dividends (7.8)   (7.8)      
Other comprehensive loss 0.0          
Issuance of restricted and unrestricted shares (shares)   440,000        
Cancellation of restricted shares (in shares)   (72,000)        
Cancellation of restricted shares (0.7)   (0.7)      
Repurchase of shares (shares)   (157,000)        
Repurchase of shares (2.0)   (2.0)      
Acquisition and disposal of shares of non-controlling interests, net (1) [1] 0.8   2.0     (1.2)
Distributions to non-controlling interests—non-redeemable holders (22.5)         (22.5)
Ending Balance, stockholders' equity (shares) at Mar. 31, 2018   48,898,000        
Ending Balance, stockholders' equity at Mar. 31, 2018 $ 1,304.8 $ 0.5 689.0 0.0 (58.8) 674.1
Beginning Balance, stockholders' equity (shares) at Dec. 31, 2018 48,869,204 48,869,000        
Beginning Balance, stockholders' equity at Dec. 31, 2018 $ 1,098.9 $ 0.5 673.5 (22.4) (247.0) 694.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (4.1)       (20.1) 16.0
Equity-based compensation 1.9   1.9      
Preferred dividends (8.5)   (8.5)      
Other comprehensive loss (11.5)     (11.5)    
Issuance of restricted and unrestricted shares (shares)   593,000        
Cancellation of restricted shares (in shares)   (76,000)        
Cancellation of restricted shares (1.0)   (1.0)      
Acquisition and disposal of shares of non-controlling interests, net (1) [1] 14.1   8.0     6.1
Distributions to non-controlling interests—non-redeemable holders $ (23.5)         (23.5)
Ending Balance, stockholders' equity (shares) at Mar. 31, 2019 49,385,974 49,386,000        
Ending Balance, stockholders' equity at Mar. 31, 2019 $ 1,084.3 $ 0.5 $ 673.9 $ (33.9) $ (249.1) $ 692.9
[1] Includes post acquisition date adjustments.
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income $ 3.5 $ 5.1
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 18.8 15.7
Non-cash interest income, net (0.3) (0.1)
Non-cash lease expense 10.1 0.0
Equity-based compensation 1.9 2.0
Loss on disposals and deconsolidations, net 0.6 0.0
Deferred income taxes 1.3 1.4
Income from equity investments, net of distributions received 0.2 0.3
Changes in operating assets and liabilities, net of acquisitions and divestitures:    
Accounts receivable 13.4 14.1
Other operating assets and liabilities (29.0) (8.5)
Net cash provided by operating activities 20.5 30.0
Cash flows from investing activities:    
Purchases of property and equipment (11.8) (10.0)
Payments for acquisitions, net of cash acquired (7.6) (25.6)
Proceeds from disposals of facilities and other assets 1.2 0.0
Other investing activities (0.2) (0.8)
Net cash used in investing activities (18.4) (36.4)
Cash flows from financing activities:    
Principal payments on long-term debt (12.9) (16.3)
Borrowings of long-term debt 2.4 0.4
Payments of preferred dividends 0.0 (3.9)
Distributions to non-controlling interest holders (33.8) (30.9)
Receipts (payments) related to ownership transactions with non-controlling interest holders 1.5 (0.8)
Repurchase of shares 0.0 (2.0)
Other financing activities (1.1) (2.2)
Net cash used in financing activities (43.9) (55.7)
Net decrease in cash, cash equivalents and restricted cash (41.8) (62.1)
Cash, cash equivalents and restricted cash at beginning of period 184.6 175.2
Cash, cash equivalents and restricted cash at end of period $ 142.8 $ 113.1
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Summary of Accounting Policies
Organization and Summary of Accounting Policies
Organization
Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."
As of March 31, 2019, the Company owned or operated a portfolio of 123 surgical facilities, comprised of 108 ASCs and 15 surgical hospitals in 31 states. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in 84 of the surgical facilities and consolidated 106 of these facilities for financial reporting purposes.
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Boards ("FASB") Accounting Standards Codification 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of both March 31, 2019 and December 31, 2018, the consolidated VIEs include four surgical facilities, three anesthesia practices and four physician practices.
The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of March 31, 2019 and December 31, 2018, were $11.0 million and $11.2 million, respectively, and the total liabilities of the consolidated VIEs were $3.4 million and $3.6 million, respectively.
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.
A summary of the carrying amounts and fair values of the Company's long-term debt follows (in millions):
 
 
Carrying Amount
 
Fair Value
 
 
March 31,
2019
 
December 31,
2018
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
 
 
 
 
Term Loan
 
$
1,444.4

 
$
1,447.9

 
$
1,417.3

 
$
1,382.8

Senior Unsecured Notes due 2021
 
$
406.1

 
$
406.7

 
$
411.2

 
$
407.2

Senior Unsecured Notes due 2025
 
$
370.0

 
$
370.0

 
$
333.0

 
$
320.5


The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations approximate their fair values under Level 3 calculations.
In 2018, the Company entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activity"). The fair value of these derivative instruments was $33.9 million and $22.4 million at March 31, 2019 and December 31, 2018, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation. As of March 31, 2019 and December 31, 2018, the fair value of both the assets and liabilities in the SERP were $1.3 million and $1.4 million, respectively, and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.
Revenues
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
A summary of revenues by service type as a percentage of total revenues follows:
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Patient service revenues:
 
 
 
 
   Surgical facilities revenues
 
93.8
%
 
93.5
%
   Ancillary services revenues
 
4.7
%
 
4.9
%
 
 
98.5
%
 
98.4
%
Other service revenues:
 
 
 
 
   Optical services revenues
 
0.3
%
 
0.7
%
   Other revenues
 
1.2
%
 
0.9
%
 
 
1.5
%
 
1.6
%
Total revenues
 
100.0
%
 
100.0
%

Patient service revenues. This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.
Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Other service revenues. Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
215.3

 
52.4
%
 
$
216.5

 
53.5
%
Government
 
164.9

 
40.2
%
 
156.9

 
38.8
%
Self-pay
 
10.8

 
2.6
%
 
12.8

 
3.1
%
Other (1)
 
19.8

 
4.8
%
 
18.5

 
4.6
%
Total patient service revenues
 
410.8

 
100.0
%
 
404.7

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
1.1

 
 
 
2.9

 
 
Other revenues
 
4.9

 
 
 
3.7

 
 
Total revenues
 
$
416.8

 
 
 
$
411.3

 
 
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Cash, Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.
Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both March 31, 2019 and December 31, 2018. These restricted investments represents restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities’ cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.
Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of March 31, 2019 and December 31, 2018, the Company had a net third-party Medicaid settlements liability of $7.6 million and $4.8 million, respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient’s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were $10.6 million and $8.5 million at March 31, 2019 and December 31, 2018, respectively.
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the three months ended March 31, 2019 is included in Note 2. "Acquisitions."
A summary of activity related to goodwill for the three months ended March 31, 2019 is as follows (in millions):
Balance at December 31, 2018
 
$
3,382.8

Acquisitions, including post acquisition adjustments
 
10.2

Divestitures and deconsolidations
 

Balance at March 31, 2019
 
$
3,393.0


Derivative Instruments and Hedging Activities
In accordance with Accounting Standards Codification 815, Derivatives and Hedging, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interestsredeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.
A summary of activity related to the non-controlling interests—redeemable is as follows (in millions):
Balance at December 31, 2018
 
$
326.6

Net income attributable to non-controlling interests—redeemable
 
7.6

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
(9.3
)
Distributions to non-controlling interest—redeemable holders
 
(10.3
)
Balance at March 31, 2019
 
$
314.6

(1)
Includes post acquisition date adjustments.
Income Taxes
The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in healthcare regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.
The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company’s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.
The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was $18.0 million reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.
The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company’s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions
3 Months Ended
Mar. 31, 2019
Business Combinations [Abstract]  
Acquisitions
Acquisitions
During the three months ended March 31, 2019, the Company paid cash consideration of $7.6 million for acquisitions, which primarily consisted of a physician practice. The acquisition was funded through cash from operations. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):
Cash consideration
 
$
7.6

Fair value of non-controlling interests
 
3.7

Aggregate acquisition date fair value
 
$
11.3

Net assets acquired:
 
 
Current Assets
 
$
0.6

Property and equipment
 
0.2

Goodwill
 
10.6

Current liabilities
 
(0.1
)
Aggregate acquisition date fair value
 
$
11.3


The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the three months ended March 31, 2019, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2018. The goodwill acquired was primarily allocated to the Company's ancillary services reportable segment. The results of operations of the acquisitions are included in the Company’s results of operations beginning on the dates of acquisition, and were not considered significant for the three months ended March 31, 2019.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Long-Term Debt
3 Months Ended
Mar. 31, 2019
Debt Disclosure [Abstract]  
Long-Term Debt
Long-Term Debt
A summary of long-term debt is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Revolver
 
$

 
$

Term Loan (1)
 
1,444.4

 
1,447.9

Senior Unsecured Notes due 2021 (2)

406.1

 
406.7

Senior Unsecured Notes due 2025
 
370.0

 
370.0

Notes payable and secured loans
 
79.3

 
79.4

Finance lease obligations (3)
 
144.6

 
25.4

Less: unamortized debt issuance costs and original issue discount
 
(2.7
)
 
(2.9
)
Total debt
 
2,441.7

 
2,326.5

Less: Current maturities
 
57.1

 
55.6

Total long-term debt
 
$
2,384.6

 
$
2,270.9


(1)
Includes unamortized fair value discount of $5.4 million and $5.5 million as of March 31, 2019 and December 31, 2018, respectively.
(2)
Includes unamortized fair value premium of $6.1 million and $6.7 million as of March 31, 2019 and December 31, 2018, respectively.
(3)
In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Leases
3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Leases
Leases
On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted.
The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities.
The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years, and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at March 31, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Balance Sheets
 
March 31, 2019
Assets:
 
 
 
 
Operating lease assets
 
Other long-term assets
 
$
288.3

Finance lease assets
 
Property and equipment, net of accumulated depreciation
 
144.0

Total leased assets
 
 
 
$
432.3

 
 
 
 
 
Liabilities:
 
 
 
 
Operating lease liabilities:
 
 
 
 
Current
 
Other current liabilities
 
$
36.6

Long-term
 
Other long-term liabilities
 
255.7

Total operating lease liabilities
 
 
 
292.3

Finance lease liabilities:
 
 
 
 
Current
 
Current maturities of long-term debt
 
10.2

Long-term
 
Long-term debt, less current maturities
 
134.4

Total finance lease liabilities
 
 
 
144.6

Total lease liabilities
 

 
$
436.9


The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the three months ended March 31, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Statement of Operations
 
March 31, 2019
 
 
 
 
 
Operating lease costs
 
Lease expense and general and administrative expenses
 
$
17.5

Finance lease costs
 
 
 
 
Amortization of leased assets
 
Depreciation and amortization
 
4.5

Interest on lease liabilities
 
Interest expense, net
 
3.8

Total finance lease costs
 
 
 
8.3

Variable and short term lease costs
 
Lease expense and general and administrative expenses
 
2.4

Total lease costs
 
 
 
$
28.2


During the three months ended March 31, 2019, the Company incurred lease expense of $5.2 million under operating lease agreements with physician investors who are related parties. During the three months ended March 31, 2019, the Company paid rent of $1.6 million under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.
The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):
 
 
March 31, 2019
Weighted-average remaining lease term (years)
 
 
Operating leases
 
8.4

Finance leases
 
13.4

Weighted-average discount rate
 
 
Operating leases
 
10.2
%
Finance leases
 
10.8
%
 
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Operating cash outflows from operating leases
 
$
16.8

Operating cash outflows from finance leases
 
$
3.8

Financing cash outflows from finance leases
 
$
2.3

 
 
 
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases
 
$
1.2

Finance leases
 
$
2.3


Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
51.2

 
$
20.4

2020
 
60.6

 
24.8

2021
 
52.9

 
22.9

2022
 
48.5

 
20.3

2023
 
45.1

 
18.4

Thereafter
 
187.5

 
187.4

Total lease payments
 
445.8

 
294.2

Less: imputed interest
 
(153.5
)
 
(149.6
)
Total lease obligations
 
$
292.3

 
$
144.6


Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portions of the finance obligations were $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
Leases
Leases
On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted.
The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities.
The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years, and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at March 31, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Balance Sheets
 
March 31, 2019
Assets:
 
 
 
 
Operating lease assets
 
Other long-term assets
 
$
288.3

Finance lease assets
 
Property and equipment, net of accumulated depreciation
 
144.0

Total leased assets
 
 
 
$
432.3

 
 
 
 
 
Liabilities:
 
 
 
 
Operating lease liabilities:
 
 
 
 
Current
 
Other current liabilities
 
$
36.6

Long-term
 
Other long-term liabilities
 
255.7

Total operating lease liabilities
 
 
 
292.3

Finance lease liabilities:
 
 
 
 
Current
 
Current maturities of long-term debt
 
10.2

Long-term
 
Long-term debt, less current maturities
 
134.4

Total finance lease liabilities
 
 
 
144.6

Total lease liabilities
 

 
$
436.9


The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the three months ended March 31, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Statement of Operations
 
March 31, 2019
 
 
 
 
 
Operating lease costs
 
Lease expense and general and administrative expenses
 
$
17.5

Finance lease costs
 
 
 
 
Amortization of leased assets
 
Depreciation and amortization
 
4.5

Interest on lease liabilities
 
Interest expense, net
 
3.8

Total finance lease costs
 
 
 
8.3

Variable and short term lease costs
 
Lease expense and general and administrative expenses
 
2.4

Total lease costs
 
 
 
$
28.2


During the three months ended March 31, 2019, the Company incurred lease expense of $5.2 million under operating lease agreements with physician investors who are related parties. During the three months ended March 31, 2019, the Company paid rent of $1.6 million under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.
The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):
 
 
March 31, 2019
Weighted-average remaining lease term (years)
 
 
Operating leases
 
8.4

Finance leases
 
13.4

Weighted-average discount rate
 
 
Operating leases
 
10.2
%
Finance leases
 
10.8
%
 
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Operating cash outflows from operating leases
 
$
16.8

Operating cash outflows from finance leases
 
$
3.8

Financing cash outflows from finance leases
 
$
2.3

 
 
 
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases
 
$
1.2

Finance leases
 
$
2.3


Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
51.2

 
$
20.4

2020
 
60.6

 
24.8

2021
 
52.9

 
22.9

2022
 
48.5

 
20.3

2023
 
45.1

 
18.4

Thereafter
 
187.5

 
187.4

Total lease payments
 
445.8

 
294.2

Less: imputed interest
 
(153.5
)
 
(149.6
)
Total lease obligations
 
$
292.3

 
$
144.6


Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portions of the finance obligations were $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Redeemable Preferred Stock
3 Months Ended
Mar. 31, 2019
Temporary Equity Disclosure [Abstract]  
Redeemable Preferred Stock
Redeemable Preferred Stock
On August 31, 2017, the Company issued 310,000 shares of Series A Preferred Stock to Bain at a purchase price of $1,000 per share for an aggregate purchase price of $310.0 million (the "Preferred Private Placement").
A summary of activity related to the redeemable preferred stock follows (in millions):
Balance at December 31, 2018
 
$
359.3

Dividends accrued
 
8.5

Cash dividends declared
 

Balance at March 31, 2019
 
$
367.8


There were no unpaid cash dividends declared at both March 31, 2019 and December 31, 2018. The aggregate and per share amounts of unpaid cumulative preferred dividends as of March 31, 2019 was $42.3 million and $136.31, respectively.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Derivatives and Hedging Activities
3 Months Ended
Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives and Hedging Activities
Derivatives and Hedging Activities
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During the first quarter of 2019, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company’s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. Over the next 12 months, the Company estimates that an additional $6.6 million will be reclassified as a reduction to interest expense.
As of both March 31, 2019 and December 31, 2018, the Company had three interest rate swaps with a current notional amount of $900.0 million and a termination date of November 30, 2023. The Company classifies its derivative financial instruments as a long-term liability included in other long-term liabilities in the condensed consolidated balance sheets.
For the three months ended March 31, 2019, the Company incurred losses related to the effective portion of derivatives, which were recognized in accumulated other comprehensive income, gross of tax effect, of $12.8 million. For the three months ended March 31, 2019, the Company reclassified $1.3 million of losses from accumulated other comprehensive income to interest expense, gross of tax effect. The Company held no derivative financial instruments during the three months ended March 31, 2018.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings Per Share
3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with ASC 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.
A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Numerator:
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
 
$
(20.1
)
 
$
(17.5
)
Less: amounts allocated to participating securities (1)
 
(8.5
)
 
(7.8
)
Net loss attributable to common stockholders
 
$
(28.6
)
 
$
(25.3
)
 
 
 
 
 
Denominator:
 
 
 
 
Weighted average shares outstanding- basic
 
48,047

 
48,007

Effect of dilutive securities (2)
 

 

Weighted average shares outstanding- diluted
 
48,047

 
48,007

 
 
 
 
 
Loss per share:
 
 
 
 
Basic
 
$
(0.60
)
 
$
(0.53
)
Diluted (2)
 
$
(0.60
)
 
$
(0.53
)
 
 
 
 
 
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
 
 
 
 
Stock options
 

 
123

Restricted shares
 
18

 
58

Convertible preferred stock
 
N/A

 
N/A

(1)
Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.
(2)
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
Share Repurchase Transactions
On December 15, 2017, the Company's Board of Directors authorized a share repurchase program of up to $50.0 million of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
There were no share repurchases under the share repurchase program during the three months ended March 31, 2019. During the three months ended March 31, 2018, the Company repurchased 156,818 shares of its common stock stock at an average price of $12.64 per share through market purchases. At March 31, 2019, the Company had $46.0 million of repurchase authorization available under the December 2017 authorization.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Other Assets and Liabilities
3 Months Ended
Mar. 31, 2019
Balance Sheet Related Disclosures [Abstract]  
Other Assets and Liabilities
Other Assets and Liabilities
Other Long-Term Assets
A summary of other long-term assets is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease assets
 
$
288.3

 
$

Other
 
30.5

 
36.9

Total
 
$
318.8

 
$
36.9


Other Current Liabilities
A summary of other current liabilities is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Accrued legal settlement
 
$
42.2

 
$
42.3

Right-of-use operating lease liabilities
 
36.6

 

Interest payable
 
23.1

 
20.8

Amounts due to patients and payors
 
19.4

 
20.0

Accrued expenses and other
 
70.5

 
72.1

Total
 
$
191.8

 
$
155.2


Other Long-Term Liabilities
A summary of other long-term liabilities is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease liabilities
 
$
255.7

 
$

Facility lease obligations
 

 
149.8

Other
 
114.3

 
121.5

Total
 
$
370.0

 
$
271.3


At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.
Other Assets and Liabilities
Other Assets and Liabilities
Other Long-Term Assets
A summary of other long-term assets is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease assets
 
$
288.3

 
$

Other
 
30.5

 
36.9

Total
 
$
318.8

 
$
36.9


Other Current Liabilities
A summary of other current liabilities is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Accrued legal settlement
 
$
42.2

 
$
42.3

Right-of-use operating lease liabilities
 
36.6

 

Interest payable
 
23.1

 
20.8

Amounts due to patients and payors
 
19.4

 
20.0

Accrued expenses and other
 
70.5

 
72.1

Total
 
$
191.8

 
$
155.2


Other Long-Term Liabilities
A summary of other long-term liabilities is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease liabilities
 
$
255.7

 
$

Facility lease obligations
 

 
149.8

Other
 
114.3

 
121.5

Total
 
$
370.0

 
$
271.3


At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies
Professional, General and Workers' Compensation Liability Risks
The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.
Insurance Reserves
The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i) claims made during the policy period, which are offset by insurance recoveries and (ii) an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of March 31, 2019 and December 31, 2018 were $18.5 million and $18.2 million, respectively. The balances include expected insurance recoveries of $12.0 million at each of March 31, 2019 and December 31, 2018.
Laws and Regulations
Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.
On October 23, 2017, the Company received several civil investigative demands (“CIDs”) from the federal government under the False Claims Act (“FCA”) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company’s physicians and submitted to laboratories owned and operated by the Company. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS. The Company has been providing information to the government in response to the CIDs and currently has a non-binding agreement in principle with the DOJ on the financial terms of a settlement with the goal of resolving these matters. Based on those discussions, which are still ongoing, the Company recorded a litigation-related charge of $46.0 million relating to these matters on the consolidated statements of operations for the year ended December 31, 2018. The Company believes that this reserve is sufficient to cover a potential resolution with the government relating to these matters, including legal expenses relating to the settlement that have not previously been recorded in operating expenses. The ultimate timing, amount and/or final terms of any such resolution may differ materially from those anticipated or the Company may not be able to reach a resolution at all. It is reasonably possible that the Company will incur additional losses above the amount reserved, but the Company is not able to estimate such amounts at this time. See Item 1A “Risk Factors” in the Company's Annual Report on Form 10-K for the period ended December 31, 2018 under the heading “Risk Factors - Risks Related to Government Regulation - Companies within the healthcare industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims.” 
Acquired Facilities
The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.
The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.
Potential Physician Investor Liability
A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.
Tax Receivable Agreement
On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the “TRA”), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company’s projected realized tax savings over the next six years and are not dependent on the Company’s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 500 basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.
Assuming the Company’s effective tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately $68.2 million and $64.6 million as of March 31, 2019 and December 31, 2018, respectively. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company’s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $52.6 million and $48.5 million as of March 31, 2019 and December 31, 2018, respectively. The current portion of the liability was $8.1 million and $7.6 million as of March 31, 2019 and December 31, 2018, respectively, and was included as a component of other current liabilities in the condensed consolidated balance sheet. The long-term portion was included as a component of other long-term liabilities in the condensed consolidated balance sheets.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Reporting
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting
The Company operates in three major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. The surgical facility services segment consists of the operation of ASCs and surgical hospitals, and includes anesthesia services. The ancillary services segment consists of a diagnostic laboratory and multi-specialty physician practices. The optical services segment consists of an optical products group purchasing organization. "All other" primarily consists of the Company's corporate general and administrative functions.
The following tables present financial information for each reportable segment (in millions):

 
Three Months Ended March 31,

 
2019
 
2018
Revenues:
 
 
 
 
Surgical facility services
 
$
395.8

 
$
388.2

Ancillary services
 
19.9

 
20.1

Optical services
 
1.1

 
3.0

Total
 
$
416.8

 
$
411.3

 
 
 
 
 
Adjusted EBITDA:
 
 
 
 
Surgical facility services
 
$
68.4

 
$
66.5

Ancillary services
 
1.2

 
1.1

Optical services
 
0.5

 
0.8

All other
 
(19.4
)
 
(21.3
)
Total
 
$
50.7

 
$
47.1

 
 
 
 
 
Cash purchases of property and equipment, net:
 
 
 
 
Surgical facility services
 
$
10.9

 
$
7.9

Ancillary services
 
0.1

 
0.2

Optical services
 

 

All other
 
0.8

 
1.9

Total
 
$
11.8

 
$
10.0


A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows (in millions):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Adjusted EBITDA
 
$
50.7

 
$
47.1

Net income attributable to non-controlling interests
 
23.6

 
22.6

Depreciation and amortization
 
(18.8
)
 
(15.7
)
Interest expense, net
 
(42.0
)
 
(34.3
)
Equity-based compensation
 
(1.9
)
 
(2.0
)
Contingent acquisition compensation expense
 

 
(0.5
)
Transaction, integration and acquisition costs (1)
 
(3.4
)
 
(5.5
)
Reserve adjustments (2)
 

 
(4.8
)
Loss on disposals and deconsolidations, net
 
(0.6
)
 

Tax receivable agreement expense
 
(2.4
)
 

Income before income taxes
 
$
5.2

 
$
6.9


(1)
This amount includes transaction and integration costs of $2.0 million and $5.0 million for three months ended March 31, 2019 and 2018, respectively. This amount includes acquisition costs of $0.2 million and $0.5 million for three months ended March 31, 2019 and 2018, respectively. This amount includes start-up costs related to a de novo surgical hospital of $1.2 million for the three months ended March 31, 2019. There were no comparable costs in the 2018 period.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.
 
 
March 31,
2019
 
December 31,
2018
Assets:
 
 
 
 
Surgical facility services
 
$
4,417.8

 
$
4,204.3

Ancillary services
 
82.3

 
52.7

Optical services
 
22.3

 
20.1

All other
 
358.5

 
399.2

Total assets
 
$
4,880.9

 
$
4,676.3

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events
3 Months Ended
Mar. 31, 2019
Subsequent Events [Abstract]  
Subsequent Events
Subsequent Events
As previously disclosed in a Current Report on Form 8-K filed on April 12, 2019, on April 11, 2019, the Company completed the issuance and sale of $430.0 million in gross proceeds of senior unsecured notes due 2027 (the "2027 Unsecured Notes"). The 2027 Unsecured Notes bear interest at the rate of 10.000% per year, payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2019. The 2027 Unsecured Notes are senior unsecured obligations of Surgery Center Holdings, Inc. and are guaranteed on a senior unsecured basis by each of Surgery Center Holdings, Inc.'s existing and future domestic wholly-owned restricted subsidiaries that guarantees the existing 2017 Senior Secured Credit Facilities (subject to certain exceptions). In connection with issuance of the 2027 Unsecured Notes, the Company redeemed in whole the existing 2021 Unsecured Notes. The redemption price was equal to 104.438% of the outstanding principal amount plus accrued and unpaid interest. Additionally, as previously announced, on March 25, 2019, the Company entered into an amendment to the credit agreement governing its revolving credit facility. On April 11, 2019, in connection with the completion of the issuance of the 2027 Unsecured Notes, the outstanding commitments under the Company's revolving credit facility were increased by $45.0 million.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Boards ("FASB") Accounting Standards Codification 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of both March 31, 2019 and December 31, 2018, the consolidated VIEs include four surgical facilities, three anesthesia practices and four physician practices.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.
The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations approximate their fair values under Level 3 calculations.
In 2018, the Company entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activity"). The fair value of these derivative instruments was $33.9 million and $22.4 million at March 31, 2019 and December 31, 2018, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation.
Revenues
Patient service revenues. This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.
Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Other service revenues. Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.
Revenues
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.
Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both March 31, 2019 and December 31, 2018. These restricted investments represents restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities’ cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.
Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of March 31, 2019 and December 31, 2018, the Company had a net third-party Medicaid settlements liability of $7.6 million and $4.8 million, respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient’s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets.
Goodwill
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.
Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Activities
In accordance with Accounting Standards Codification 815, Derivatives and Hedging, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During the first quarter of 2019, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company’s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt.
Non-Controlling Interests—Redeemable
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interestsredeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company’s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.
The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was $18.0 million reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.
The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company’s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.
Leases
On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted.
The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities.
The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years, and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.
Earnings Per Share
Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with ASC 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Carrying Amounts and Fair Values of Long-Term Debt
A summary of the carrying amounts and fair values of the Company's long-term debt follows (in millions):
 
 
Carrying Amount
 
Fair Value
 
 
March 31,
2019
 
December 31,
2018
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
 
 
 
 
Term Loan
 
$
1,444.4

 
$
1,447.9

 
$
1,417.3

 
$
1,382.8

Senior Unsecured Notes due 2021
 
$
406.1

 
$
406.7

 
$
411.2

 
$
407.2

Senior Unsecured Notes due 2025
 
$
370.0

 
$
370.0

 
$
333.0

 
$
320.5


Schedule of Revenues by Service Type
A summary of revenues by service type as a percentage of total revenues follows:
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Patient service revenues:
 
 
 
 
   Surgical facilities revenues
 
93.8
%
 
93.5
%
   Ancillary services revenues
 
4.7
%
 
4.9
%
 
 
98.5
%
 
98.4
%
Other service revenues:
 
 
 
 
   Optical services revenues
 
0.3
%
 
0.7
%
   Other revenues
 
1.2
%
 
0.9
%
 
 
1.5
%
 
1.6
%
Total revenues
 
100.0
%
 
100.0
%
Schedule of Revenue Sources for Patient Service Revenues
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
215.3

 
52.4
%
 
$
216.5

 
53.5
%
Government
 
164.9

 
40.2
%
 
156.9

 
38.8
%
Self-pay
 
10.8

 
2.6
%
 
12.8

 
3.1
%
Other (1)
 
19.8

 
4.8
%
 
18.5

 
4.6
%
Total patient service revenues
 
410.8

 
100.0
%
 
404.7

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
1.1

 
 
 
2.9

 
 
Other revenues
 
4.9

 
 
 
3.7

 
 
Total revenues
 
$
416.8

 
 
 
$
411.3

 
 
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Schedule of Rollforward of Goodwill
A summary of activity related to goodwill for the three months ended March 31, 2019 is as follows (in millions):
Balance at December 31, 2018
 
$
3,382.8

Acquisitions, including post acquisition adjustments
 
10.2

Divestitures and deconsolidations
 

Balance at March 31, 2019
 
$
3,393.0

Schedule of Rollforward of Noncontrolling Interest - Redeemable
A summary of activity related to the non-controlling interests—redeemable is as follows (in millions):
Balance at December 31, 2018
 
$
326.6

Net income attributable to non-controlling interests—redeemable
 
7.6

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
(9.3
)
Distributions to non-controlling interest—redeemable holders
 
(10.3
)
Balance at March 31, 2019
 
$
314.6

(1)
Includes post acquisition date adjustments.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions (Tables)
3 Months Ended
Mar. 31, 2019
Business Combinations [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed
The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):
Cash consideration
 
$
7.6

Fair value of non-controlling interests
 
3.7

Aggregate acquisition date fair value
 
$
11.3

Net assets acquired:
 
 
Current Assets
 
$
0.6

Property and equipment
 
0.2

Goodwill
 
10.6

Current liabilities
 
(0.1
)
Aggregate acquisition date fair value
 
$
11.3

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Long-Term Debt (Tables)
3 Months Ended
Mar. 31, 2019
Debt Disclosure [Abstract]  
Summary of Long-term Debt
A summary of long-term debt is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Revolver
 
$

 
$

Term Loan (1)
 
1,444.4

 
1,447.9

Senior Unsecured Notes due 2021 (2)

406.1

 
406.7

Senior Unsecured Notes due 2025
 
370.0

 
370.0

Notes payable and secured loans
 
79.3

 
79.4

Finance lease obligations (3)
 
144.6

 
25.4

Less: unamortized debt issuance costs and original issue discount
 
(2.7
)
 
(2.9
)
Total debt
 
2,441.7

 
2,326.5

Less: Current maturities
 
57.1

 
55.6

Total long-term debt
 
$
2,384.6

 
$
2,270.9


(1)
Includes unamortized fair value discount of $5.4 million and $5.5 million as of March 31, 2019 and December 31, 2018, respectively.
(2)
Includes unamortized fair value premium of $6.1 million and $6.7 million as of March 31, 2019 and December 31, 2018, respectively.
(3)
In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Leases (Tables)
3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Schedule of Components of Right-of-use Assets and Liabilities Related to Leases
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at March 31, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Balance Sheets
 
March 31, 2019
Assets:
 
 
 
 
Operating lease assets
 
Other long-term assets
 
$
288.3

Finance lease assets
 
Property and equipment, net of accumulated depreciation
 
144.0

Total leased assets
 
 
 
$
432.3

 
 
 
 
 
Liabilities:
 
 
 
 
Operating lease liabilities:
 
 
 
 
Current
 
Other current liabilities
 
$
36.6

Long-term
 
Other long-term liabilities
 
255.7

Total operating lease liabilities
 
 
 
292.3

Finance lease liabilities:
 
 
 
 
Current
 
Current maturities of long-term debt
 
10.2

Long-term
 
Long-term debt, less current maturities
 
134.4

Total finance lease liabilities
 
 
 
144.6

Total lease liabilities
 

 
$
436.9

Schedule of Lease Expense and Cash Flow Information
The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):
 
 
March 31, 2019
Weighted-average remaining lease term (years)
 
 
Operating leases
 
8.4

Finance leases
 
13.4

Weighted-average discount rate
 
 
Operating leases
 
10.2
%
Finance leases
 
10.8
%
 
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Operating cash outflows from operating leases
 
$
16.8

Operating cash outflows from finance leases
 
$
3.8

Financing cash outflows from finance leases
 
$
2.3

 
 
 
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases
 
$
1.2

Finance leases
 
$
2.3


The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the three months ended March 31, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Statement of Operations
 
March 31, 2019
 
 
 
 
 
Operating lease costs
 
Lease expense and general and administrative expenses
 
$
17.5

Finance lease costs
 
 
 
 
Amortization of leased assets
 
Depreciation and amortization
 
4.5

Interest on lease liabilities
 
Interest expense, net
 
3.8

Total finance lease costs
 
 
 
8.3

Variable and short term lease costs
 
Lease expense and general and administrative expenses
 
2.4

Total lease costs
 
 
 
$
28.2

Maturity of Operating Leases
Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
51.2

 
$
20.4

2020
 
60.6

 
24.8

2021
 
52.9

 
22.9

2022
 
48.5

 
20.3

2023
 
45.1

 
18.4

Thereafter
 
187.5

 
187.4

Total lease payments
 
445.8

 
294.2

Less: imputed interest
 
(153.5
)
 
(149.6
)
Total lease obligations
 
$
292.3

 
$
144.6

Maturity of Finance Leases
Future maturities of lease liabilities at March 31, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
51.2

 
$
20.4

2020
 
60.6

 
24.8

2021
 
52.9

 
22.9

2022
 
48.5

 
20.3

2023
 
45.1

 
18.4

Thereafter
 
187.5

 
187.4

Total lease payments
 
445.8

 
294.2

Less: imputed interest
 
(153.5
)
 
(149.6
)
Total lease obligations
 
$
292.3

 
$
144.6

Maturity of Leases Prior to Adoption of 842
Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portions of the finance obligations were $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
Maturity of Leases Prior to Adoption of 842
Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligation payments to the lessors of certain financing obligations payable to the lessors of certain land, buildings and improvements. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portions of the finance obligations were $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Redeemable Preferred Stock (Tables)
3 Months Ended
Mar. 31, 2019
Temporary Equity Disclosure [Abstract]  
Activity Related to Redeemable Preferred Stock
A summary of activity related to the redeemable preferred stock follows (in millions):
Balance at December 31, 2018
 
$
359.3

Dividends accrued
 
8.5

Cash dividends declared
 

Balance at March 31, 2019
 
$
367.8

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Numerator:
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
 
$
(20.1
)
 
$
(17.5
)
Less: amounts allocated to participating securities (1)
 
(8.5
)
 
(7.8
)
Net loss attributable to common stockholders
 
$
(28.6
)
 
$
(25.3
)
 
 
 
 
 
Denominator:
 
 
 
 
Weighted average shares outstanding- basic
 
48,047

 
48,007

Effect of dilutive securities (2)
 

 

Weighted average shares outstanding- diluted
 
48,047

 
48,007

 
 
 
 
 
Loss per share:
 
 
 
 
Basic
 
$
(0.60
)
 
$
(0.53
)
Diluted (2)
 
$
(0.60
)
 
$
(0.53
)
 
 
 
 
 
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
 
 
 
 
Stock options
 

 
123

Restricted shares
 
18

 
58

Convertible preferred stock
 
N/A

 
N/A

(1)
Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.
(2)
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Other Assets and Liabilities (Tables)
3 Months Ended
Mar. 31, 2019
Balance Sheet Related Disclosures [Abstract]  
Schedule of Other Long-term Assets
A summary of other long-term assets is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease assets
 
$
288.3

 
$

Other
 
30.5

 
36.9

Total
 
$
318.8

 
$
36.9

Summary of Other Current Liabilities
A summary of other current liabilities is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Accrued legal settlement
 
$
42.2

 
$
42.3

Right-of-use operating lease liabilities
 
36.6

 

Interest payable
 
23.1

 
20.8

Amounts due to patients and payors
 
19.4

 
20.0

Accrued expenses and other
 
70.5

 
72.1

Total
 
$
191.8

 
$
155.2

Summary of Other Long-term Liabilities
A summary of other long-term liabilities is as follows (in millions):
 
 
March 31,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease liabilities
 
$
255.7

 
$

Facility lease obligations
 

 
149.8

Other
 
114.3

 
121.5

Total
 
$
370.0

 
$
271.3

XML 39 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Schedule of Financial Information by Reportable Segment
The following tables present financial information for each reportable segment (in millions):

 
Three Months Ended March 31,

 
2019
 
2018
Revenues:
 
 
 
 
Surgical facility services
 
$
395.8

 
$
388.2

Ancillary services
 
19.9

 
20.1

Optical services
 
1.1

 
3.0

Total
 
$
416.8

 
$
411.3

 
 
 
 
 
Adjusted EBITDA:
 
 
 
 
Surgical facility services
 
$
68.4

 
$
66.5

Ancillary services
 
1.2

 
1.1

Optical services
 
0.5

 
0.8

All other
 
(19.4
)
 
(21.3
)
Total
 
$
50.7

 
$
47.1

 
 
 
 
 
Cash purchases of property and equipment, net:
 
 
 
 
Surgical facility services
 
$
10.9

 
$
7.9

Ancillary services
 
0.1

 
0.2

Optical services
 

 

All other
 
0.8

 
1.9

Total
 
$
11.8

 
$
10.0

Schedule of Segment Operating Income
A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows (in millions):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
 
 
 
Adjusted EBITDA
 
$
50.7

 
$
47.1

Net income attributable to non-controlling interests
 
23.6

 
22.6

Depreciation and amortization
 
(18.8
)
 
(15.7
)
Interest expense, net
 
(42.0
)
 
(34.3
)
Equity-based compensation
 
(1.9
)
 
(2.0
)
Contingent acquisition compensation expense
 

 
(0.5
)
Transaction, integration and acquisition costs (1)
 
(3.4
)
 
(5.5
)
Reserve adjustments (2)
 

 
(4.8
)
Loss on disposals and deconsolidations, net
 
(0.6
)
 

Tax receivable agreement expense
 
(2.4
)
 

Income before income taxes
 
$
5.2

 
$
6.9


(1)
This amount includes transaction and integration costs of $2.0 million and $5.0 million for three months ended March 31, 2019 and 2018, respectively. This amount includes acquisition costs of $0.2 million and $0.5 million for three months ended March 31, 2019 and 2018, respectively. This amount includes start-up costs related to a de novo surgical hospital of $1.2 million for the three months ended March 31, 2019. There were no comparable costs in the 2018 period.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.
Reconciliation of Assets from Segment to Consolidated
 
 
March 31,
2019
 
December 31,
2018
Assets:
 
 
 
 
Surgical facility services
 
$
4,417.8

 
$
4,204.3

Ancillary services
 
82.3

 
52.7

Optical services
 
22.3

 
20.1

All other
 
358.5

 
399.2

Total assets
 
$
4,880.9

 
$
4,676.3

XML 40 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Organization (Details)
Mar. 31, 2019
surgical_facility
state
Products And Services [Line Items]  
Number of surgical facilities owned 123
Number of states in which entity operates | state 31
Number of surgical facilities owned, majority interest 84
Number of surgical facilities owned, consolidated 106
Facilities, Ambulatory Surgery Centers  
Products And Services [Line Items]  
Number of surgical facilities owned 108
Facilities, Surgical Hospitals  
Products And Services [Line Items]  
Number of surgical facilities owned 15
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Variable Interest Entities (Details)
$ in Millions
Mar. 31, 2019
Anesthesia_Practice
Mar. 31, 2019
surgical_facility
Mar. 31, 2019
physician_practice
Mar. 31, 2019
USD ($)
Dec. 31, 2018
Anesthesia_Practice
Dec. 31, 2018
surgical_facility
Dec. 31, 2018
physician_practice
Dec. 31, 2018
USD ($)
Variable Interest Entity [Line Items]                
Number of facilities included in VIE 3 4 4   3 4 4  
Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure                
Variable Interest Entity [Line Items]                
Total assets related to VIE       $ 11.0       $ 11.2
Total liabilities related to VIE       $ 3.4       $ 3.6
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) - Senior Notes - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Senior Unsecured Notes due 2021    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt $ 406.1 $ 406.7
Senior Unsecured Notes due 2021 | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 406.1 406.7
Senior Unsecured Notes due 2021 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 411.2 407.2
Senior Unsecured Notes due 2025    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 370.0 370.0
Senior Unsecured Notes due 2025 | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 370.0 370.0
Senior Unsecured Notes due 2025 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 333.0 320.5
Revolving Credit Facility | Term Loan | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 1,444.4 1,447.9
Revolving Credit Facility | Term Loan | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt $ 1,417.3 $ 1,382.8
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Interest rate swap agreement $ 33.9 $ 22.4
Fair Value, Inputs, Level 1    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Assets of SERP $ 1.3 $ 1.4
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) - Revenue Source - Revenue
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue from External Customer [Line Items]    
Service revenues as a percentage of total revenues 100.00% 100.00%
Healthcare Organization, Patient Service    
Revenue from External Customer [Line Items]    
Service revenues as a percentage of total revenues 98.50% 98.40%
Surgical Facility Services    
Revenue from External Customer [Line Items]    
Service revenues as a percentage of total revenues 93.80% 93.50%
Ancillary Services    
Revenue from External Customer [Line Items]    
Service revenues as a percentage of total revenues 4.70% 4.90%
Healthcare Organization, Other Service    
Revenue from External Customer [Line Items]    
Service revenues as a percentage of total revenues 1.50% 1.60%
Optical Services    
Revenue from External Customer [Line Items]    
Service revenues as a percentage of total revenues 0.30% 0.70%
Other    
Revenue from External Customer [Line Items]    
Service revenues as a percentage of total revenues 1.20% 0.90%
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Total revenues $ 416.8 $ 411.3
Healthcare Organization, Patient Service    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Total revenues $ 410.8 $ 404.7
Healthcare Organization, Patient Service | Customer | Revenue    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Service revenues as a percentage of total revenues 100.00% 100.00%
Healthcare Organization, Patient Service | Private insurance    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Total revenues $ 215.3 $ 216.5
Healthcare Organization, Patient Service | Private insurance | Customer | Revenue    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Service revenues as a percentage of total revenues 52.40% 53.50%
Healthcare Organization, Patient Service | Government    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Total revenues $ 164.9 $ 156.9
Healthcare Organization, Patient Service | Government | Customer | Revenue    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Service revenues as a percentage of total revenues 40.20% 38.80%
Healthcare Organization, Patient Service | Self-pay    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Total revenues $ 10.8 $ 12.8
Healthcare Organization, Patient Service | Self-pay | Customer | Revenue    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Service revenues as a percentage of total revenues 2.60% 3.10%
Healthcare Organization, Patient Service | Other    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Total revenues $ 19.8 $ 18.5
Healthcare Organization, Patient Service | Other | Customer | Revenue    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Service revenues as a percentage of total revenues 4.80% 4.60%
Optical Services    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Total revenues $ 1.1 $ 2.9
Other    
Health Care Organization, Receivable and Revenue Disclosures [Line Items]    
Total revenues $ 4.9 $ 3.7
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Restricted invested assets included in other long-term assets $ 0.3 $ 0.3
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Third-Party Medicaid settlement liability $ 7.6 $ 4.8
Optical products receivable $ 10.6 $ 8.5
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details)
$ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
Goodwill [Roll Forward]  
Goodwill, beginning of period $ 3,382.8
Acquisitions, including post acquisition adjustments 10.2
Divestitures and deconsolidations 0.0
Goodwill, end of period $ 3,393.0
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)
$ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
Non-Controlling Interests - Redeemable [Roll Forward]  
Beginning balance $ 326.6
Net income attributable to non-controlling interests—redeemable 7.6
Acquisition and disposal of shares of non-controlling interests, net—redeemable (9.3)
Distributions to non-controlling interest—redeemable holders (10.3)
Ending balance $ 314.6
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Accounting Policies - Recent Accounting Pronouncements (Details)
$ in Millions
Jan. 01, 2019
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cumulative effect of accounting change, adjustment to retained deficit $ 18.0
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions - Additional Information (Details)
$ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
physician_practice
Mar. 31, 2018
USD ($)
Business Acquisition [Line Items]    
Payments for acquisitions, net of cash acquired $ 7.6 $ 25.6
Physician Practice    
Business Acquisition [Line Items]    
Payments for acquisitions, net of cash acquired $ 7.6  
Number of businesses acquired | physician_practice 1,000  
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Net assets acquired:    
Goodwill $ 3,393.0 $ 3,382.8
Physician Practice    
Business Acquisition [Line Items]    
Cash consideration 7.6  
Fair value of non-controlling interests 3.7  
Acquisition date fair value 11.3  
Net assets acquired:    
Current Assets 0.6  
Property and equipment 0.2  
Goodwill 10.6  
Current liabilities (0.1)  
Aggregate acquisition date fair value $ 11.3  
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Long-Term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Debt Instrument [Line Items]    
Total lease obligations $ 144.6 $ 25.4
Less: unamortized debt issuance costs and original issue discount (2.7) (2.9)
Total debt 2,441.7 2,326.5
Less: Current maturities 57.1 55.6
Total long-term debt 2,384.6 2,270.9
Unamortized fair value discount (5.4) (5.5)
Unamortized fair value premium 6.1 6.7
Secured Debt | Term Loan    
Debt Instrument [Line Items]    
Long-term debt 1,444.4 1,447.9
Secured Debt | Revolving Credit Facility | Revolver    
Debt Instrument [Line Items]    
Long-term debt 0.0 0.0
Senior Notes | Senior Unsecured Notes Due 2021    
Debt Instrument [Line Items]    
Long-term debt 406.1 406.7
Senior Notes | Senior Unsecured Notes Due 2025    
Debt Instrument [Line Items]    
Long-term debt 370.0 370.0
Notes payable and secured loans    
Debt Instrument [Line Items]    
Long-term debt $ 79.3 $ 79.4
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Assets:    
Operating lease assets $ 288.3 $ 0.0
Finance lease assets 144.0  
Total leased assets 432.3  
Operating lease liabilities:    
Current 36.6 0.0
Long-term 255.7 0.0
Total operating lease liabilities 292.3  
Finance lease liabilities:    
Current 10.2 7.0
Long-term 134.4 149.8
Total finance lease liabilities 144.6 $ 25.4
Total lease liabilities $ 436.9  
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Lease Expense and Cash Flow Information (Details)
$ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
Lessee, Lease, Description [Line Items]  
Operating lease costs $ 17.5
Finance lease costs  
Amortization of leased assets 4.5
Interest on lease liabilities 3.8
Total finance lease costs 8.3
Variable and short term lease costs 2.4
Total lease costs $ 28.2
Weighted-average remaining lease term, operating leases 8 years 5 months
Weighted-average remaining lease term, finance leases 13 years 5 months
Weighted-average discount rate, operating leases 10.20%
Weighted-average discount rate, finance leases 10.80%
Operating cash outflows from operating leases $ 16.8
Operating cash outflows from finance leases 3.8
Financing cash outflows from finance leases 2.3
Right-of-use assets obtained in exchange for operating leases 1.2
Right-of-use assets obtained in exchange for finance leases 2.3
Physician Investors  
Lessee, Lease, Description [Line Items]  
Operating lease costs 5.2
Noncontrolling Interest  
Finance lease costs  
Rent paid under finance lease agreement, allocated to principal and interest $ 1.6
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Maturities of Lease Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Operating Leases    
2019 $ 51.2  
2020 60.6  
2021 52.9  
2022 48.5  
2023 45.1  
Thereafter 187.5  
Total lease payments 445.8  
Less: imputed interest (153.5)  
Total lease obligations 292.3  
Finance Leases    
2019 20.4  
2020 24.8  
2021 22.9  
2022 20.3  
2023 18.4  
Thereafter 187.4  
Total lease payments 294.2  
Less: imputed interest (149.6)  
Total lease obligations $ 144.6 $ 25.4
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Maturities of Leases Prior to Adoption of 842 (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Operating Leases (1)    
2019   $ 81.5
2020   75.6
2021   66.7
2022   61.3
2023   57.2
Thereafter   470.2
Total lease payments   812.5
Capital Leases    
2019   8.8
2020   6.7
2021   4.7
2022   2.9
2023   1.5
Thereafter   4.3
Total lease payments   28.9
Less: imputed interest   (3.5)
Capital lease obligations   25.4
Current portion of finance lease $ 10.2 7.0
Noncurrent portion of finance lease $ 134.4 $ 149.8
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.19.1
Redeemable Preferred Stock - Additional Information (Details) - Series A Preferred Stock - USD ($)
3 Months Ended
Aug. 31, 2017
Mar. 31, 2019
Dec. 31, 2018
Temporary Equity [Line Items]      
Dividends payable   $ 0 $ 0
Cumulative preferred dividends   $ 42,300,000  
Preferred dividends payable (in USD per share)   $ 136.31  
Majority Shareholder      
Temporary Equity [Line Items]      
Stock issued during period (shares) 310,000    
Purchase price per share (in USD per share) $ 1,000    
Proceeds from issuance of preferred shares $ 310,000,000    
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.19.1
Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details)
$ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
Increase (Decrease) in Temporary Equity [Roll Forward]  
Beginning balance $ 359.3
Ending balance 367.8
Series A Preferred Stock  
Increase (Decrease) in Temporary Equity [Roll Forward]  
Beginning balance 359.3
Dividends accrued 8.5
Cash dividends declared 0.0
Ending balance $ 367.8
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.19.1
Derivatives and Hedging Activities (Details)
$ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
swap
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]  
Estimated reduction to interest expense $ 6.6
Number of interest rate swaps | swap 3
Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect $ 12.8
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect 1.3
Interest Rate Swap One  
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]  
Derivative notional amount $ 900.0
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings Per Share (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 15, 2017
Numerator:      
Net loss attributable to Surgery Partners, Inc. $ (20,100,000) $ (17,500,000)  
Less: amounts allocated to participating securities (8,500,000) (7,800,000)  
Net loss attributable to common stockholders $ (28,600,000) $ (25,300,000)  
Denominator:      
Weighted average shares outstanding- basic (shares) 48,047,000 48,007,000  
Effect of dilutive securities (shares) 0 0  
Weighted average shares outstanding- diluted (shares) [1] 48,047,000 48,007,000  
Loss per share:      
Basic (in USD per share) $ (0.60) $ (0.53)  
Diluted (in USD per share) [1] $ (0.60) $ (0.53)  
Authorized share repurchase amount     $ 50,000,000.0
Stock repurchased (shares) 0 156,818  
Average repurchase cost (in USD per share)   $ 12.64  
Remaining repurchase authorization available $ 46,000,000    
Stock options      
Loss per share:      
Antidilutive securities excluded from computation of (loss) per share (shares) 0 123,000  
Restricted shares      
Loss per share:      
Antidilutive securities excluded from computation of (loss) per share (shares) 18,000 58,000  
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.19.1
Other Assets and Liabilities - Other Long-term Assets (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]    
Right-of-use operating lease assets $ 288.3 $ 0.0
Other 30.5 36.9
Total $ 318.8 $ 36.9
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.19.1
Other Assets and Liabilities - Other Current Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]    
Accrued legal settlement $ 42.2 $ 42.3
Right-of-use operating lease liabilities 36.6 0.0
Interest payable 23.1 20.8
Amounts due to patients and payors 19.4 20.0
Accrued expenses and other 70.5 72.1
Total $ 191.8 $ 155.2
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.19.1
Other Assets and Liabilities - Other Long-Term Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]    
Right-of-use operating lease liabilities $ 255.7 $ 0.0
Facility lease obligations 0.0 149.8
Other 114.3 121.5
Total $ 370.0 $ 271.3
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Guarantor Obligations [Line Items]    
Professional, general and workers' compensation insurance reserve $ 18.5 $ 18.2
Expected insurance recoveries $ 12.0 12.0
Litigation related charge   46.0
Federal effective tax rate 24.00%  
Long-term tax receivable agreement liability $ 68.2 64.6
Net long-term tax receivable agreement liability 52.6 48.5
Current portion of tax liability $ 8.1 $ 7.6
Materially More Restrictive | LIBOR    
Guarantor Obligations [Line Items]    
Debt instrument, basis spread on variable rate 5.00%  
Not Materially More Restrictive | LIBOR    
Guarantor Obligations [Line Items]    
Debt instrument, basis spread on variable rate 3.00%  
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Reporting - Revenues and Purchases of Property and Equipment by Reportable Segment (Details)
$ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
segment
Mar. 31, 2018
USD ($)
Segment Reporting [Abstract]    
Number of operating segments | segment 3  
Segment Reporting Information [Line Items]    
Revenues $ 416.8 $ 411.3
Adjusted EBITDA 50.7 47.1
Purchases of property and equipment, net 11.8 10.0
Operating Segments | Surgical Facility Services    
Segment Reporting Information [Line Items]    
Revenues 395.8 388.2
Adjusted EBITDA 68.4 66.5
Purchases of property and equipment, net 10.9 7.9
Operating Segments | Ancillary Services    
Segment Reporting Information [Line Items]    
Revenues 19.9 20.1
Adjusted EBITDA 1.2 1.1
Purchases of property and equipment, net 0.1 0.2
Operating Segments | Optical Services    
Segment Reporting Information [Line Items]    
Revenues 1.1 3.0
Adjusted EBITDA 0.5 0.8
Purchases of property and equipment, net 0.0 0.0
All Other    
Segment Reporting Information [Line Items]    
Adjusted EBITDA (19.4) (21.3)
Purchases of property and equipment, net $ 0.8 $ 1.9
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Reporting - Segment Operating Income (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Segment Reporting [Abstract]    
Adjusted EBITDA $ 50,700,000 $ 47,100,000
Net income attributable to non-controlling interests 23,600,000 22,600,000
Depreciation and amortization (18,800,000) (15,700,000)
Interest expense, net (42,000,000) (34,300,000)
Equity-based compensation (1,900,000) (2,000,000)
Contingent acquisition compensation expense 0 (500,000)
Transaction, integration and practice acquisition costs (3,400,000) (5,500,000)
Reserve adjustments 0 (4,800,000)
Loss on disposals and deconsolidations, net (600,000) 0
Tax receivable agreement expense (2,400,000) 0
Income before income taxes 5,200,000 6,900,000
Transaction and integration costs 2,000,000 5,000,000
Practice acquisition costs 200,000 500,000
Start-up costs related to de novo surgical hospital $ 1,200,000 $ 0
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Reporting - Assets by Operating Segment (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Segment Reporting Information [Line Items]    
Assets $ 4,880.9 $ 4,676.3
Operating Segments | Surgical Facility Services    
Segment Reporting Information [Line Items]    
Assets 4,417.8 4,204.3
Operating Segments | Ancillary Services    
Segment Reporting Information [Line Items]    
Assets 82.3 52.7
Operating Segments | Optical Services    
Segment Reporting Information [Line Items]    
Assets 22.3 20.1
All Other    
Segment Reporting Information [Line Items]    
Assets $ 358.5 $ 399.2
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events (Details) - Subsequent Event
Apr. 11, 2019
USD ($)
Senior Notes | Senior Unsecured Notes, Due 2027  
Subsequent Event [Line Items]  
Face value of debt issued $ 430,000,000.0
Stated interest rate 10.00%
Senior Notes | Senior Unsecured Notes Due 2021  
Subsequent Event [Line Items]  
Redemption price of debt 104.438%
Revolving Credit Facility | Secured Debt | Revolver  
Subsequent Event [Line Items]  
Outstanding commitments under revolving credit facility $ 45,000,000
XML 70 R9999.htm IDEA: XBRL DOCUMENT v3.19.1
Label Element Value
Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ 18,000,000
EXCEL 71 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 72 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 73 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 140 304 1 true 50 0 false 10 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.surgerypartners.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.surgerypartners.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001001 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.surgerypartners.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1004000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 1005000 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1006000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - Organization and Summary of Accounting Policies Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPolicies Organization and Summary of Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - Acquisitions Sheet http://www.surgerypartners.com/role/Acquisitions Acquisitions Notes 9 false false R10.htm 2103100 - Disclosure - Long-Term Debt Sheet http://www.surgerypartners.com/role/LongTermDebt Long-Term Debt Notes 10 false false R11.htm 2104100 - Disclosure - Leases Sheet http://www.surgerypartners.com/role/Leases Leases Notes 11 false false R12.htm 2105100 - Disclosure - Redeemable Preferred Stock Sheet http://www.surgerypartners.com/role/RedeemablePreferredStock Redeemable Preferred Stock Notes 12 false false R13.htm 2106100 - Disclosure - Derivatives and Hedging Activities Sheet http://www.surgerypartners.com/role/DerivativesAndHedgingActivities Derivatives and Hedging Activities Notes 13 false false R14.htm 2107100 - Disclosure - Earnings Per Share Sheet http://www.surgerypartners.com/role/EarningsPerShare Earnings Per Share Notes 14 false false R15.htm 2108100 - Disclosure - Other Assets and Liabilities Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilities Other Assets and Liabilities Notes 15 false false R16.htm 2109100 - Disclosure - Commitments and Contingencies Sheet http://www.surgerypartners.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 2110100 - Disclosure - Segment Reporting Sheet http://www.surgerypartners.com/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 2114100 - Disclosure - Subsequent Events Sheet http://www.surgerypartners.com/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 2201201 - Disclosure - Organization and Summary of Accounting Policies (Policies) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesPolicies Organization and Summary of Accounting Policies (Policies) Policies http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPolicies 19 false false R20.htm 2301302 - Disclosure - Organization and Summary of Accounting Policies (Tables) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesTables Organization and Summary of Accounting Policies (Tables) Tables http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPolicies 20 false false R21.htm 2302301 - Disclosure - Acquisitions (Tables) Sheet http://www.surgerypartners.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.surgerypartners.com/role/Acquisitions 21 false false R22.htm 2303301 - Disclosure - Long-Term Debt (Tables) Sheet http://www.surgerypartners.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.surgerypartners.com/role/LongTermDebt 22 false false R23.htm 2304301 - Disclosure - Leases (Tables) Sheet http://www.surgerypartners.com/role/LeasesTables Leases (Tables) Tables http://www.surgerypartners.com/role/Leases 23 false false R24.htm 2305301 - Disclosure - Redeemable Preferred Stock (Tables) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockTables Redeemable Preferred Stock (Tables) Tables http://www.surgerypartners.com/role/RedeemablePreferredStock 24 false false R25.htm 2307301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.surgerypartners.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.surgerypartners.com/role/EarningsPerShare 25 false false R26.htm 2308301 - Disclosure - Other Assets and Liabilities (Tables) Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilitiesTables Other Assets and Liabilities (Tables) Tables http://www.surgerypartners.com/role/OtherAssetsAndLiabilities 26 false false R27.htm 2310301 - Disclosure - Segment Reporting (Tables) Sheet http://www.surgerypartners.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.surgerypartners.com/role/SegmentReporting 27 false false R28.htm 2401403 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesOrganizationDetails Organization and Summary of Accounting Policies - Organization (Details) Details 28 false false R29.htm 2401404 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesVariableInterestEntitiesDetails Organization and Summary of Accounting Policies - Variable Interest Entities (Details) Details 29 false false R30.htm 2401405 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesCarryingAmountAndFairValueOfLongTermDebtDetails Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) Details 30 false false R31.htm 2401406 - Disclosure - Organization and Summary of Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesFairValueOfFinancialInstrumentsNarrativeDetails Organization and Summary of Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) Details 31 false false R32.htm 2401407 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesScheduleOfRevenuesByServiceTypeDetails Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) Details 32 false false R33.htm 2401408 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesScheduleOfRevenuesBySourcesDetails Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) Details 33 false false R34.htm 2401409 - Disclosure - Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) Details 34 false false R35.htm 2401410 - Disclosure - Organization and Summary of Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesAccountsReceivableAndAllowancesForContractualAdjustmentsAndDoubtfulAccountsDetails Organization and Summary of Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) Details 35 false false R36.htm 2401411 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesRollforwardOfGoodwillAndInformationOnImpairmentsDetails Organization and Summary of Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) Details 36 false false R37.htm 2401412 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesScheduleOfNonControllingInterestsRedeemableDetails Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) Details 37 false false R38.htm 2401413 - Disclosure - Organization and Summary of Accounting Policies - Recent Accounting Pronouncements (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesRecentAccountingPronouncementsDetails Organization and Summary of Accounting Policies - Recent Accounting Pronouncements (Details) Details 38 false false R39.htm 2402402 - Disclosure - Acquisitions - Additional Information (Details) Sheet http://www.surgerypartners.com/role/AcquisitionsAdditionalInformationDetails Acquisitions - Additional Information (Details) Details 39 false false R40.htm 2402403 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details) Sheet http://www.surgerypartners.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails Acquisitions - Assets Acquired and Liabilities Assumed (Details) Details 40 false false R41.htm 2403402 - Disclosure - Long-Term Debt (Details) Sheet http://www.surgerypartners.com/role/LongTermDebtDetails Long-Term Debt (Details) Details http://www.surgerypartners.com/role/LongTermDebtTables 41 false false R42.htm 2404402 - Disclosure - Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details) Sheet http://www.surgerypartners.com/role/LeasesComponentsOfRightOfUsAssetsAndLiabilitiesRelatedToLeasesDetails Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details) Details 42 false false R43.htm 2404403 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details) Sheet http://www.surgerypartners.com/role/LeasesLeaseExpenseAndCashFlowInformationDetails Leases - Lease Expense and Cash Flow Information (Details) Details 43 false false R44.htm 2404404 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.surgerypartners.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 44 false false R45.htm 2404405 - Disclosure - Leases - Maturities of Leases Prior to Adoption of 842 (Details) Sheet http://www.surgerypartners.com/role/LeasesMaturitiesOfLeasesPriorToAdoptionOf842Details Leases - Maturities of Leases Prior to Adoption of 842 (Details) Details 45 false false R46.htm 2405402 - Disclosure - Redeemable Preferred Stock - Additional Information (Details) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockAdditionalInformationDetails Redeemable Preferred Stock - Additional Information (Details) Details 46 false false R47.htm 2405403 - Disclosure - Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockRedeemablePreferredStockActivityDetails Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) Details 47 false false R48.htm 2406401 - Disclosure - Derivatives and Hedging Activities (Details) Sheet http://www.surgerypartners.com/role/DerivativesAndHedgingActivitiesDetails Derivatives and Hedging Activities (Details) Details http://www.surgerypartners.com/role/DerivativesAndHedgingActivities 48 false false R49.htm 2407402 - Disclosure - Earnings Per Share (Details) Sheet http://www.surgerypartners.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.surgerypartners.com/role/EarningsPerShareTables 49 false false R50.htm 2408402 - Disclosure - Other Assets and Liabilities - Other Long-term Assets (Details) Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilitiesOtherLongTermAssetsDetails Other Assets and Liabilities - Other Long-term Assets (Details) Details 50 false false R51.htm 2408403 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details) Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilitiesOtherCurrentLiabilitiesDetails Other Assets and Liabilities - Other Current Liabilities (Details) Details 51 false false R52.htm 2408404 - Disclosure - Other Assets and Liabilities - Other Long-Term Liabilities (Details) Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilitiesOtherLongTermLiabilitiesDetails Other Assets and Liabilities - Other Long-Term Liabilities (Details) Details 52 false false R53.htm 2409401 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.surgerypartners.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.surgerypartners.com/role/CommitmentsAndContingencies 53 false false R54.htm 2410402 - Disclosure - Segment Reporting - Revenues and Purchases of Property and Equipment by Reportable Segment (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingRevenuesAndPurchasesOfPropertyAndEquipmentByReportableSegmentDetails Segment Reporting - Revenues and Purchases of Property and Equipment by Reportable Segment (Details) Details 54 false false R55.htm 2410403 - Disclosure - Segment Reporting - Segment Operating Income (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingSegmentOperatingIncomeDetails Segment Reporting - Segment Operating Income (Details) Details 55 false false R56.htm 2410404 - Disclosure - Segment Reporting - Assets by Operating Segment (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingAssetsByOperatingSegmentDetails Segment Reporting - Assets by Operating Segment (Details) Details 56 false false R57.htm 2414401 - Disclosure - Subsequent Events (Details) Sheet http://www.surgerypartners.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.surgerypartners.com/role/SubsequentEvents 57 false false R9999.htm Uncategorized Items - sgry-20190331.xml Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - sgry-20190331.xml Cover 58 false false All Reports Book All Reports sgry-20190331.xml sgry-20190331.xsd sgry-20190331_cal.xml sgry-20190331_def.xml sgry-20190331_lab.xml sgry-20190331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/invest/2013-01-31 true true ZIP 76 0001638833-19-000038-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001638833-19-000038-xbrl.zip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�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

>IK(Y M *LWSX=!614QSTH+6:%>H5[ID1:A49A4=B$=TH.G"IT:"4R[19QR>&+AC1.W M]V]7>,,V*_7,Q5&4( D&209))DS2*:"@;P%L_^S7/59RHL$$\[G>'J;*^2H"E+2][(^50?R"R]M.9%.*LT@@;(C2." M5W%9!5P.@UB6R+B$LG:^C=FO)64Y,J( ?>*)#TGVDH#C+ 2I/N7!4F@)GBW- M*^C<[:<=Y$=TT!SO4[?5[<"@AT8/FRF["?$W)L0[65PO3HN(18PS$:%UJ9Y_ M],S@OKE\4'\4S5\YFZ;>5-4M'S=?^:G/7M".].5P/R:S4O!>TR(@">EY!UX1.KZ6Z\3\L)$_7=?YU%_>$^> M8]>3[TH0.)0^'PYS>_*3E=>)N)U7@W/3UY'4S@_@.?CB^9:+]L\*Z\N>$9)KJ?23/5.0 MJ,.(F#"V(CW9J<(+)+

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�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end